Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Diseases

  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 860 articles:
HTML format

Single Articles

    January 2021
  1. SPOGIS J, Hagen F, Thaiss WM, Hoffmann T, et al
    Sonographic findings in coronavirus disease-19 associated liver damage.
    PLoS One. 2021;16:e0244781.
    PubMed     Abstract available

  2. OHIRA S, Kanayama N, Wada K, Ikawa T, et al
    Improvement of image quality and assessment of respiratory motion for hepatocellular carcinoma with portal vein tumor thrombosis using contrast-enhanced four-dimensional dual-energy computed tomography.
    PLoS One. 2021;16:e0244079.
    PubMed     Abstract available

  3. ZHAO N, Tan H, Wang L, Han L, et al
    Palmitate induces fat accumulation via repressing FoxO1-mediated ATGL-dependent lipolysis in HepG2 hepatocytes.
    PLoS One. 2021;16:e0243938.
    PubMed     Abstract available

  4. SETO WK, Mandell MS
    Chronic liver disease: Global perspectives and future challenges to delivering quality health care.
    PLoS One. 2021;16:e0243607.

  5. YEN YH, Cheng YF, Wang JH, Lin CC, et al
    Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosis: When East meets West.
    PLoS One. 2021;16:e0244939.
    PubMed     Abstract available

  6. LI X, Zhong X, Wang Y, Zeng X, et al
    Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0250602.
    PubMed     Abstract available

  7. FERSTL PG, Filmann N, Heilgenthal EM, Schnitzbauer AA, et al
    Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidates.
    PLoS One. 2021;16:e0245091.
    PubMed     Abstract available

  8. DA FONSECA RD, Santos PR, Monteiro MS, Fernandes LA, et al
    Parametric evaluation of impedance curve in radiofrequency ablation: A quantitative description of the asymmetry and dynamic variation of impedance in bovine ex vivo model.
    PLoS One. 2021;16:e0245145.
    PubMed     Abstract available

  9. FRANKOVA S, Lunova M, Gottfriedova H, Senkerikova R, et al
    Liver stiffness measured by two-dimensional shear-wave elastography predicts hepatic vein pressure gradient at high values in liver transplant candidates with advanced liver cirrhosis.
    PLoS One. 2021;16:e0244934.
    PubMed     Abstract available

  10. WANG F, Numata K, Takeda A, Ogushi K, et al
    Safety and efficacy study: Short-term application of radiofrequency ablation and stereotactic body radiotherapy for Barcelona Clinical Liver Cancer stage 0-B1 hepatocellular carcinoma.
    PLoS One. 2021;16:e0245076.
    PubMed     Abstract available

  11. CARTER JK, Bhattacharya D, Borgerding JN, Fiel MI, et al
    Modeling dysbiosis of human NASH in mice: Loss of gut microbiome diversity and overgrowth of Erysipelotrichales.
    PLoS One. 2021;16:e0244763.
    PubMed     Abstract available

  12. JOBIRA B, Frank DN, Silveira LJ, Pyle L, et al
    Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome.
    PLoS One. 2021;16:e0245219.
    PubMed     Abstract available

  13. FATTAHI N, Rezaei N, Asadi-Lari M, Yousefi M, et al
    Hepatocellular carcinoma incidence at national and provincial levels in Iran from 2000 to 2016: A meta-regression analysis.
    PLoS One. 2021;16:e0245468.
    PubMed     Abstract available

  14. VAN AMERONGEN MJ, Vos AM, van der Woude W, Nagtegaal ID, et al
    Does perfusion computed tomography correlate to pathology in colorectal liver metastases?
    PLoS One. 2021;16:e0245764.
    PubMed     Abstract available

  15. CHENG K, Liu W, You J, Shah S, et al
    Safety of laparoscopic pancreaticoduodenectomy in patients with liver cirrhosis using propensity score matching.
    PLoS One. 2021;16:e0246364.
    PubMed     Abstract available

  16. CHO Y, Lee S, Park SJ
    Effectiveness of intraprocedural dual-phase cone-beam computed tomography in detecting hepatocellular carcinoma and improving treatment outcomes following conventional transarterial chemoembolization.
    PLoS One. 2021;16:e0245911.
    PubMed     Abstract available

  17. LIN X, You F, Liu H, Fang Y, et al
    Site-specific risk of colorectal neoplasms in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0245921.
    PubMed     Abstract available

  18. CHEN BW, Chiu GW, He YC, Huang CY, et al
    Extracellular and intracellular intermittent magnetic-fluid hyperthermia treatment of SK-Hep1 hepatocellular carcinoma cells based on magnetic nanoparticles coated with polystyrene sulfonic acid.
    PLoS One. 2021;16:e0245286.
    PubMed     Abstract available

  19. NIRIELLA MA, Ediriweera DS, Kasturiratne A, De Silva ST, et al
    Outcomes of NAFLD and MAFLD: Results from a community-based, prospective cohort study.
    PLoS One. 2021;16:e0245762.
    PubMed     Abstract available

    January 2020
  20. KLEIN WM, Sonnemans LJP, Franckenberg S, Fliss B, et al
    Pseudolesion in the right parafissural liver parenchyma on CT: The base is found in embryology and collagen content.
    PLoS One. 2020;15:e0221544.
    PubMed     Abstract available

  21. LEE JM, Park YM, Yun JS, Ahn YB, et al
    The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study.
    PLoS One. 2020;15:e0226351.
    PubMed     Abstract available

  22. JUN BG, Lee WC, Jang JY, Jeong SW, et al
    Relation of fibroblast growth factor receptor 2 expression to hepatocellular carcinoma recurrence after liver resection.
    PLoS One. 2020;15:e0227440.
    PubMed     Abstract available

  23. LIN Y, Li H, Jin C, Wang H, et al
    The diagnostic accuracy of liver fibrosis in non-viral liver diseases using acoustic radiation force impulse elastography: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0227358.
    PubMed     Abstract available

  24. RAHMAN MM, Zhang C, Swe KT, Rahman MS, et al
    Disease-specific out-of-pocket healthcare expenditure in urban Bangladesh: A Bayesian analysis.
    PLoS One. 2020;15:e0227565.
    PubMed     Abstract available

  25. DU S, Yang JZ, Chen J, Zhou WG, et al
    Comparisons of recurrence-free survival and overall survival between microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: A multiple centers retrospective cohort study with propensity score matching.
    PLoS One. 2020;15:e0227242.
    PubMed     Abstract available

  26. HAUBOLD J, Ludwig JM, Li Y, Buechter M, et al
    Measuring the density of iodine depositions: Detecting an invisible residual tumor after conventional transarterial chemoembolization.
    PLoS One. 2020;15:e0227972.
    PubMed     Abstract available

  27. MATSUMOTO M, Yashiro H, Ogino H, Aoyama K, et al
    Acetyl-CoA carboxylase 1 and 2 inhibition ameliorates steatosis and hepatic fibrosis in a MC4R knockout murine model of nonalcoholic steatohepatitis.
    PLoS One. 2020;15:e0228212.
    PubMed     Abstract available

  28. RAIGANI S, Karimian N, Huang V, Zhang AM, et al
    Metabolic and lipidomic profiling of steatotic human livers during ex situ normothermic machine perfusion guides resuscitation strategies.
    PLoS One. 2020;15:e0228011.
    PubMed     Abstract available

  29. TSUKUDA S, Ikeura T, Ito T, Nakamaru K, et al
    Clinical implications of elevated serum interleukin-6 in IgG4-related disease.
    PLoS One. 2020;15:e0227479.
    PubMed     Abstract available

  30. OKAMOTO K, Koda M, Okamoto T, Onoyama T, et al
    Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease.
    PLoS One. 2020;15:e0219412.
    PubMed     Abstract available

  31. ARTHUIS C, Diguisto C, Lorphelin H, Dochez V, et al
    Perinatal outcomes of intrahepatic cholestasis during pregnancy: An 8-year case-control study.
    PLoS One. 2020;15:e0228213.
    PubMed     Abstract available

  32. YANG B, Liang J, Qu Z, Yang F, et al
    Transarterial strategies for the treatment of unresectable hepatocellular carcinoma: A systematic review.
    PLoS One. 2020;15:e0227475.
    PubMed     Abstract available

  33. LANZA E, Muglia R, Bolengo I, Poretti D, et al
    Survival analysis of 230 patients with unresectable hepatocellular carcinoma treated with bland transarterial embolization.
    PLoS One. 2020;15:e0227711.
    PubMed     Abstract available

  34. SEO JY, Lee JE, Chung GE, Shin E, et al
    A genome-wide association study on liver enzymes in Korean population.
    PLoS One. 2020;15:e0229374.
    PubMed     Abstract available

  35. DIAZ-RIVERA A, Meza-Rios A, Chagoya de Sanchez V, Velasco-Loyden G, et al
    Hydrodynamics-based liver transfection achieves gene silencing of CB1 using short hairpin RNA plasmid in cirrhotic rats.
    PLoS One. 2020;15:e0228729.
    PubMed     Abstract available

  36. VAZQUEZ C, Gonzalez ML, Ferraris A, Bandi JC, et al
    Bevacizumab for treating Hereditary Hemorrhagic Telangiectasia patients with severe hepatic involvement or refractory anemia.
    PLoS One. 2020;15:e0228486.
    PubMed     Abstract available

  37. DINIZ MFHS, Beleigoli AMR, Bensenor IM, Lotufo PA, et al
    Association between TSH levels within the reference range and adiposity markers at the baseline of the ELSA-Brasil study.
    PLoS One. 2020;15:e0228801.
    PubMed     Abstract available

  38. LIANG X, Shu W, Linyong Z, Jianshui L, et al
    Preoperative nutritional evaluation of patients with hepatic alveolar echinococcosis.
    PLoS One. 2020;15:e0229396.
    PubMed     Abstract available

  39. CHANG TS, Tsai YH, Lin YH, Chen CH, et al
    Limited effects of antibiotic prophylaxis in patients with Child-Pugh class A/B cirrhosis and upper gastrointestinal bleeding.
    PLoS One. 2020;15:e0229101.
    PubMed     Abstract available

  40. GIANNELLI G, Santoro A, Kelley RK, Gane E, et al
    Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-betaRI inhibitor galunisertib.
    PLoS One. 2020;15:e0222259.
    PubMed     Abstract available

  41. ZHANG J, Chen G, Zhang P, Zhang J, et al
    The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0228857.
    PubMed     Abstract available

  42. KELLER LM, Eighmy S, Li C, Winter L, et al
    Association of novel markers of liver disease with neonatal liver disease in premature baboons, Papio sp.
    PLoS One. 2020;15:e0228985.
    PubMed     Abstract available

  43. DING W, Tan Y, Qian Y, Xue W, et al
    First-line targ veted therapies of advanced hepatocellular carcinoma: A Bayesian network analysis of randomized controlled trials.
    PLoS One. 2020;15:e0229492.
    PubMed     Abstract available

  44. MOON AM, Jiang Y, Rogal SS, Becker J, et al
    In inpatients with cirrhosis opioid use is common and associated with length of stay and persistent use post-discharge.
    PLoS One. 2020;15:e0229497.
    PubMed     Abstract available

  45. LIN N, Li J, Ke Q, Xin F, et al
    Does the intermittent Pringle maneuver affect the recurrence following surgical resection for hepatocellular carcinoma? A systematic review.
    PLoS One. 2020;15:e0229870.
    PubMed     Abstract available

  46. CHOI J, Lee D, Shim JH, Kim KM, et al
    Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma.
    PLoS One. 2020;15:e0229696.
    PubMed     Abstract available

  47. WARD MD, King MA, Gabrial C, Kenefick RW, et al
    Biochemical recovery from exertional heat stroke follows a 16-day time course.
    PLoS One. 2020;15:e0229616.
    PubMed     Abstract available

  48. MITCHELL RA, Rathi S, Dahiya M, Zhu J, et al
    Public awareness of acetaminophen and risks of drug induced liver injury: Results of a large outpatient clinic survey.
    PLoS One. 2020;15:e0229070.
    PubMed     Abstract available

  49. YANG G, Zhang M, Zhao Y, Pan Y, et al
    HNF-4alpha inhibits hepatocellular carcinoma cell proliferation through mir-122-adam17 pathway.
    PLoS One. 2020;15:e0230450.
    PubMed     Abstract available

  50. DIEDRICH T, Kummer S, Galante A, Drolz A, et al
    Characterization of the immune cell landscape of patients with NAFLD.
    PLoS One. 2020;15:e0230307.
    PubMed     Abstract available

  51. YEN YH, Cheng YF, Wang JH, Lin CC, et al
    Real world clinical practice in treating advanced hepatocellular carcinoma: When East meets West.
    PLoS One. 2020;15:e0230005.
    PubMed     Abstract available

  52. HEINTZ MM, McRee R, Kumar R, Baldwin WS, et al
    Gender differences in diet-induced steatotic disease in Cyp2b-null mice.
    PLoS One. 2020;15:e0229896.
    PubMed     Abstract available

  53. USON PLS JUNIOR, Tolentino FDS, Santos VM, Rother ET, et al
    The impact of metastatic sites in advanced pancreatic adenocarcinoma, systematic review and meta-analysis of prospective randomized studies.
    PLoS One. 2020;15:e0230060.
    PubMed     Abstract available

  54. OKUBO H, Ando H, Ishizuka K, Kitagawa R, et al
    Carnitine insufficiency is associated with fatigue during lenvatinib treatment in patients with hepatocellular carcinoma.
    PLoS One. 2020;15:e0229772.
    PubMed     Abstract available

  55. THURING J, Kuhl CK, Barabasch A, Hitpass L, et al
    Signal changes in T2-weighted MRI of liver metastases under bevacizumab-A practical imaging biomarker?
    PLoS One. 2020;15:e0230553.
    PubMed     Abstract available

  56. RAINES MILENKOV A, Felini M, Baker E, Acharya R, et al
    Uptake of cancer screenings among a multiethnic refugee population in North Texas, 2014-2018.
    PLoS One. 2020;15:e0230675.
    PubMed     Abstract available

  57. LIU YW, Lin CC, Yong CC, Wang CC, et al
    Prognosis after resection of single large hepatocellular carcinoma: Results from an Asian high-volume liver surgery center.
    PLoS One. 2020;15:e0230897.
    PubMed     Abstract available

  58. LI S, Feng X, Cao G, Wang Q, et al
    Prognostic significance of inflammatory indices in hepatocellular carcinoma treated with transarterial chemoembolization: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0230879.
    PubMed     Abstract available

  59. ZHANG F, Zhu Y, Wu S, Hou G, et al
    MLK3 is a newly identified microRNA-520b target that regulates liver cancer cell migration.
    PLoS One. 2020;15:e0230716.
    PubMed     Abstract available

  60. MIKHAIL AS, Mauda-Havakuk M, Partanen A, Karanian JW, et al
    Liver-specific 3D sectioning molds for correlating in vivo CT and MRI with tumor histopathology in woodchucks (Marmota monax).
    PLoS One. 2020;15:e0230794.
    PubMed     Abstract available

  61. ABID A, Subhani F, Kayani F, Awan S, et al
    Drug induced liver injury is associated with high mortality-A study from a tertiary care hospital in Pakistan.
    PLoS One. 2020;15:e0231398.
    PubMed     Abstract available

  62. FUCHIGAMI A, Imai Y, Uchida Y, Uchiya H, et al
    Therapeutic efficacy of lenvatinib for patients with unresectable hepatocellular carcinoma based on the middle-term outcome.
    PLoS One. 2020;15:e0231427.
    PubMed     Abstract available

  63. PIEL S, Chamkha I, Dehlin AK, Ehinger JK, et al
    Cell-permeable succinate prodrugs rescue mitochondrial respiration in cellular models of acute acetaminophen overdose.
    PLoS One. 2020;15:e0231173.
    PubMed     Abstract available

  64. YU S, Wang Y, Hou J, Li W, et al
    Tumor-infiltrating immune cells in hepatocellular carcinoma: Tregs is correlated with poor overall survival.
    PLoS One. 2020;15:e0231003.
    PubMed     Abstract available

  65. HAUKELAND JW, Smastuen MC, Palsdatter PP, Ismail M, et al
    Effect of gender on mortality and causes of death in cirrhotic patients with gastroesophageal varices. A retrospective study in Norway.
    PLoS One. 2020;15:e0230263.
    PubMed     Abstract available

  66. ZHANG M, Haughey M, Wang NY, Blease K, et al
    Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs.
    PLoS One. 2020;15:e0229445.
    PubMed     Abstract available

  67. KIRINO S, Tsuchiya K, Kurosaki M, Kaneko S, et al
    Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma.
    PLoS One. 2020;15:e0231828.
    PubMed     Abstract available

  68. LIU Y, Gao H, He YD
    A compound attributes-based predictive model for drug induced liver injury in humans.
    PLoS One. 2020;15:e0231252.
    PubMed     Abstract available

  69. WU YH, Wu CY, Cheng CY, Tsai SF, et al
    Severe hyperbilirubinemia is associated with higher risk of contrast-related acute kidney injury following contrast-enhanced computed tomography.
    PLoS One. 2020;15:e0231264.
    PubMed     Abstract available

  70. SCHOMAKER S, Potter D, Warner R, Larkindale J, et al
    Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments.
    PLoS One. 2020;15:e0229753.
    PubMed     Abstract available

  71. NAKANO D, Kawaguchi T, Iwamoto H, Hayakawa M, et al
    Effects of canagliflozin on growth and metabolic reprograming in hepatocellular carcinoma cells: Multi-omics analysis of metabolomics and absolute quantification proteomics (iMPAQT).
    PLoS One. 2020;15:e0232283.
    PubMed     Abstract available

  72. SAITO K, Fukasawa M, Shirasago Y, Suzuki R, et al
    Comparative characterization of flavivirus production in two cell lines: Human hepatoma-derived Huh7.5.1-8 and African green monkey kidney-derived Vero.
    PLoS One. 2020;15:e0232274.
    PubMed     Abstract available

  73. DAVIDSON CQ, Tharmalingam S, Niccoli S, Nemec-Bakk A, et al
    Dose threshold for radiation induced fetal programming in a mouse model at 4 months of age: Hepatic expression of genes and proteins involved in glucose metabolism and glucose uptake in brown adipose tissue.
    PLoS One. 2020;15:e0231650.
    PubMed     Abstract available

  74. BENZ F, Bogen A, Praktiknjo M, Jansen C, et al
    Serum levels of bone sialoprotein correlate with portal pressure in patients with liver cirrhosis.
    PLoS One. 2020;15:e0231701.
    PubMed     Abstract available

  75. SATAPATHY SK, Gonzalez HC, Vanatta J, Dyer A, et al
    A pilot study of ex-vivo MRI-PDFF of donor livers for assessment of steatosis and predicting early graft dysfunction.
    PLoS One. 2020;15:e0232006.
    PubMed     Abstract available

  76. RAIGANI S, Carroll C, Griffith S, Pendexter C, et al
    Improvement of steatotic rat liver function with a defatting cocktail during ex situ normothermic machine perfusion is not directly related to liver fat content.
    PLoS One. 2020;15:e0232886.
    PubMed     Abstract available

  77. CAPUTO F, Dadduzio V, Tovoli F, Bertolini G, et al
    The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib.
    PLoS One. 2020;15:e0232449.
    PubMed     Abstract available

  78. WELBERRY C, Macdonald I, McElveen J, Parsy-Kowalska C, et al
    Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma.
    PLoS One. 2020;15:e0232247.
    PubMed     Abstract available

  79. YU Y, Bai M, Ma F, Zhang W, et al
    Regional citrate anticoagulation versus no-anticoagulation for continuous venovenous hemofiltration in patients with liver failure and increased bleeding risk: A retrospective case-control study.
    PLoS One. 2020;15:e0232516.
    PubMed     Abstract available

  80. PETZOLD G, Lasser J, Ruhl J, Bremer SCB, et al
    Diagnostic accuracy of B-Mode ultrasound and Hepatorenal Index for graduation of hepatic steatosis in patients with chronic liver disease.
    PLoS One. 2020;15:e0231044.
    PubMed     Abstract available

  81. GRIMALDI M, Palisi A, Marino C, Montoro P, et al
    NMR-based metabolomic profile of hypercholesterolemic human sera: Relationship with in vitro gene expression?
    PLoS One. 2020;15:e0231506.
    PubMed     Abstract available

  82. SI H, Genna B, Zhuang X, Wang J, et al
    DaHuangWan targets EGF signaling to inhibit the proliferation of hepatoma cells.
    PLoS One. 2020;15:e0231466.
    PubMed     Abstract available

  83. KANG JK, Heo S, Kim HP, Song SH, et al
    Liquid biopsy-based tumor profiling for metastatic colorectal cancer patients with ultra-deep targeted sequencing.
    PLoS One. 2020;15:e0232754.
    PubMed     Abstract available

  84. WANG Y, Zhou X, Zhao D, Wang X, et al
    Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytes.
    PLoS One. 2020;15:e0232630.
    PubMed     Abstract available

  85. LANZA E, Masetti C, Messana G, Muglia R, et al
    Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
    PLoS One. 2020;15:e0232371.
    PubMed     Abstract available

  86. MASUYA T, Suzuki M, Tsujimura J, Kanamori S, et al
    Ablation of Iah1, a candidate gene for diet-induced fatty liver, does not affect liver lipid accumulation in mice.
    PLoS One. 2020;15:e0233087.
    PubMed     Abstract available

  87. CHEN L, Zhang L, Wang W, Qiu W, et al
    Polysaccharides isolated from Cordyceps Sinensis contribute to the progression of NASH by modifying the gut microbiota in mice fed a high-fat diet.
    PLoS One. 2020;15:e0232972.
    PubMed     Abstract available

  88. BELAUNZARAN-ZAMUDIO PF, Caro-Vega Y, Giganti MJ, Castilho JL, et al
    Frequency of non-communicable diseases in people 50 years of age and older receiving HIV care in Latin America.
    PLoS One. 2020;15:e0233965.
    PubMed     Abstract available

  89. NGUYEN TN, Nguyen HQ, Le DH
    Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses.
    PLoS One. 2020;15:e0229276.
    PubMed     Abstract available

  90. NAGATA S, Ozawa F, Nie M, Takeuchi S, et al
    3D culture of functional human iPSC-derived hepatocytes using a core-shell microfiber.
    PLoS One. 2020;15:e0234441.
    PubMed     Abstract available

  91. CHU YW, Chien CH, Sung MI, Chen CW, et al
    dBMHCC: A comprehensive hepatocellular carcinoma (HCC) biomarker database provides a reliable prediction system for novel HCC phosphorylated biomarkers.
    PLoS One. 2020;15:e0234084.
    PubMed     Abstract available

  92. LI C, Ge S, Zhou J, Peng J, et al
    Exploration of the effects of the CYCLOPS gene RBM17 in hepatocellular carcinoma.
    PLoS One. 2020;15:e0234062.
    PubMed     Abstract available

  93. BAEZA-RAJA B, Goodyear A, Liu X, Lam K, et al
    Pharmacological inhibition of P2RX7 ameliorates liver injury by reducing inflammation and fibrosis.
    PLoS One. 2020;15:e0234038.
    PubMed     Abstract available

  94. ALBAKHEET SS, Yoon H, Shin HJ, Koh H, et al
    Bone marrow fat change in pediatric patients with non-alcoholic fatty liver disease.
    PLoS One. 2020;15:e0234096.
    PubMed     Abstract available

  95. MULEY M, Vespasiani-Gentilucci U, De Vincentis A, Santonico M, et al
    Voltammetric analysis for distinguishing portal hypertension-related from malignancy-related ascites: A proof of concept study.
    PLoS One. 2020;15:e0233350.
    PubMed     Abstract available

  96. STOCKHOFF L, Schultalbers M, Tergast TL, Hinrichs JB, et al
    Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascites.
    PLoS One. 2020;15:e0235199.
    PubMed     Abstract available

  97. HAYASHI H, Yamashita YI, Okabe H, Imai K, et al
    Varied application of intercostal trans-diaphragmatic ports for laparoscopic hepatectomy.
    PLoS One. 2020;15:e0234919.
    PubMed     Abstract available

  98. CHANDRASHEKAR DS, Golonka RM, Yeoh BS, Gonzalez DJ, et al
    Fermentable fiber-induced hepatocellular carcinoma in mice recapitulates gene signatures found in human liver cancer.
    PLoS One. 2020;15:e0234726.
    PubMed     Abstract available

  99. QIAO C, Qian H, Wang J, Zhao T, et al
    PD173074 blocks G1/S transition via CUL3-mediated ubiquitin protease in HepG2 and Hep3B cells.
    PLoS One. 2020;15:e0234708.
    PubMed     Abstract available

  100. UESATO Y, Sasahira N, Ozaka M, Sasaki T, et al
    Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis.
    PLoS One. 2020;15:e0235623.
    PubMed     Abstract available

  101. KOCH C, Bette T, Waidmann O, Filmann N, et al
    AFP ratio predicts HCC recurrence after liver transplantation.
    PLoS One. 2020;15:e0235576.
    PubMed     Abstract available

  102. COHEN AM, Chamberlin S, Deloughery T, Nguyen M, et al
    Detecting rare diseases in electronic health records using machine learning and knowledge engineering: Case study of acute hepatic porphyria.
    PLoS One. 2020;15:e0235574.
    PubMed     Abstract available

  103. NICHOLS PH, Pan Y, May B, Pavlicova M, et al
    Effect of TSH on Non-Alcoholic Fatty Liver Disease (NAFLD) independent of obesity in children of predominantly Hispanic/Latino ancestry by causal mediation analysis.
    PLoS One. 2020;15:e0234985.
    PubMed     Abstract available

  104. SZUCS A, Paku S, Sebestyen E, Nagy P, et al
    Postnatal, ontogenic liver growth accomplished by biliary/oval cell proliferation and differentiation.
    PLoS One. 2020;15:e0233736.
    PubMed     Abstract available

  105. FORTEA JI, Puerto M, Fernandez-Mena C, Asensio I, et al
    Sevoflurane versus ketamine+diazepam anesthesia for assessing systemic and hepatic hemodynamics in rats with non-cirrhotic portal hypertension.
    PLoS One. 2020;15:e0233778.
    PubMed     Abstract available

  106. NUDISCHER R, Renggli K, Hierlemann A, Roth AB, et al
    Characterization of a long-term mouse primary liver 3D tissue model recapitulating innate-immune responses and drug-induced liver toxicity.
    PLoS One. 2020;15:e0235745.
    PubMed     Abstract available

  107. WANG J, Shen P, Liao S, Duan L, et al
    Selenoprotein P inhibits cell proliferation and ROX production in HCC cells.
    PLoS One. 2020;15:e0236491.
    PubMed     Abstract available

  108. KRISS M, Golden-Mason L, Kaplan J, Mirshahi F, et al
    Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development.
    PLoS One. 2020;15:e0236353.
    PubMed     Abstract available

  109. GOURRONC FA, Markan KR, Kulhankova K, Zhu Z, et al
    Pdgfralpha-Cre mediated knockout of the aryl hydrocarbon receptor protects mice from high-fat diet induced obesity and hepatic steatosis.
    PLoS One. 2020;15:e0236741.
    PubMed     Abstract available

  110. DIESINGER T, Buko V, Lautwein A, Dvorsky R, et al
    Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.
    PLoS One. 2020;15:e0235990.
    PubMed     Abstract available

  111. OKUSHIN K, Tsutsumi T, Ikeuchi K, Kado A, et al
    Heterozygous knockout of Bile salt export pump ameliorates liver steatosis in mice fed a high-fat diet.
    PLoS One. 2020;15:e0234750.
    PubMed     Abstract available

  112. PELTONEN R, Gramkow MH, Dehlendorff C, Osterlund PJ, et al
    Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases.
    PLoS One. 2020;15:e0236569.
    PubMed     Abstract available

  113. YASUI D, Yamane A, Itoh H, Kobayashi M, et al
    In vivo evaluation of a monodisperse solid-in-oil-in-water miriplatin/ lipiodol emulsion in transcatheter arterial chemoembolization using a rabbit VX2 tumor model.
    PLoS One. 2020;15:e0222553.
    PubMed     Abstract available

  114. STEMMER A, Shadmi R, Bregman-Amitai O, Chettrit D, et al
    Using machine learning algorithms to review computed tomography scans and assess risk for cardiovascular disease: Retrospective analysis from the National Lung Screening Trial (NLST).
    PLoS One. 2020;15:e0236021.
    PubMed     Abstract available

  115. SHEN Q, Hu G, Wu J, Lv L, et al
    A new clinical prognostic nomogram for liver cancer based on immune score.
    PLoS One. 2020;15:e0236622.
    PubMed     Abstract available

  116. YOO JJ, Lim YS, Kim MS, Lee B, et al
    Risk of fatty liver after long-term use of tamoxifen in patients with breast cancer.
    PLoS One. 2020;15:e0236506.
    PubMed     Abstract available

  117. RASHIDI-ALAVIJEH J, Ceylan AS, Wedemeyer H, Kleefisch M, et al
    Standard coagulation tests are superior to thromboelastometry in predicting outcome of patients with liver cirrhosis.
    PLoS One. 2020;15:e0236528.
    PubMed     Abstract available

  118. SERPER M, Vujkovic M, Kaplan DE, Carr RM, et al
    Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program.
    PLoS One. 2020;15:e0237430.
    PubMed     Abstract available

  119. FUKUDA H, Sato D, Moriwaki K, Ishida H, et al
    Differences in healthcare expenditure estimates according to statistical approach: A nationwide claims database study on patients with hepatocellular carcinoma.
    PLoS One. 2020;15:e0237316.
    PubMed     Abstract available

  120. HAL WA, Straza MW, Chen X, Mickevicius N, et al
    Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac.
    PLoS One. 2020;15:e0236570.
    PubMed     Abstract available

  121. CHEN K, Sng WK, Quah JH, Liu J, et al
    Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus.
    PLoS One. 2020;15:e0236977.
    PubMed     Abstract available

  122. FORLANO R, Mullish BH, Mukherjee SK, Nathwani R, et al
    In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19.
    PLoS One. 2020;15:e0240400.
    PubMed     Abstract available

  123. SOGABE M, Okahisa T, Kurihara T, Takehara M, et al
    Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome.
    PLoS One. 2020;15:e0238388.
    PubMed     Abstract available

  124. TAMAI Y, Iwasa M, Eguchi A, Shigefuku R, et al
    Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma.
    PLoS One. 2020;15:e0237370.
    PubMed     Abstract available

  125. CHANG TT, Ho CH
    Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma.
    PLoS One. 2020;15:e0238251.
    PubMed     Abstract available

  126. LIRA MMP, de Medeiros Filho JEM, Baccin Martins VJ, da Silva G, et al
    Association of worsening of nonalcoholic fatty liver disease with cardiometabolic function and intestinal bacterial overgrowth: A cross-sectional study.
    PLoS One. 2020;15:e0237360.
    PubMed     Abstract available

  127. RONDA OAHO, van de Heijning BJM, de Bruin A, Thomas RE, et al
    Spontaneous liver disease in wild-type C57BL/6JOlaHsd mice fed semisynthetic diet.
    PLoS One. 2020;15:e0232069.
    PubMed     Abstract available

  128. LEE J, Vali Y, Boursier J, Duffin K, et al
    Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0238717.
    PubMed     Abstract available

  129. ROGAL SS, Yakovchenko V, Gonzalez R, Park A, et al
    Characterizing patient-reported outcomes in veterans with cirrhosis.
    PLoS One. 2020;15:e0238712.
    PubMed     Abstract available

  130. HAYASHI M, Abe K, Fujita M, Takahashi A, et al
    Association between serum ficolin-1 level and disease progression in primary biliary cholangitis.
    PLoS One. 2020;15:e0238300.
    PubMed     Abstract available

  131. RAJCIC D, Brandt A, Jin CJ, Sanchez V, et al
    Exchanging dietary fat source with extra virgin olive oil does not prevent progression of diet-induced non-alcoholic fatty liver disease and insulin resistance.
    PLoS One. 2020;15:e0237946.
    PubMed     Abstract available

  132. STRADOMSKA TJ, Syczewska M, Jamroz E, Pleskaczynska A, et al
    Serum very long-chain fatty acids (VLCFA) levels as predictive biomarkers of diseases severity and probability of survival in peroxisomal disorders.
    PLoS One. 2020;15:e0238796.
    PubMed     Abstract available

  133. CORREA F, Hidalgo C, Stoore C, Jimenez M, et al
    Cattle co-infection of Echinococcus granulosus and Fasciola hepatica results in a different systemic cytokine profile than single parasite infection.
    PLoS One. 2020;15:e0238909.
    PubMed     Abstract available

  134. MAUNG K, Ramalingam S, Chaudhry M, Ren Y, et al
    Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality.
    PLoS One. 2020;15:e0238824.
    PubMed     Abstract available

  135. GRIFFETT K, Bedia-Diaz G, Elgendy B, Burris TP, et al
    REV-ERB agonism improves liver pathology in a mouse model of NASH.
    PLoS One. 2020;15:e0236000.
    PubMed     Abstract available

  136. SANTOIEMMA PP, Dakwar O, Angarone MP
    A retrospective analysis of cases of Spontaneous Bacterial Peritonitis in cirrhosis patients.
    PLoS One. 2020;15:e0239470.
    PubMed     Abstract available

  137. LOOSEN SH, Wirtz TH, Roy S, Vucur M, et al
    Circulating levels of microRNA193a-5p predict outcome in early stage hepatocellular carcinoma.
    PLoS One. 2020;15:e0239386.
    PubMed     Abstract available

  138. WANG S, Toy M, Hang Pham TT, So S, et al
    Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the U.S., 2010-2019.
    PLoS One. 2020;15:e0239393.
    PubMed     Abstract available

  139. KANEKO S, Kurosaki M, Nagata K, Taki R, et al
    Liver injury with COVID-19 based on gastrointestinal symptoms and pneumonia severity.
    PLoS One. 2020;15:e0241663.
    PubMed     Abstract available

  140. PENG J, Zhou M, Chen C, Xie X, et al
    Identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms.
    PLoS One. 2020;15:e0239266.
    PubMed     Abstract available

  141. CHOI JW, Lee JM, Lee DH, Yoon JH, et al
    Radiofrequency ablation using internally cooled wet electrodes in bipolar mode for the treatment of recurrent hepatocellular carcinoma after locoregional treatment: A randomized prospective comparative study.
    PLoS One. 2020;15:e0239733.
    PubMed     Abstract available

  142. REY R M, Delgado AF, De Zubiria A, Pinto R, et al
    Prevalence and short-term outcome of hepatorenal syndrome: A 9-year experience in a high-complexity hospital in Colombia.
    PLoS One. 2020;15:e0239834.
    PubMed     Abstract available

  143. RIEXINGER A, Laun FB, Bickelhaupt S, Seuss H, et al
    On the dependence of the cardiac motion artifact on the breathing cycle in liver diffusion-weighted imaging.
    PLoS One. 2020;15:e0239743.
    PubMed     Abstract available

  144. MANN JP, Carter P, Armstrong MJ, Abdelaziz HK, et al
    Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors.
    PLoS One. 2020;15:e0241357.
    PubMed     Abstract available

  145. GOODSON ML, Knotts TA, Campbell EL, Snyder CA, et al
    Specific ablation of the NCoR corepressor delta splice variant reveals alternative RNA splicing as a key regulator of hepatic metabolism.
    PLoS One. 2020;15:e0241238.
    PubMed     Abstract available

  146. KIM MC, Lee JI, Kim JH, Kim HJ, et al
    Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease.
    PLoS One. 2020;15:e0240195.
    PubMed     Abstract available

  147. SORINO P, Caruso MG, Misciagna G, Bonfiglio C, et al
    Selecting the best machine learning algorithm to support the diagnosis of Non-Alcoholic Fatty Liver Disease: A meta learner study.
    PLoS One. 2020;15:e0240867.
    PubMed     Abstract available

  148. HASSAN S, Peluso J, Chalhoub S, Idoux Gillet Y, et al
    Quercetin potentializes the respective cytotoxic activity of gemcitabine or doxorubicin on 3D culture of AsPC-1 or HepG2 cells, through the inhibition of HIF-1alpha and MDR1.
    PLoS One. 2020;15:e0240676.
    PubMed     Abstract available

  149. LIN YJ, Lin CN, Sedghi T, Hsu SH, et al
    Treatment patterns and survival in hepatocellular carcinoma in the United States and Taiwan.
    PLoS One. 2020;15:e0240542.
    PubMed     Abstract available

  150. ZHANG L, Yuan Q, Xu Y, Wang W, et al
    Comparative clinical outcomes of robot-assisted liver resection versus laparoscopic liver resection: A meta-analysis.
    PLoS One. 2020;15:e0240593.
    PubMed     Abstract available

  151. CHURCH RJ, Schomaker SJ, Eaddy JS, Boucher GG, et al
    Glutamate dehydrogenase as a biomarker for mitotoxicity; insights from furosemide hepatotoxicity in the mouse.
    PLoS One. 2020;15:e0240562.
    PubMed     Abstract available

  152. YAN B, Luo J, Kaltenmeier C, Du Q, et al
    Interferon Regulatory Factor-1 (IRF1) activates autophagy to promote liver ischemia/reperfusion injury by inhibiting beta-catenin in mice.
    PLoS One. 2020;15:e0239119.
    PubMed     Abstract available

  153. GRANATA V, Fusco R, Avallone A, Cassata A, et al
    Abbreviated MRI protocol for colorectal liver metastases: How the radiologist could work in pre surgical setting.
    PLoS One. 2020;15:e0241431.
    PubMed     Abstract available

  154. BAUMLER W, Schicho A, Schaible J, Verloh N, et al
    Changes in gadoxetic-acid-enhanced MR imaging during the first year after irreversible electroporation of malignant hepatic tumors.
    PLoS One. 2020;15:e0242093.
    PubMed     Abstract available

  155. ZHAO Y, Zhu C, Chang Q, Peng P, et al
    MiR-424-5p regulates cell cycle and inhibits proliferation of hepatocellular carcinoma cells by targeting E2F7.
    PLoS One. 2020;15:e0242179.
    PubMed     Abstract available

  156. GUO B, Tan X, Cen H
    EZH2 is a negative prognostic biomarker associated with immunosuppression in hepatocellular carcinoma.
    PLoS One. 2020;15:e0242191.
    PubMed     Abstract available

  157. FENG L, Dong K, Zhang X, Ma B, et al
    Clinical significance of IgG antimitochondrial M2 antibody levels in primary biliary cholangitis: A single center study from China.
    PLoS One. 2020;15:e0242164.
    PubMed     Abstract available

  158. CHEN HY, Lu SN, Hung CH, Wang JH, et al
    Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation.
    PLoS One. 2020;15:e0242113.
    PubMed     Abstract available

  159. GALIERO R, Pafundi PC, Simeon V, Rinaldi L, et al
    Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study.
    PLoS One. 2020;15:e0243700.
    PubMed     Abstract available

  160. VISARIA A, Pai S, Fayngersh A, Kothari N, et al
    Association between alanine aminotransferase within the normal range and all-cause and cause-specific mortality: A nationwide cohort study.
    PLoS One. 2020;15:e0242431.
    PubMed     Abstract available

  161. SAKAMAKI A, Yokoyama K, Koyama K, Morita S, et al
    Obesity and accumulation of subcutaneous adipose tissue are poor prognostic factors in patients with alcoholic liver cirrhosis.
    PLoS One. 2020;15:e0242582.
    PubMed     Abstract available

  162. PARK JH, Chung YE, Seo N, Choi JY, et al
    Gadoxetic acid-enhanced MRI of hepatocellular carcinoma: Diagnostic performance of category-adjusted LR-5 using modified criteria.
    PLoS One. 2020;15:e0242344.
    PubMed     Abstract available

  163. CHOI J, Kim SH, Han S, Lee D, et al
    A simple and clinically applicable model to predict liver-related morbidity after hepatic resection for hepatocellular carcinoma.
    PLoS One. 2020;15:e0241808.
    PubMed     Abstract available

  164. CHIU TJ, Chen YJ, Kuo FY, Chen YY, et al
    Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular-cholangiocarcinoma.
    PLoS One. 2020;15:e0240791.
    PubMed     Abstract available

  165. MOLE DJ, Fallowfield JA, Sherif AE, Kendall T, et al
    Quantitative magnetic resonance imaging predicts individual future liver performance after liver resection for cancer.
    PLoS One. 2020;15:e0238568.
    PubMed     Abstract available

  166. LEUNG CCT, Wong CKC
    Effects of stanniocalcin-1 overexpressing hepatocellular carcinoma cells on macrophage migration.
    PLoS One. 2020;15:e0241932.
    PubMed     Abstract available

  167. PALLADINI G, Ferrigno A, Di Pasqua LG, Berardo C, et al
    Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease.
    PLoS One. 2020;15:e0243179.
    PubMed     Abstract available

  168. LUONG XG, Stevens SK, Jekle A, Lin TI, et al
    Regulation of gene transcription by thyroid hormone receptor beta agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH).
    PLoS One. 2020;15:e0240338.
    PubMed     Abstract available

  169. HIROSE S, Matsumoto K, Tatemichi M, Tsuruya K, et al
    Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients.
    PLoS One. 2020;15:e0241770.
    PubMed     Abstract available

  170. XIAO C, Fu X, Wang Y, Liu H, et al
    Transferrin receptor regulates malignancies and the stemness of hepatocellular carcinoma-derived cancer stem-like cells by affecting iron accumulation.
    PLoS One. 2020;15:e0243812.
    PubMed     Abstract available

  171. ADHYAPOK P, Fu X, Sluka JP, Clendenon SG, et al
    A computational model of liver tissue damage and repair.
    PLoS One. 2020;15:e0243451.
    PubMed     Abstract available

  172. BRAUNWARTH E, Rumpf B, Primavesi F, Pereyra D, et al
    Sex differences in disease presentation, surgical and oncological outcome of liver resection for primary and metastatic liver tumors-A retrospective multicenter study.
    PLoS One. 2020;15:e0243539.
    PubMed     Abstract available

  173. LEE S, Kim JH, Moon H, Lee HJ, et al
    Combined treatment of sorafenib and doxorubicin-loaded microbubble-albumin nanoparticle complex for hepatocellular carcinoma: A feasibility study.
    PLoS One. 2020;15:e0243815.
    PubMed     Abstract available

  174. BAYOUMI A, Jalil I, Metwally M, Adams LA, et al
    Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease.
    PLoS One. 2020;15:e0243590.
    PubMed     Abstract available

  175. BAE CR, Zhang H, Kwon YG
    The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
    PLoS One. 2020;15:e0243497.
    PubMed     Abstract available

  176. SOHN W, Ham CB, Kim NH, Kim HJ, et al
    Effect of acute kidney injury on the patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    PLoS One. 2020;15:e0243780.
    PubMed     Abstract available

  177. YEN FS, Lai JN, Wei JC, Chiu LT, et al
    Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis.
    PLoS One. 2020;15:e0243783.
    PubMed     Abstract available

  178. YUAN Y, Naito H, Kitamori K, Hashimoto S, et al
    The antihypertensive agent hydralazine reduced extracellular matrix synthesis and liver fibrosis in nonalcoholic steatohepatitis exacerbated by hypertension.
    PLoS One. 2020;15:e0243846.
    PubMed     Abstract available

  179. WANG G, Wang Q, Bai J, Li G, et al
    RYGB increases postprandial gastric nesfatin-1 and rapid relieves NAFLD via gastric nerve detachment.
    PLoS One. 2020;15:e0243640.
    PubMed     Abstract available

  180. LIU L, Liu C, Zhao M, Zhang Q, et al
    The pharmacodynamic and differential gene expression analysis of PPAR alpha/delta agonist GFT505 in CDAHFD-induced NASH model.
    PLoS One. 2020;15:e0243911.
    PubMed     Abstract available

  181. MANJARIN R, Maj MA, La Frano MR, Glanz H, et al
    %polynova_2way: A SAS macro for implementation of mixed models for metabolomics data.
    PLoS One. 2020;15:e0244013.
    PubMed     Abstract available

  182. HSIEH MH, Kao TY, Hsieh TH, Kao CC, et al
    Prognostic roles of diabetes mellitus and hypertension in advanced hepatocellular carcinoma treated with sorafenib.
    PLoS One. 2020;15:e0244293.
    PubMed     Abstract available

  183. WEISSINGER M, Vogel J, Kupferschlager J, Dittmann H, et al
    Correlation of C-arm CT acquired parenchymal blood volume (PBV) with 99mTc-macroaggregated albumin (MAA) SPECT/CT for radioembolization work-up.
    PLoS One. 2020;15:e0244235.
    PubMed     Abstract available

  184. RYU H, Kim JH, Lee S, Han JK, et al
    Therapeutic response monitoring after targeted therapy in an orthotopic rat model of hepatocellular carcinoma using contrast-enhanced ultrasound: Focusing on inter-scanner, and inter-operator reproducibility.
    PLoS One. 2020;15:e0244304.
    PubMed     Abstract available

  185. SEMMLER G, Bachmayer S, Wernly S, Wernly B, et al
    Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease.
    PLoS One. 2020;15:e0244514.
    PubMed     Abstract available

  186. BORTOLAMI M, Comparato A, Benna C, Errico A, et al
    Gene and protein expression of mTOR and LC3 in hepatocellular carcinoma, colorectal liver metastasis and "normal" liver tissues.
    PLoS One. 2020;15:e0244356.
    PubMed     Abstract available

  187. HAYASHI T, Shibata M, Oe S, Miyagawa K, et al
    C-reactive protein can predict dose intensity, time to treatment failure and overall survival in HCC treated with lenvatinib.
    PLoS One. 2020;15:e0244370.
    PubMed     Abstract available

  188. THULUVATH PJ, Amjad W, Zhang T
    Liver transplant waitlist removal, transplantation rates and post-transplant survival in Hispanics.
    PLoS One. 2020;15:e0244744.
    PubMed     Abstract available

  189. PILLING D, Karhadkar TR, Gomer RH
    A CD209 ligand and a sialidase inhibitor differentially modulate adipose tissue and liver macrophage populations and steatosis in mice on the Methionine and Choline-Deficient (MCD) diet.
    PLoS One. 2020;15:e0244762.
    PubMed     Abstract available

    January 2019
  190. CHAO X, Wang G, Tang Y, Dong C, et al
    The effects and mechanism of peiminine-induced apoptosis in human hepatocellular carcinoma HepG2 cells.
    PLoS One. 2019;14:e0201864.
    PubMed     Abstract available

  191. SONG JU, Jang Y, Lim SY, Ryu S, et al
    Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study.
    PLoS One. 2019;14:e0208736.
    PubMed     Abstract available

  192. SEPULVEDA-VILLEGAS M, Roman S, Rivera-Iniguez I, Ojeda-Granados C, et al
    High prevalence of nonalcoholic steatohepatitis and abnormal liver stiffness in a young and obese Mexican population.
    PLoS One. 2019;14:e0208926.
    PubMed     Abstract available

  193. NORONA LM, Nguyen DG, Gerber DA, Presnell SC, et al
    Bioprinted liver provides early insight into the role of Kupffer cells in TGF-beta1 and methotrexate-induced fibrogenesis.
    PLoS One. 2019;14:e0208958.
    PubMed     Abstract available

  194. OHASHI T, Nakade Y, Ibusuki M, Kitano R, et al
    Conophylline inhibits high fat diet-induced non-alcoholic fatty liver disease in mice.
    PLoS One. 2019;14:e0210068.
    PubMed     Abstract available

  195. KWON J, Kim S, Yoo H, Lee E, et al
    Nimesulide-induced hepatotoxicity: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0209264.
    PubMed     Abstract available

  196. CHEN QF, Huang T, Shen L, Li W, et al
    Predictive value of a nomogram for hepatocellular carcinoma with brain metastasis at initial diagnosis: A population-based study.
    PLoS One. 2019;14:e0209293.
    PubMed     Abstract available

  197. NISHIMURA T, Takami T, Sasaki R, Aibe Y, et al
    Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis model.
    PLoS One. 2019;14:e0210588.
    PubMed     Abstract available

  198. MELIS M, Tang XH, Trasino SE, Patel VM, et al
    Effects of AM80 compared to AC261066 in a high fat diet mouse model of liver disease.
    PLoS One. 2019;14:e0211071.
    PubMed     Abstract available

  199. SINN DH, Choi GS, Park HC, Kim JM, et al
    Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients.
    PLoS One. 2019;14:e0210730.
    PubMed     Abstract available

  200. HASHEM MM, Salama MM, Mohammed FF, Tohamy AF, et al
    Metabolic profile and hepatoprotective effect of Aeschynomene elaphroxylon (Guill. & Perr.).
    PLoS One. 2019;14:e0210576.
    PubMed     Abstract available

  201. PAQUETTE K, Coltin H, Boivin A, Amre D, et al
    Cancer risk in children and young adults born preterm: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0210366.
    PubMed     Abstract available

  202. YU MH, Kim YJ, Park HS, Jung SI, et al
    Shrinkage of hepatocellular carcinoma after radiofrequency ablation following transcatheter arterial chemoembolization: Analysis of contributing factors.
    PLoS One. 2019;14:e0210667.
    PubMed     Abstract available

  203. WANG S, Shen HW, Chai H, Liang Y, et al
    Complex harmonic regularization with differential evolution in a memetic framework for biomarker selection.
    PLoS One. 2019;14:e0210786.
    PubMed     Abstract available

  204. CHOUNG S, Kim JM, Joung KH, Lee ES, et al
    Epidermal growth factor receptor inhibition attenuates non-alcoholic fatty liver disease in diet-induced obese mice.
    PLoS One. 2019;14:e0210828.
    PubMed     Abstract available

  205. APPLEBY RN, Moghul I, Khan S, Yee M, et al
    Non-alcoholic fatty liver disease is associated with dysregulated bile acid synthesis and diarrhea: A prospective observational study.
    PLoS One. 2019;14:e0211348.
    PubMed     Abstract available

  206. KIM SH, Kim JK, Park EY, Joo J, et al
    Liver metastasis and Heng risk are prognostic factors in patients with non-nephrectomized synchronous metastatic renal cell carcinoma treated with systemic therapy.
    PLoS One. 2019;14:e0211105.
    PubMed     Abstract available

  207. TAKADA H, Kurosaki M, Nakanishi H, Takahashi Y, et al
    Real-life experience of lusutrombopag for cirrhotic patients with low platelet counts being prepared for invasive procedures.
    PLoS One. 2019;14:e0211122.
    PubMed     Abstract available

  208. KLOSE J, Trefz S, Wagner T, Steffen L, et al
    Salinomycin: Anti-tumor activity in a pre-clinical colorectal cancer model.
    PLoS One. 2019;14:e0211916.
    PubMed     Abstract available

  209. WANG Y, Cobanoglu MC, Li J, Hidvegi T, et al
    An analog of glibenclamide selectively enhances autophagic degradation of misfolded alpha1-antitrypsin Z.
    PLoS One. 2019;14:e0209748.
    PubMed     Abstract available

  210. MAKONDI PT, Wei PL, Huang CY, Chang YJ, et al
    Development of novel predictive miRNA/target gene pathways for colorectal cancer distance metastasis to the liver using a bioinformatic approach.
    PLoS One. 2019;14:e0211968.
    PubMed     Abstract available

  211. TOLEDANO MN, Vera P, Tilly H, Jardin F, et al
    Comparison of therapeutic evaluation criteria in FDG-PET/CT in patients with diffuse large-cell B-cell lymphoma: Prognostic impact of tumor/liver ratio.
    PLoS One. 2019;14:e0211649.
    PubMed     Abstract available

  212. SCHWARZKOPF KM, Queck A, Thomas D, Angioni C, et al
    Omega-3 and -6 fatty acid plasma levels are not associated with liver cirrhosis-associated systemic inflammation.
    PLoS One. 2019;14:e0211537.
    PubMed     Abstract available

  213. LEE YJ, Shu MS, Kim JY, Kim YH, et al
    Cilostazol protects hepatocytes against alcohol-induced apoptosis via activation of AMPK pathway.
    PLoS One. 2019;14:e0211415.
    PubMed     Abstract available

  214. ISHIKAWA T, Yokoyama H, Matsuura T, Fujiwara Y, et al
    Fc gamma RIIb expression levels in human liver sinusoidal endothelial cells during progression of non-alcoholic fatty liver disease.
    PLoS One. 2019;14:e0211543.
    PubMed     Abstract available

  215. MUKTHINUTHALAPATI VVPK, Akinyeye S, Fricker ZP, Syed M, et al
    Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitals.
    PLoS One. 2019;14:e0211811.
    PubMed     Abstract available

  216. WALKER S, Wankell M, Ho V, White R, et al
    Targeting mTOR and Src restricts hepatocellular carcinoma growth in a novel murine liver cancer model.
    PLoS One. 2019;14:e0212860.
    PubMed     Abstract available

  217. REUSCHEL E, Jilg W, Seelbach-Goebel B, Deml L, et al
    Comparative purification and characterization of hepatitis B virus-like particles produced by recombinant vaccinia viruses in human hepatoma cells and human primary hepatocytes.
    PLoS One. 2019;14:e0212800.
    PubMed     Abstract available

  218. XIONG X, Yu J, Fan R, Zhang C, et al
    NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice.
    PLoS One. 2019;14:e0212523.
    PubMed     Abstract available

  219. IMAI Y, Yoshida O, Watanabe T, Yukimoto A, et al
    Stimulated hepatic stellate cell promotes progression of hepatocellular carcinoma due to protein kinase R activation.
    PLoS One. 2019;14:e0212589.
    PubMed     Abstract available

  220. TURCIOS L, Chacon E, Garcia C, Eman P, et al
    Autophagic flux modulation by Wnt/beta-catenin pathway inhibition in hepatocellular carcinoma.
    PLoS One. 2019;14:e0212538.
    PubMed     Abstract available

  221. YAMADA S, Shimada M, Morine Y, Imura S, et al
    A new formula to calculate the resection limit in hepatectomy based on Gd-EOB-DTPA-enhanced magnetic resonance imaging.
    PLoS One. 2019;14:e0210579.
    PubMed     Abstract available

  222. WEI PL, Huang CY, Chang YJ
    Propyl gallate inhibits hepatocellular carcinoma cell growth through the induction of ROS and the activation of autophagy.
    PLoS One. 2019;14:e0210513.
    PubMed     Abstract available

  223. CHIU SY, Chung HJ, Chen YT, Huang MS, et al
    A nonsense mutant of the hepatitis B virus large S protein antagonizes multiple tumor suppressor pathways through c-Jun activation domain-binding protein1.
    PLoS One. 2019;14:e0208665.
    PubMed     Abstract available

  224. MOSHER V, Swain M, Pang J, Kaplan G, et al
    Primary biliary cholangitis patients exhibit MRI changes in structure and function of interoceptive brain regions.
    PLoS One. 2019;14:e0211906.
    PubMed     Abstract available

  225. KIM J, Sinn DH, Choi MS, Kang W, et al
    Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?
    PLoS One. 2019;14:e0213547.
    PubMed     Abstract available

  226. YANG B, Pan CS, Li Q, Yang Z, et al
    Inhibitory effects of Chanling Gao on the proliferation and liver metastasis of transplanted colorectal cancer in nude mice.
    PLoS One. 2019;14:e0201504.
    PubMed     Abstract available

  227. BAI X, Liu Z, Shao X, Wang D, et al
    The heterogeneity of plasma miRNA profiles in hepatocellular carcinoma patients and the exploration of diagnostic circulating miRNAs for hepatocellular carcinoma.
    PLoS One. 2019;14:e0211581.
    PubMed     Abstract available

  228. GEBRELIBANOS HIBEN M, de Haan L, Spenkelink B, Wesseling S, et al
    Effects of Maerua subcordata (Gilg) DeWolf on electrophile-responsive element (EpRE)-mediated gene expression in vitro.
    PLoS One. 2019;14:e0215155.
    PubMed     Abstract available

  229. JAMES G, Reisberg S, Lepik K, Galwey N, et al
    An exploratory phenome wide association study linking asthma and liver disease genetic variants to electronic health records from the Estonian Biobank.
    PLoS One. 2019;14:e0215026.
    PubMed     Abstract available

  230. SCHMILOVITZ-WEISS H, Gingold-Belfer R, Grossman A, Issa N, et al
    Lowering the upper limit of serum alanine aminotransferase levels may reveal significant liver disease in the elderly.
    PLoS One. 2019;14:e0212737.
    PubMed     Abstract available

  231. STAFMAN LL, Williams AP, Marayati R, Aye JM, et al
    PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cells.
    PLoS One. 2019;14:e0214469.
    PubMed     Abstract available

  232. TOLEDANO MB, Mukherjee SK, Howell J, Westaby D, et al
    The emerging burden of liver disease in cystic fibrosis patients: A UK nationwide study.
    PLoS One. 2019;14:e0212779.
    PubMed     Abstract available

  233. SINGH A, Banerjee T, Kumar R, Shukla SK, et al
    Prevalence of cases of amebic liver abscess in a tertiary care centre in India: A study on risk factors, associated microflora and strain variation of Entamoeba histolytica.
    PLoS One. 2019;14:e0214880.
    PubMed     Abstract available

  234. WILLSON NL, Van TTH, Bhattarai SP, Courtice JM, et al
    Feed supplementation with biochar may reduce poultry pathogens, including Campylobacter hepaticus, the causative agent of Spotty Liver Disease.
    PLoS One. 2019;14:e0214471.
    PubMed     Abstract available

  235. GARCIA-JARAMILLO M, Spooner MH, Lohr CV, Wong CP, et al
    Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female Ldlr -/- mice.
    PLoS One. 2019;14:e0214387.
    PubMed     Abstract available

  236. DING S, Yuan C, Si B, Wang M, et al
    Combined effects of ambient particulate matter exposure and a high-fat diet on oxidative stress and steatohepatitis in mice.
    PLoS One. 2019;14:e0214680.
    PubMed     Abstract available

  237. CANBAY A, Kalsch J, Neumann U, Rau M, et al
    Non-invasive assessment of NAFLD as systemic disease-A machine learning perspective.
    PLoS One. 2019;14:e0214436.
    PubMed     Abstract available

  238. YUN Y, Kim HN, Lee EJ, Ryu S, et al
    Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects.
    PLoS One. 2019;14:e0213692.
    PubMed     Abstract available

  239. LIU B, Anno K, Kobayashi T, Piao J, et al
    Influence of donor liver telomere and G-tail on clinical outcome after living donor liver transplantation.
    PLoS One. 2019;14:e0213462.
    PubMed     Abstract available

  240. FAHLENKAMP UL, Engel G, Adams LC, Boker SM, et al
    Improved visualisation of hepatic metastases in gadoxetate disodium-enhanced MRI: Potential of contrast-optimised (phase-sensitive) inversion recovery imaging.
    PLoS One. 2019;14:e0213408.
    PubMed     Abstract available

  241. FARD N, Schlemmer HP, Raue F, Jobke B, et al
    CT- and ultrasound-characteristics of hepatic lesions in patients with multiple endocrine neoplasia syndrome. A retrospective image review of 25 cases.
    PLoS One. 2019;14:e0212865.
    PubMed     Abstract available

  242. LUO X, Zhao M, Wang X, Jiang M, et al
    Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft.
    PLoS One. 2019;14:e0212658.
    PubMed     Abstract available

  243. NUNEZ KG, Frank A, Gonzalez-Rosario J, Galliano G, et al
    Interleukin-33 / Cyclin D1 imbalance in severe liver steatosis predicts susceptibility to ischemia reperfusion injury.
    PLoS One. 2019;14:e0216242.
    PubMed     Abstract available

  244. HUNG TH, Tseng CW, Tsai CC, Lee HF, et al
    Effect of proton pump inhibitors on mortality of cirrhotic patients with pneumonia.
    PLoS One. 2019;14:e0216041.
    PubMed     Abstract available

  245. MIGLIACCIO V, Scudiero R, Sica R, Lionetti L, et al
    Oxidative stress and mitochondrial uncoupling protein 2 expression in hepatic steatosis induced by exposure to xenobiotic DDE and high fat diet in male Wistar rats.
    PLoS One. 2019;14:e0215955.
    PubMed     Abstract available

  246. HUNG TH, Tsai CC, Lee HF
    Statin use in cirrhotic patients with infectious diseases: A population-based study.
    PLoS One. 2019;14:e0215839.
    PubMed     Abstract available

  247. BACHTIAR V, Kelly MD, Wilman HR, Jacobs J, et al
    Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver.
    PLoS One. 2019;14:e0214921.
    PubMed     Abstract available

  248. AMIN S, Rattner J, Keramati MR, Farshidfar F, et al
    A strategy for early detection of response to chemotherapy drugs based on treatment-related changes in the metabolome.
    PLoS One. 2019;14:e0213942.
    PubMed     Abstract available

  249. BELMONTE FR, Dedousis N, Sipula I, Desai NA, et al
    Petite Integration Factor 1 (PIF1) helicase deficiency increases weight gain in Western diet-fed female mice without increased inflammatory markers or decreased glucose clearance.
    PLoS One. 2019;14:e0203101.
    PubMed     Abstract available

  250. TOKSVANG LN, Schmidt MS, Arup S, Larsen RH, et al
    Hepatotoxicity during 6-thioguanine treatment in inflammatory bowel disease and childhood acute lymphoblastic leukaemia: A systematic review.
    PLoS One. 2019;14:e0212157.
    PubMed     Abstract available

  251. KESSLER SM, Leber B, Hoppstadter J, Golob-Schwarzl N, et al
    Diethylnitrosamine (DENA) recapitulates formation of hepatic angiosarcoma in pigs.
    PLoS One. 2019;14:e0214756.
    PubMed     Abstract available

  252. VERLOH N, Probst U, Utpatel K, Zeman F, et al
    Influence of hepatic fibrosis and inflammation: Correlation between histopathological changes and Gd-EOB-DTPA-enhanced MR imaging.
    PLoS One. 2019;14:e0215752.
    PubMed     Abstract available

  253. ANWAR SL, Hasemeier B, Schipper E, Vogel A, et al
    LINE-1 hypomethylation in human hepatocellular carcinomas correlates with shorter overall survival and CIMP phenotype.
    PLoS One. 2019;14:e0216374.
    PubMed     Abstract available

  254. LEE YG, Chang Y, Kang J, Koo DH, et al
    Risk factors for incident anemia of chronic diseases: A cohort study.
    PLoS One. 2019;14:e0216062.
    PubMed     Abstract available

  255. SINGH N, Kallollimath P, Shah MH, Kapoor S, et al
    Genetic analysis of ATP7B in 102 south Indian families with Wilson disease.
    PLoS One. 2019;14:e0215779.
    PubMed     Abstract available

  256. MEISCHL T, Rasoul-Rockenschaub S, Gyori G, Sieghart W, et al
    C-reactive protein is an independent predictor for hepatocellular carcinoma recurrence after liver transplantation.
    PLoS One. 2019;14:e0216677.
    PubMed     Abstract available

  257. CHANG PY, Chung CH, Chang WC, Lin CS, et al
    The effect of propranolol on the prognosis of hepatocellular carcinoma: A nationwide population-based study.
    PLoS One. 2019;14:e0216828.
    PubMed     Abstract available

  258. WETZ C, Genseke P, Apostolova I, Furth C, et al
    The association of intra-therapeutic heterogeneity of somatostatin receptor expression with morphological treatment response in patients undergoing PRRT with [177Lu]-DOTATATE.
    PLoS One. 2019;14:e0216781.
    PubMed     Abstract available

  259. ZHAO Z, Wu W, Duan X, Zeng G, et al
    The value of cytoreductive nephrectomy on the survival of metastatic renal carcinoma patients based on the number of site-specific metastases.
    PLoS One. 2019;14:e0215861.
    PubMed     Abstract available

  260. JEON MY, Kim HS, Lim TS, Han DH, et al
    Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection.
    PLoS One. 2019;14:e0214613.
    PubMed     Abstract available

  261. WANG Z, Gu X, Thrift AP
    Factors associated with favorable survival outcomes for Asians with hepatocellular carcinoma: A sequential matching cohort study.
    PLoS One. 2019;14:e0214721.
    PubMed     Abstract available

  262. GUPTA P, Sata TN, Yadav AK, Mishra A, et al
    TGF-beta induces liver fibrosis via miRNA-181a-mediated down regulation of augmenter of liver regeneration in hepatic stellate cells.
    PLoS One. 2019;14:e0214534.
    PubMed     Abstract available

  263. LAWRENCE YA, Guard BC, Steiner JM, Suchodolski JS, et al
    Untargeted metabolomic profiling of urine from healthy dogs and dogs with chronic hepatic disease.
    PLoS One. 2019;14:e0217797.
    PubMed     Abstract available

  264. GASSER E, Braunwarth E, Riedmann M, Cardini B, et al
    Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score.
    PLoS One. 2019;14:e0217411.
    PubMed     Abstract available

  265. HAMAOKA M, Kobayashi T, Tanaka Y, Mashima H, et al
    Clinical significance of glypican-3-positive circulating tumor cells of hepatocellular carcinoma patients: A prospective study.
    PLoS One. 2019;14:e0217586.
    PubMed     Abstract available

  266. SOMMA F, Stoia V, Serra N, D'Angelo R, et al
    Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: The impact of portal vein thrombosis on survival.
    PLoS One. 2019;14:e0216935.
    PubMed     Abstract available

  267. LI F, Dong YZ, Zhang D, Zhang XM, et al
    Molecular mechanisms involved in drug-induced liver injury caused by urate-lowering Chinese herbs: A network pharmacology study and biology experiments.
    PLoS One. 2019;14:e0216948.
    PubMed     Abstract available

  268. GANI SA, Muhammad SA, Kura AU, Barahuie F, et al
    Effect of protocatechuic acid-layered double hydroxide nanoparticles on diethylnitrosamine/phenobarbital-induced hepatocellular carcinoma in mice.
    PLoS One. 2019;14:e0217009.
    PubMed     Abstract available

  269. SOMDA S, Lebrun A, Tranchart H, Lamouri K, et al
    Adaptation of controlled attenuation parameter (CAP) measurement depth in morbidly obese patients addressed for bariatric surgery.
    PLoS One. 2019;14:e0217093.
    PubMed     Abstract available

  270. CARBONELL G, Berna-Serna JD, Oltra L, Martinez CM, et al
    Evaluation of rat liver with ARFI elastography: In vivo and ex vivo study.
    PLoS One. 2019;14:e0217297.
    PubMed     Abstract available

  271. EL AWDAN SA, Abdel Rahman RF, Ibrahim HM, Hegazy RR, et al
    Regression of fibrosis by cilostazol in a rat model of thioacetamide-induced liver fibrosis: Up regulation of hepatic cAMP, and modulation of inflammatory, oxidative stress and apoptotic biomarkers.
    PLoS One. 2019;14:e0216301.
    PubMed     Abstract available

  272. WITTAUER EM, Oldhafer F, Augstein E, Beetz O, et al
    Porcine model for the study of liver regeneration enhanced by non-invasive 13C-methacetin breath test (LiMAx test) and permanent portal venous access.
    PLoS One. 2019;14:e0217488.
    PubMed     Abstract available

  273. CUMSILLE P, Godoy M, Gerdtzen ZP, Conca C, et al
    Parameter estimation and mathematical modeling for the quantitative description of therapy failure due to drug resistance in gastrointestinal stromal tumor metastasis to the liver.
    PLoS One. 2019;14:e0217332.
    PubMed     Abstract available

  274. CHLEBUS G, Meine H, Thoduka S, Abolmaali N, et al
    Reducing inter-observer variability and interaction time of MR liver volumetry by combining automatic CNN-based liver segmentation and manual corrections.
    PLoS One. 2019;14:e0217228.
    PubMed     Abstract available

  275. HERATH RP, Siriwardana SR, Ekanayake CD, Abeysekara V, et al
    Non-alcoholic fatty liver disease and pregnancy complications among Sri Lankan women: A cross sectional analytical study.
    PLoS One. 2019;14:e0215326.
    PubMed     Abstract available

  276. HONG M, Hwang JT, Shin EJ, Hur HJ, et al
    Genome-wide analysis of DNA methylation identifies novel differentially methylated regions associated with lipid accumulation improved by ethanol extracts of Allium tubersosum and Capsella bursa-pastoris in a cell model.
    PLoS One. 2019;14:e0217877.
    PubMed     Abstract available

  277. JANSEN MJA, Kuijf HJ, Veldhuis WB, Wessels FJ, et al
    Automatic classification of focal liver lesions based on MRI and risk factors.
    PLoS One. 2019;14:e0217053.
    PubMed     Abstract available

  278. PARK J, Lee J, Kwon A, Choi HJ, et al
    The 2016 ASE/EACVI recommendations may be able to more accurately identify patients at risk for diastolic dysfunction in living donor liver transplantation.
    PLoS One. 2019;14:e0215603.
    PubMed     Abstract available

  279. FELL GL, Anez-Bustillos L, Dao DT, Baker MA, et al
    Alpha-tocopherol in intravenous lipid emulsions imparts hepatic protection in a murine model of hepatosteatosis induced by the enteral administration of a parenteral nutrition solution.
    PLoS One. 2019;14:e0217155.
    PubMed     Abstract available

  280. YEE C, Main NM, Terry A, Stevanovski I, et al
    CD147 mediates intrahepatic leukocyte aggregation and determines the extent of liver injury.
    PLoS One. 2019;14:e0215557.
    PubMed     Abstract available

  281. KAR S, Paglialunga S, Jaycox SH, Islam R, et al
    Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis.
    PLoS One. 2019;14:e0217263.
    PubMed     Abstract available

  282. PEDROZA M, To S, Smith J, Agarwal SK, et al
    Cadherin-11 contributes to liver fibrosis induced by carbon tetrachloride.
    PLoS One. 2019;14:e0218971.
    PubMed     Abstract available

  283. PENG CH, Lee HC, Jiang CB, Hsu CK, et al
    Serum vitamin D level is inversely associated with liver fibrosis in post Kasai's portoenterostomy biliary atresia patients living with native liver.
    PLoS One. 2019;14:e0218896.
    PubMed     Abstract available

  284. RIBERA J, Rodriguez-Vita J, Cordoba B, Portoles I, et al
    Functionalized cerium oxide nanoparticles mitigate the oxidative stress and pro-inflammatory activity associated to the portal vein endothelium of cirrhotic rats.
    PLoS One. 2019;14:e0218716.
    PubMed     Abstract available

  285. SALIC K, Kleemann R, Wilkins-Port C, McNulty J, et al
    Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-/-.Leiden mice.
    PLoS One. 2019;14:e0218459.
    PubMed     Abstract available

  286. LEE SK, Song MJ, Kim SH, Park M, et al
    Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study.
    PLoS One. 2019;14:e0216173.
    PubMed     Abstract available

  287. PANG K, Zhu Z, Zhu S, Han L, et al
    A high dose of conjugated linoleic acid increases fatty liver and insulin resistance in lactating mice.
    PLoS One. 2019;14:e0214903.
    PubMed     Abstract available

  288. KONG J, Wang T, Shen S, Zhang Z, et al
    A nomogram predicting the prognosis of young adult patients diagnosed with hepatocellular carcinoma: A population-based analysis.
    PLoS One. 2019;14:e0219654.
    PubMed     Abstract available

  289. DOLD L, Nielsen MJ, Praktiknjo M, Schwarze-Zander C, et al
    Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART.
    PLoS One. 2019;14:e0219526.
    PubMed     Abstract available

  290. HAGE C, Hoves S, Ashoff M, Schandl V, et al
    Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy.
    PLoS One. 2019;14:e0219517.
    PubMed     Abstract available

  291. MAIPANG K, Potranun P, Chainuvati S, Nimanong S, et al
    Validation of the prognostic models in acute-on-chronic liver failure precipitated by hepatic and extrahepatic insults.
    PLoS One. 2019;14:e0219516.
    PubMed     Abstract available

  292. DONNER DB, Nakakura EK, Venook AP, Lenz HJ, et al
    High thymidylate synthase gene expression predicts poor outcome after resection of hepatocellular carcinoma.
    PLoS One. 2019;14:e0219469.
    PubMed     Abstract available

  293. PENG W, Li JW, Zhang XY, Li C, et al
    A novel model for predicting posthepatectomy liver failure in patients with hepatocellular carcinoma.
    PLoS One. 2019;14:e0219219.
    PubMed     Abstract available

  294. WANG H, Lu J, Dolezal J, Kulkarni S, et al
    Inhibition of hepatocellular carcinoma by metabolic normalization.
    PLoS One. 2019;14:e0218186.
    PubMed     Abstract available

  295. YI H, Cai B, Ai X, Liu R, et al
    Value of contrast-enhanced ultrasound for preoperative assessment of liver reserve function in patients with liver tumors.
    PLoS One. 2019;14:e0222514.
    PubMed     Abstract available

  296. KOIZUMI Y, Hirooka M, Tamaki N, Yada N, et al
    New diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient on ultrasound B mode.
    PLoS One. 2019;14:e0221548.
    PubMed     Abstract available

  297. LEE SM, Kim BJ, Koo JN, Norwitz ER, et al
    Nonalcoholic fatty liver disease is a risk factor for large-for-gestational-age birthweight.
    PLoS One. 2019;14:e0221400.
    PubMed     Abstract available

  298. PFLUGRAD H, Tryc AB, Goldbecker A, Barg-Hock H, et al
    Cerebral metabolite alterations in patients with posttransplant encephalopathy after liver transplantation.
    PLoS One. 2019;14:e0221626.
    PubMed     Abstract available

  299. WAGNER J, Fillebeen C, Haliotis T, Charlebois E, et al
    Mouse models of hereditary hemochromatosis do not develop early liver fibrosis in response to a high fat diet.
    PLoS One. 2019;14:e0221455.
    PubMed     Abstract available

  300. ZHANG T, Runge JH, Lavini C, Stoker J, et al
    A pharmacokinetic model including arrival time for two inputs and compensating for varying applied flip-angle in dynamic gadoxetic acid-enhanced MR imaging.
    PLoS One. 2019;14:e0220835.
    PubMed     Abstract available

  301. KAIBORI M, Matsui K, Yoshii K, Ishizaki M, et al
    Perioperative exercise capacity in chronic liver injury patients with hepatocellular carcinoma undergoing hepatectomy.
    PLoS One. 2019;14:e0221079.
    PubMed     Abstract available

  302. PARK MR, Wong MS, Arauzo-Bravo MJ, Lee H, et al
    Oct4 and Hnf4alpha-induced hepatic stem cells ameliorate chronic liver injury in liver fibrosis model.
    PLoS One. 2019;14:e0221085.
    PubMed     Abstract available

  303. KIMMANN M, Tergast TL, Schultalbers M, Laser H, et al
    Sustained impact of nosocomial-acquired spontaneous bacterial peritonitis in different stages of decompensated liver cirrhosis.
    PLoS One. 2019;14:e0220666.
    PubMed     Abstract available

  304. LIN YM, Chiou YY, Wu MH, Huang SS, et al
    Postablation assessment of hepatocellular carcinoma using dual-energy CT: Comparison of half versus standard iodine contrast medium.
    PLoS One. 2019;14:e0219577.
    PubMed     Abstract available

  305. LI L, Shi M, Salerno S, Tang M, et al
    Microbial and metabolomic remodeling by a formula of Sichuan dark tea improves hyperlipidemia in apoE-deficient mice.
    PLoS One. 2019;14:e0219010.
    PubMed     Abstract available

  306. QUECK A, Thomas D, Jansen C, Schreiber Y, et al
    Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosis.
    PLoS One. 2019;14:e0222840.
    PubMed     Abstract available

  307. ZHANG BH, Li B, Kong LX, Yan LN, et al
    Diagnostic accuracy of midkine on hepatocellular carcinoma: A meta-analysis.
    PLoS One. 2019;14:e0223514.
    PubMed     Abstract available

  308. BROCK GN, Washburn K, Marvin MR
    Use of rapid Model for End-Stage Liver Disease (MELD) increases for liver transplant registrant prioritization after MELD-Na and Share 35, an evaluation using data from the United Network for Organ Sharing.
    PLoS One. 2019;14:e0223053.
    PubMed     Abstract available

  309. BERNI ER, Jones BI, Berni TR, Whitehouse J, et al
    The Model of Mortality with Incident Cirrhosis (MoMIC) and the model of Long-term Outlook of Mortality in Cirrhosis (LOMiC).
    PLoS One. 2019;14:e0223253.
    PubMed     Abstract available

  310. ZHAO Y, Zhang Y, Vazirinejad Mehdiabad M, Zhou K, et al
    Enhanced anti-tumor effect of liposomal Fasudil on hepatocellular carcinoma in vitro and in vivo.
    PLoS One. 2019;14:e0223232.
    PubMed     Abstract available

  311. OUD L
    In-hospital cardiopulmonary resuscitation of patients with cirrhosis: A population-based analysis.
    PLoS One. 2019;14:e0222873.
    PubMed     Abstract available

  312. NAVARRO VJ, Belle SH, D'Amato M, Adfhal N, et al
    Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial.
    PLoS One. 2019;14:e0221683.
    PubMed     Abstract available

  313. SONG SK, Jung WY, Park SK, Chung CW, et al
    Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection.
    PLoS One. 2019;14:e0216847.
    PubMed     Abstract available

  314. ZHANG J, Zhao Z, Bai H, Wang M, et al
    Genetic polymorphisms in PXR and NF-kappaB1 influence susceptibility to anti-tuberculosis drug-induced liver injury.
    PLoS One. 2019;14:e0222033.
    PubMed     Abstract available

  315. KAUR H, Bhalla S, Raghava GPS
    Classification of early and late stage liver hepatocellular carcinoma patients from their genomics and epigenomics profiles.
    PLoS One. 2019;14:e0221476.
    PubMed     Abstract available

  316. TEREFE TESFAYE B, Gudina EK, Bosho DD, Mega TA, et al
    Short-term clinical outcomes of patients admitted with chronic liver disease to selected teaching hospitals in Ethiopia.
    PLoS One. 2019;14:e0221806.
    PubMed     Abstract available

  317. WARGNY M, Smati S, Pichelin M, Bigot-Corbel E, et al
    Fatty liver index is a strong predictor of changes in glycemic status in people with prediabetes: The IT-DIAB study.
    PLoS One. 2019;14:e0221524.
    PubMed     Abstract available

  318. VAN DEN BERG EH, Corsetti JP, Bakker SJL, Dullaart RPF, et al
    Plasma ApoE elevations are associated with NAFLD: The PREVEND Study.
    PLoS One. 2019;14:e0220659.
    PubMed     Abstract available

  319. WONG RJ, Tran T, Kaufman H, Niles J, et al
    Increasing metabolic co-morbidities are associated with higher risk of advanced fibrosis in nonalcoholic steatohepatitis.
    PLoS One. 2019;14:e0220612.
    PubMed     Abstract available

  320. GERHARD GS, Hanson A, Wilhelmsen D, Piras IS, et al
    AEBP1 expression increases with severity of fibrosis in NASH and is regulated by glucose, palmitate, and miR-372-3p.
    PLoS One. 2019;14:e0219764.
    PubMed     Abstract available

  321. CHOI C, Son A, Lee GH, Shin SW, et al
    Targeting DNA-dependent protein kinase sensitizes hepatocellular carcinoma cells to proton beam irradiation through apoptosis induction.
    PLoS One. 2019;14:e0218049.
    PubMed     Abstract available

  322. RENNERT J, Wiesinger I, Schicho A, Beyer LP, et al
    Color coded perfusion imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following trans-arterial chemoembolization (TACE) of hepatocellular carcinoma.
    PLoS One. 2019;14:e0217599.
    PubMed     Abstract available

  323. OLDANI G, Peloso A, Slits F, Gex Q, et al
    The impact of short-term machine perfusion on the risk of cancer recurrence after rat liver transplantation with donors after circulatory death.
    PLoS One. 2019;14:e0224890.
    PubMed     Abstract available

  324. ARAI T, Atsukawa M, Tsubota A, Kawano T, et al
    Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease.
    PLoS One. 2019;14:e0224184.
    PubMed     Abstract available

  325. SEMMLER G, Scheiner B, Schwabl P, Bucsics T, et al
    The impact of hepatic steatosis on portal hypertension.
    PLoS One. 2019;14:e0224506.
    PubMed     Abstract available

  326. NIRIELLA MA, Kasturiratna A, Beddage T, Ediriweera DS, et al
    Non-resolution of non-alcoholic fatty liver disease (NAFLD) among urban, adult Sri Lankans in the general population: A prospective, cohort follow-up study.
    PLoS One. 2019;14:e0224474.
    PubMed     Abstract available

  327. CHUANG PY, Yang TY, Huang TW, Tsai YH, et al
    Hepatic disease and the risk of mortality of Vibrio vulnificus necrotizing skin and soft tissue infections: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0223513.
    PubMed     Abstract available

  328. MARTINEZ-HERRERO MDC, Garijo-Toledo MM, Gonzalez F, Bilic I, et al
    Membrane associated proteins of two Trichomonas gallinae clones vary with the virulence.
    PLoS One. 2019;14:e0224032.
    PubMed     Abstract available

  329. FOLADOR L, Torres FS, Zampieri JF, Machado BC, et al
    Hepatopulmonary syndrome has low prevalence of pulmonary vascular abnormalities on chest computed tomography.
    PLoS One. 2019;14:e0223805.
    PubMed     Abstract available

  330. KIM BK, Kim DY, Han KH, Seong J, et al
    Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study.
    PLoS One. 2019;14:e0223678.
    PubMed     Abstract available

  331. DING W, Tan Y, Qian Y, Xue W, et al
    Clinicopathologic and prognostic significance of tumor-associated macrophages in patients with hepatocellular carcinoma: A meta-analysis.
    PLoS One. 2019;14:e0223971.
    PubMed     Abstract available

  332. KAYS JK, Milgrom DP, Butler JR, Liang TW, et al
    Specialized care improves outcomes for patients with cirrhosis who require general surgical operations.
    PLoS One. 2019;14:e0223454.
    PubMed     Abstract available

  333. WU VC, Chen SW, Chou AH, Ting PC, et al
    Dual antiplatelet therapy in patients with cirrhosis and acute myocardial infarction - A 13-year nationwide cohort study.
    PLoS One. 2019;14:e0223380.
    PubMed     Abstract available

  334. HIGARZA SG, Arboleya S, Gueimonde M, Gomez-Lazaro E, et al
    Neurobehavioral dysfunction in non-alcoholic steatohepatitis is associated with hyperammonemia, gut dysbiosis, and metabolic and functional brain regional deficits.
    PLoS One. 2019;14:e0223019.
    PubMed     Abstract available

  335. SAEKI I, Yamasaki T, Maeda M, Hisanaga T, et al
    Effect of body composition on survival benefit of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: A comparison with sorafenib therapy.
    PLoS One. 2019;14:e0218136.
    PubMed     Abstract available

  336. WERNBERG CW, Schaffalitzky de Muckadell OB, Vilstrup H, M Lauridsen M, et al
    Prediction of overt hepatic encephalopathy by the continuous reaction time method and the portosystemic encephalopathy syndrome test in clinically mentally unimpaired patients with cirrhosis.
    PLoS One. 2019;14:e0226283.
    PubMed     Abstract available

  337. KATO S, Iwasaki A, Kurita Y, Arimoto J, et al
    Three-dimensional analysis of pancreatic fat by fat-water magnetic resonance imaging provides detailed characterization of pancreatic steatosis with improved reproducibility.
    PLoS One. 2019;14:e0224921.
    PubMed     Abstract available

  338. FU CP, Ali H, Rachakonda VP, Oczypok EA, et al
    The ZJU index is a powerful surrogate marker for NAFLD in severely obese North American women.
    PLoS One. 2019;14:e0224942.
    PubMed     Abstract available

  339. KONNO R, Tatebe S, Sugimura K, Satoh K, et al
    Prognostic value of the model for end-stage liver disease excluding INR score (MELD-XI) in patients with adult congenital heart disease.
    PLoS One. 2019;14:e0225403.
    PubMed     Abstract available

  340. LOHOFER FK, Kaissis GA, Muller-Leisse C, Franz D, et al
    Acceleration of chemical shift encoding-based water fat MRI for liver proton density fat fraction and T2* mapping using compressed sensing.
    PLoS One. 2019;14:e0224988.
    PubMed     Abstract available

  341. YANG M, Zhang X, Liu J
    Prognostic value of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma treated with transarterial chemotherapy: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0225170.
    PubMed     Abstract available

  342. YUAN WH, Li AF, Hsu HC, Hu YS, et al
    Initial clinical radiological findings and staging to predict prognosis of primary hepatic angiosarcoma: A retrospective analysis.
    PLoS One. 2019;14:e0225043.
    PubMed     Abstract available

  343. ERHARTOVA D, Cahova M, Dankova H, Heczkova M, et al
    Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation.
    PLoS One. 2019;14:e0224820.
    PubMed     Abstract available

  344. GROENER JB, Valkanou A, Kender Z, Pfeiffenberger J, et al
    Asprosin response in hypoglycemia is not related to hypoglycemia unawareness but rather to insulin resistance in type 1 diabetes.
    PLoS One. 2019;14:e0222771.
    PubMed     Abstract available

  345. GARNAES E, Mortensen C, Hobolth L, Andersen O, et al
    Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis.
    PLoS One. 2019;14:e0220697.
    PubMed     Abstract available

  346. HOWELL AK, McCann CM, Wickstead F, Williams DJL, et al
    Co-infection of cattle with Fasciola hepatica or F. gigantica and Mycobacterium bovis: A systematic review.
    PLoS One. 2019;14:e0226300.
    PubMed     Abstract available

  347. SUDJARITRUK T, Bunupuradah T, Aurpibul L, Kosalaraksa P, et al
    Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy.
    PLoS One. 2019;14:e0226375.
    PubMed     Abstract available

  348. ERKAN B, Meier J, Clark TJ, Kaplan J, et al
    Non-invasive diagnostic criteria of hepatocellular carcinoma: Comparison of diagnostic accuracy of updated LI-RADS with clinical practice guidelines of OPTN-UNOS, AASLD, NCCN, EASL-EORTC, and KLSCG-NCC.
    PLoS One. 2019;14:e0226291.
    PubMed     Abstract available

  349. ABBASS MA, Ahmad SA, Mahalingam N, Krothapalli KS, et al
    In vivo ultrasound thermal ablation control using echo decorrelation imaging in rabbit liver and VX2 tumor.
    PLoS One. 2019;14:e0226001.
    PubMed     Abstract available

  350. SU RC, Lad A, Breidenbach JD, Blomquist TM, et al
    Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD).
    PLoS One. 2019;14:e0225604.
    PubMed     Abstract available

  351. ZHONG GC, Liu S, Wu YL, Xia M, et al
    ABO blood group and risk of newly diagnosed nonalcoholic fatty liver disease: A case-control study in Han Chinese population.
    PLoS One. 2019;14:e0225792.
    PubMed     Abstract available

  352. SCOTT C, Stokes R, Cha KM, Clouston A, et al
    Myeloid cell deletion of Aryl hydrocarbon Receptor Nuclear Translocator (ARNT) induces non-alcoholic steatohepatitis.
    PLoS One. 2019;14:e0225332.
    PubMed     Abstract available

  353. WELDEAREGAY KT, Gebrekidan MG, Gezahegne AA
    Health impact of hepatic-venous-occlusive disease in a small town in Ethiopia-Case study from Tahtay koraro district in Tigray region, 2017.
    PLoS One. 2019;14:e0224659.
    PubMed     Abstract available

  354. SENDRA L, Herrero MJ, Montalva EM, Noguera I, et al
    Efficacy of interleukin 10 gene hydrofection in pig liver vascular isolated 'in vivo' by surgical procedure with interest in liver transplantation.
    PLoS One. 2019;14:e0224568.
    PubMed     Abstract available

  355. YANG S, Kwak S, Lee JH, Kang S, et al
    Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population.
    PLoS One. 2019;14:e0224626.
    PubMed     Abstract available

  356. BUCHER JN, Koenig M, Schoenberg MB, Crispin A, et al
    Liver transplantation in patients with a history of migration-A German single center comparative analysis.
    PLoS One. 2019;14:e0224116.
    PubMed     Abstract available

  357. BAJAJ JS, Fan S, Thacker LR, Fagan A, et al
    Serum and urinary metabolomics and outcomes in cirrhosis.
    PLoS One. 2019;14:e0223061.
    PubMed     Abstract available

  358. ISHIKAWA T, Sasaki R, Nishimura T, Aibe Y, et al
    A novel therapeutic strategy for esophageal varices using endoscopic treatment combined with splenic artery embolization according to the Child-Pugh classification.
    PLoS One. 2019;14:e0223153.
    PubMed     Abstract available

  359. LIU Y, Liu X, Wang Y, Yi C, et al
    Protective effect of lactobacillus plantarum on alcoholic liver injury and regulating of keap-Nrf2-ARE signaling pathway in zebrafish larvae.
    PLoS One. 2019;14:e0222339.
    PubMed     Abstract available

  360. LEVICK C, Phillips-Hughes J, Collier J, Banerjee R, et al
    Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: A proof of concept study.
    PLoS One. 2019;14:e0221066.
    PubMed     Abstract available

  361. MIN-DEBARTOLO J, Schlerman F, Akare S, Wang J, et al
    Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH).
    PLoS One. 2019;14:e0226854.
    PubMed     Abstract available

    January 2018
  362. SHI T, Yang X, Zhou H, Xi J, et al
    Activated carbon N-acetylcysteine microcapsule protects against nonalcoholic fatty liver disease in young rats via activating telomerase and inhibiting apoptosis.
    PLoS One. 2018;13:e0189856.
    PubMed     Abstract available

  363. BUCSICS T, Schoder M, Diermayr M, Feldner-Busztin M, et al
    Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experience.
    PLoS One. 2018;13:e0189414.
    PubMed     Abstract available

  364. XU R, Jiang YF, Zhang YH, Yang X, et al
    The optimal threshold of serum ceruloplasmin in the diagnosis of Wilson's disease: A large hospital-based study.
    PLoS One. 2018;13:e0190887.
    PubMed     Abstract available

  365. SARACINO A, Cozzi-Lepri A, Shanyinde M, Ceccherini Silberstein F, et al
    HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients.
    PLoS One. 2018;13:e0190302.
    PubMed     Abstract available

  366. WANG TH, Huang PI, Hu YW, Lin KH, et al
    Combined Yttrium-90 microsphere selective internal radiation therapy and external beam radiotherapy in patients with hepatocellular carcinoma: From clinical aspects to dosimetry.
    PLoS One. 2018;13:e0190098.
    PubMed     Abstract available

  367. CHEN WT, Lin GB, Lin SH, Lu CH, et al
    Static magnetic field enhances the anticancer efficacy of capsaicin on HepG2 cells via capsaicin receptor TRPV1.
    PLoS One. 2018;13:e0191078.
    PubMed     Abstract available

  368. HUANG Z, Huang J, Zhou T, Cao H, et al
    Prognostic value of liver stiffness measurement for the liver-related surgical outcomes of patients under hepatic resection: A meta-analysis.
    PLoS One. 2018;13:e0190512.
    PubMed     Abstract available

  369. CHOI YJ, Park SJ, Park YS, Park HS, et al
    EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells.
    PLoS One. 2018;13:e0190638.
    PubMed     Abstract available

  370. MULABECIROVIC A, Mjelle AB, Gilja OH, Vesterhus M, et al
    Repeatability of shear wave elastography in liver fibrosis phantoms-Evaluation of five different systems.
    PLoS One. 2018;13:e0189671.
    PubMed     Abstract available

  371. KAWAGUCHI T, Shima T, Mizuno M, Mitsumoto Y, et al
    Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers.
    PLoS One. 2018;13:e0185490.
    PubMed     Abstract available

  372. TESHIMA T, Matsumoto H, Koyama H
    Soluble factors from adipose tissue-derived mesenchymal stem cells promote canine hepatocellular carcinoma cell proliferation and invasion.
    PLoS One. 2018;13:e0191539.
    PubMed     Abstract available

  373. PAPACKOVA Z, Heczkova M, Dankova H, Sticova E, et al
    Silymarin prevents acetaminophen-induced hepatotoxicity in mice.
    PLoS One. 2018;13:e0191353.
    PubMed     Abstract available

  374. OTEGBEYE F, Ojo E, Moreton S, Mackowski N, et al
    Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models.
    PLoS One. 2018;13:e0191358.
    PubMed     Abstract available

  375. HE X, Wu J, Holtorf AP, Rinde H, et al
    Health economic assessment of Gd-EOB-DTPA MRI versus ECCM-MRI and multi-detector CT for diagnosis of hepatocellular carcinoma in China.
    PLoS One. 2018;13:e0191095.
    PubMed     Abstract available

  376. GONG L, Huang YT, Wong CH, Chao WC, et al
    Culture-independent analysis of liver abscess using nanopore sequencing.
    PLoS One. 2018;13:e0190853.
    PubMed     Abstract available

  377. BENMASSAOUD A, Ghali P, Cox J, Wong P, et al
    Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection.
    PLoS One. 2018;13:e0191985.
    PubMed     Abstract available

  378. NARAN NH, Haagensen M, Crowther NJ
    Steatosis in South African women: How much and why?
    PLoS One. 2018;13:e0191388.
    PubMed     Abstract available

  379. FERRIGNO A, Di Pasqua LG, Berardo C, Siciliano V, et al
    The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury.
    PLoS One. 2018;13:e0191430.
    PubMed     Abstract available

  380. YAMADA K, Mizukoshi E, Seike T, Horii R, et al
    Light alcohol consumption has the potential to suppress hepatocellular injury and liver fibrosis in non-alcoholic fatty liver disease.
    PLoS One. 2018;13:e0191026.
    PubMed     Abstract available

  381. LIANG DY, Huang W, Chang Q, Hou YQ, et al
    ShDcR3 sensitizes TRAIL-resistant HCC cells by inducing caspase-dependent apoptosis while suppressing NF-kappaB dependent cFLIPL expression.
    PLoS One. 2018;13:e0191545.
    PubMed     Abstract available

  382. LE CT, Nguyen G, Park SY, Choi DH, et al
    LY2405319, an analog of fibroblast growth factor 21 ameliorates alpha-smooth muscle actin production through inhibition of the succinate-G-protein couple receptor 91 (GPR91) pathway in mice.
    PLoS One. 2018;13:e0192146.
    PubMed     Abstract available

  383. CHANG W, Lee JM, Lee DH, Yoon JH, et al
    Comparison of switching bipolar ablation with multiple cooled wet electrodes and switching monopolar ablation with separable clustered electrode in treatment of small hepatocellular carcinoma: A randomized controlled trial.
    PLoS One. 2018;13:e0192173.
    PubMed     Abstract available

  384. MAIOLI M, Basoli V, Carta P, Fabbri D, et al
    Synthesis of magnolol and honokiol derivatives and their effect against hepatocarcinoma cells.
    PLoS One. 2018;13:e0192178.
    PubMed     Abstract available

  385. RAUBER P, Lammert F, Grotemeyer K, Appenrodt B, et al
    Immature platelet fraction and thrombopoietin in patients with liver cirrhosis: A cohort study.
    PLoS One. 2018;13:e0192271.
    PubMed     Abstract available

  386. GONZALEZ-CANTERO J, Martin-Rodriguez JL, Gonzalez-Cantero A, Arrebola JP, et al
    Insulin resistance in lean and overweight non-diabetic Caucasian adults: Study of its relationship with liver triglyceride content, waist circumference and BMI.
    PLoS One. 2018;13:e0192663.
    PubMed     Abstract available

  387. YANG C, Yang S, Feng C, Zhang C, et al
    Associations of hyperuricemia and obesity with remission of nonalcoholic fatty liver disease among Chinese men: A retrospective cohort study.
    PLoS One. 2018;13:e0192396.
    PubMed     Abstract available

  388. PRAKTIKNJO M, Krabbe V, Pohlmann A, Sampels M, et al
    Evolution of nodule stiffness might predict response to local ablative therapy: A series of patients with hepatocellular carcinoma.
    PLoS One. 2018;13:e0192897.
    PubMed     Abstract available

  389. EBERHARDT C, Wurnig MC, Wirsching A, Rossi C, et al
    Prediction of small for size syndrome after extended hepatectomy: Tissue characterization by relaxometry, diffusion weighted magnetic resonance imaging and magnetization transfer.
    PLoS One. 2018;13:e0192847.
    PubMed     Abstract available

  390. PACHIKIAN BD, Druart C, Catry E, Bindels LB, et al
    Implication of trans-11,trans-13 conjugated linoleic acid in the development of hepatic steatosis.
    PLoS One. 2018;13:e0192447.
    PubMed     Abstract available

  391. YETTI H, Naito H, Yuan Y, Jia X, et al
    Bile acid detoxifying enzymes limit susceptibility to liver fibrosis in female SHRSP5/Dmcr rats fed with a high-fat-cholesterol diet.
    PLoS One. 2018;13:e0192863.
    PubMed     Abstract available

  392. ROMERO-IBARGUENGOITIA ME, Vadillo-Ortega F, Caballero AE, Ibarra-Gonzalez I, et al
    Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach.
    PLoS One. 2018;13:e0193138.
    PubMed     Abstract available

  393. KAKOSCHKY B, Pleli T, Schmithals C, Zeuzem S, et al
    Selective targeting of tumor associated macrophages in different tumor models.
    PLoS One. 2018;13:e0193015.
    PubMed     Abstract available

  394. SZYMCZAK M, Kalicinski P, Kowalewski G, Broniszczak D, et al
    Acute liver failure in children-Is living donor liver transplantation justified?
    PLoS One. 2018;13:e0193327.
    PubMed     Abstract available

  395. LEE JE, Lee YJ, Chung SY, Cho HW, et al
    Severity of nonalcoholic fatty liver disease is associated with subclinical cerebro-cardiovascular atherosclerosis risk in Korean men.
    PLoS One. 2018;13:e0193191.
    PubMed     Abstract available

  396. CHRISTENSEN CU, Glavind E, Thomsen KL, Kim YO, et al
    Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease.
    PLoS One. 2018;13:e0192728.
    PubMed     Abstract available

  397. HOF J, Joosten HJ, Havenga K, de Jong KP, et al
    Radiofrequency ablation is beneficial in simultaneous treatment of synchronous liver metastases and primary colorectal cancer.
    PLoS One. 2018;13:e0193385.
    PubMed     Abstract available

  398. MAYR U, Karsten E, Lahmer T, Rasch S, et al
    Impact of large volume paracentesis on respiratory parameters including transpulmonary pressure and on transpulmonary thermodilution derived hemodynamics: A prospective study.
    PLoS One. 2018;13:e0193654.
    PubMed     Abstract available

  399. ZEKRI AN, El-Sisi ER, Youssef ASE, Kamel MM, et al
    MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection.
    PLoS One. 2018;13:e0193709.
    PubMed     Abstract available

  400. LUO L, Aubrecht J, Li D, Warner RL, et al
    Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans.
    PLoS One. 2018;13:e0193824.
    PubMed     Abstract available

  401. WATTANAVANITCHAKORN S, Rojvirat P, Chavalit T, MacDonald MJ, et al
    CCAAT-enhancer binding protein-alpha (C/EBPalpha) and hepatocyte nuclear factor 4alpha (HNF4alpha) regulate expression of the human fructose-1,6-bisphosphatase 1 (FBP1) gene in human hepatocellular carcinoma HepG2 cells.
    PLoS One. 2018;13:e0194252.
    PubMed     Abstract available

  402. HEMMINGER J, Arole V, Ayoub I, Brodsky SV, et al
    Acute glomerulonephritis with large confluent IgA-dominant deposits associated with liver cirrhosis.
    PLoS One. 2018;13:e0193274.
    PubMed     Abstract available

  403. TANNUS RK, Almeida-Carvalho SR, Loureiro-Matos CA, Miziara-Gonzalez A, et al
    Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systems.
    PLoS One. 2018;13:e0194922.
    PubMed     Abstract available

  404. SHAHEEN AA, Kaplan GG, Almishri W, Vallerand I, et al
    The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes.
    PLoS One. 2018;13:e0194839.
    PubMed     Abstract available

  405. BIAN S, Chen H, Wang L, Fei Y, et al
    Cardiac involvement in patients with primary biliary cholangitis: A 14-year longitudinal survey-based study.
    PLoS One. 2018;13:e0194397.
    PubMed     Abstract available

  406. LIAO CY, Chung CH, Chu P, Wei KY, et al
    Increased risk of osteoporosis in patients with primary biliary cirrhosis.
    PLoS One. 2018;13:e0194418.
    PubMed     Abstract available

  407. ALEXANDER KS, Zakai NA, Lidofsky SD, Callas PW, et al
    Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort.
    PLoS One. 2018;13:e0194153.
    PubMed     Abstract available

  408. KELLER S, Aigner A, Zenouzi R, Kim AC, et al
    Association of gadolinium-enhanced magnetic resonance imaging with hepatic fibrosis and inflammation in primary sclerosing cholangitis.
    PLoS One. 2018;13:e0193929.
    PubMed     Abstract available

  409. JANSEN C, Al-Kassou B, Lehmann J, Pohlmann A, et al
    Severe abnormal Heart Rate Turbulence Onset is associated with deterioration of liver cirrhosis.
    PLoS One. 2018;13:e0195631.
    PubMed     Abstract available

  410. HONDA F, Hiramatsu A, Hyogo H, Aikata H, et al
    Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring.
    PLoS One. 2018;13:e0195028.
    PubMed     Abstract available

  411. CHENG YL, Shu JH, Hsu HC, Liang Y, et al
    High health literacy is associated with less obesity and lower Framingham risk score: Sub-study of the VGH-HEALTHCARE trial.
    PLoS One. 2018;13:e0194813.
    PubMed     Abstract available

  412. ONICIU DC, Hashiguchi T, Shibazaki Y, Bisgaier CL, et al
    Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM model of NASH.
    PLoS One. 2018;13:e0194568.
    PubMed     Abstract available

  413. PARK IK, Yu JS, Cho ES, Kim JH, et al
    Apparent diffusion coefficient of hepatocellular carcinoma on diffusion-weighted imaging: Histopathologic tumor grade versus arterial vascularity during dynamic magnetic resonance imaging.
    PLoS One. 2018;13:e0197070.
    PubMed     Abstract available

  414. YUAN LT, Chuah SK, Yang SC, Liang CM, et al
    Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosis.
    PLoS One. 2018;13:e0197127.
    PubMed     Abstract available

  415. AXLEY P, Mudumbi S, Sarker S, Kuo YF, et al
    Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications.
    PLoS One. 2018;13:e0197117.
    PubMed     Abstract available

  416. MAK D, Babb de Villiers C, Chasela C, Urban MI, et al
    Analysis of risk factors associated with hepatocellular carcinoma in black South Africans: 2000-2012.
    PLoS One. 2018;13:e0196057.
    PubMed     Abstract available

  417. ZHANG B, Chen M, Zhang Y, Chen W, et al
    An ultrasonic nanobubble-mediated PNP/fludarabine suicide gene system: A new approach for the treatment of hepatocellular carcinoma.
    PLoS One. 2018;13:e0196686.
    PubMed     Abstract available

  418. SU YB, Li TH, Huang CC, Tsai HC, et al
    Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal/adipose tissue alteration in a diet-induced steatohepatitis rat model.
    PLoS One. 2018;13:e0194867.
    PubMed     Abstract available

  419. OKAMOTO M, Miyake T, Kitai K, Furukawa S, et al
    Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: A longitudinal cohort study.
    PLoS One. 2018;13:e0195147.
    PubMed     Abstract available

  420. BONNET E, Moutet ML, Baulard C, Bacq-Daian D, et al
    Performance comparison of three DNA extraction kits on human whole-exome data from formalin-fixed paraffin-embedded normal and tumor samples.
    PLoS One. 2018;13:e0195471.
    PubMed     Abstract available

  421. FRICKE IB, De Souza R, Costa Ayub L, Francia G, et al
    Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice.
    PLoS One. 2018;13:e0196892.
    PubMed     Abstract available

  422. DUTTA S, Chakraborty AK, Dey P, Kar P, et al
    Amelioration of CCl4 induced liver injury in swiss albino mice by antioxidant rich leaf extract of Croton bonplandianus Baill.
    PLoS One. 2018;13:e0196411.
    PubMed     Abstract available

  423. REITER R, Wetzel M, Hamesch K, Strnad P, et al
    Comparison of non-invasive assessment of liver fibrosis in patients with alpha1-antitrypsin deficiency using magnetic resonance elastography (MRE), acoustic radiation force impulse (ARFI) Quantification, and 2D-shear wave elastography (2D-SWE).
    PLoS One. 2018;13:e0196486.
    PubMed     Abstract available

  424. OFFOR O, Utay N, Reynoso D, Somasunderam A, et al
    Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy.
    PLoS One. 2018;13:e0196395.
    PubMed     Abstract available

  425. KROHN S, Zeller K, Bohm S, Chatzinotas A, et al
    Molecular quantification and differentiation of Candida species in biological specimens of patients with liver cirrhosis.
    PLoS One. 2018;13:e0197319.
    PubMed     Abstract available

  426. TINGUELY P, Schwalbe M, Fuss T, Guensch DP, et al
    Multi-Operational Selective Computer-Assisted Targeting of hepatocellular carcinoma-Evaluation of a novel approach for navigated tumor ablation.
    PLoS One. 2018;13:e0197914.
    PubMed     Abstract available

  427. ZHAO W, Liu W, Liu H, Yi X, et al
    Preoperative prediction of microvascular invasion of hepatocellular carcinoma with IVIM diffusion-weighted MR imaging and Gd-EOB-DTPA-enhanced MR imaging.
    PLoS One. 2018;13:e0197488.
    PubMed     Abstract available

  428. KALMAN R, Stawarz A, Nunes D, Zhang D, et al
    Biophotonic detection of high order chromatin alterations in field carcinogenesis predicts risk of future hepatocellular carcinoma: A pilot study.
    PLoS One. 2018;13:e0197427.
    PubMed     Abstract available

  429. SETHUNATH D, Morusu S, Tuceryan M, Cummings OW, et al
    Automated assessment of steatosis in murine fatty liver.
    PLoS One. 2018;13:e0197242.
    PubMed     Abstract available

  430. UMEHARA T
    Nonalcoholic fatty liver disease with elevated alanine aminotransferase levels is negatively associated with bone mineral density: Cross-sectional study in U.S. adults.
    PLoS One. 2018;13:e0197900.
    PubMed     Abstract available

  431. WANG HW, Shi HN, Cheng J, Xie F, et al
    Real-time shear wave elastography (SWE) assessment of short- and long-term treatment outcome in Budd-Chiari syndrome: A pilot study.
    PLoS One. 2018;13:e0197550.
    PubMed     Abstract available

  432. MILLINGS EJ, De Rosa MC, Fleet S, Watanabe K, et al
    ILDR2 has a negligible role in hepatic steatosis.
    PLoS One. 2018;13:e0197548.
    PubMed     Abstract available

  433. LUDWIG JM, Zhang Y, Chamulitrat W, Stremmel W, et al
    Anti-inflammatory properties of ursodeoxycholyl lysophosphatidylethanolamide in endotoxin-mediated inflammatory liver injury.
    PLoS One. 2018;13:e0197836.
    PubMed     Abstract available

  434. CALLE RUBIO M, Soriano JB, Lopez-Campos JL, Soler-Cataluna JJ, et al
    Testing for alpha-1 antitrypsin in COPD in outpatient respiratory clinics in Spain: A multilevel, cross-sectional analysis of the EPOCONSUL study.
    PLoS One. 2018;13:e0198777.
    PubMed     Abstract available

  435. TSAI WC, Kung PT, Wang YH, Kuo WY, et al
    Influence of the time interval from diagnosis to treatment on survival for early-stage liver cancer.
    PLoS One. 2018;13:e0199532.
    PubMed     Abstract available

  436. CHANG PE, Goh GBB, Leow WQ, Shen L, et al
    Second harmonic generation microscopy provides accurate automated staging of liver fibrosis in patients with non-alcoholic fatty liver disease.
    PLoS One. 2018;13:e0199166.
    PubMed     Abstract available

  437. BHATT SP, Guleria R, Vikram NK, Nandhan SV, et al
    Association of inflammatory genes in obstructive sleep apnea and non alcoholic fatty liver disease in Asian Indians residing in north India.
    PLoS One. 2018;13:e0199599.
    PubMed     Abstract available

  438. OBMANN VC, Mertineit N, Berzigotti A, Marx C, et al
    CT predicts liver fibrosis: Prospective evaluation of morphology- and attenuation-based quantitative scores in routine portal venous abdominal scans.
    PLoS One. 2018;13:e0199611.
    PubMed     Abstract available

  439. HWANG A, Shi C, Zhu E, Naaz F, et al
    Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH.
    PLoS One. 2018;13:e0198937.
    PubMed     Abstract available

  440. TAKADA H, Kurosaki M, Nakanishi H, Takahashi Y, et al
    Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma.
    PLoS One. 2018;13:e0198812.
    PubMed     Abstract available

  441. CHEN CT, Lee HL, Chiou HL, Chou CH, et al
    Impacts of WNT1-inducible signaling pathway protein 1 polymorphism on hepatocellular carcinoma development.
    PLoS One. 2018;13:e0198967.
    PubMed     Abstract available

  442. SATSANGI S, Duseja A, Sachdeva M, Tomer S, et al
    Monocyte human leukocyte antigen - Antigen D related, neutrophil oxidative burst and cytokine analysis in patients of decompensated cirrhosis with and without acute-on chronic liver failure.
    PLoS One. 2018;13:e0200644.
    PubMed     Abstract available

  443. CRESSMAN ENK, Guo C, Karbasian N
    Image-guided chemistry altering biology: An in vivo study of thermoembolization.
    PLoS One. 2018;13:e0200471.
    PubMed     Abstract available

  444. CHOI BH, Jin Z, Yi CO, Oh J, et al
    Effects of lobeglitazone on insulin resistance and hepatic steatosis in high-fat diet-fed mice.
    PLoS One. 2018;13:e0200336.
    PubMed     Abstract available

  445. DALVI PS, Yang S, Swain N, Kim J, et al
    Long-term metabolic effects of malnutrition: Liver steatosis and insulin resistance following early-life protein restriction.
    PLoS One. 2018;13:e0199916.
    PubMed     Abstract available

  446. UCHINO K, Tateishi R, Nakagomi R, Fujiwara N, et al
    Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablation.
    PLoS One. 2018;13:e0200943.
    PubMed     Abstract available

  447. RINGE KI, von Falck C, Raatschen HJ, Wacker F, et al
    Evaluation of transient respiratory motion artifact at gadoxetate disodium-enhanced MRI-Influence of different contrast agent application protocols.
    PLoS One. 2018;13:e0200887.
    PubMed     Abstract available

  448. LIMA JG, Nobrega LHC, Lima NN, Dos Santos MCF, et al
    Causes of death in patients with Berardinelli-Seip congenital generalized lipodystrophy.
    PLoS One. 2018;13:e0199052.
    PubMed     Abstract available

  449. WANG X, Kwak KJ, Yang Z, Zhang A, et al
    Extracellular mRNA detected by molecular beacons in tethered lipoplex nanoparticles for diagnosis of human hepatocellular carcinoma.
    PLoS One. 2018;13:e0198552.
    PubMed     Abstract available

  450. JARZABEK MA, Proctor WR, Vogt J, Desai R, et al
    Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancer.
    PLoS One. 2018;13:e0198099.
    PubMed     Abstract available

  451. NA SK, Choi GH, Lee HC, Shin YM, et al
    The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.
    PLoS One. 2018;13:e0198138.
    PubMed     Abstract available

  452. FRANCH-NADAL J, Caballeria L, Mata-Cases M, Mauricio D, et al
    Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study.
    PLoS One. 2018;13:e0198327.
    PubMed     Abstract available

  453. SUN S, Hanzawa F, Umeki M, Ikeda S, et al
    Time-restricted feeding suppresses excess sucrose-induced plasma and liver lipid accumulation in rats.
    PLoS One. 2018;13:e0201261.
    PubMed     Abstract available

  454. EYRAUD D, Suner L, Dupont A, Bachelot-Loza C, et al
    Evolution of platelet functions in cirrhotic patients undergoing liver transplantation: A prospective exploration over a month.
    PLoS One. 2018;13:e0200364.
    PubMed     Abstract available

  455. TANG Y, Blomenkamp KS, Fickert P, Trauner M, et al
    NorUDCA promotes degradation of alpha1-antitrypsin mutant Z protein by inducing autophagy through AMPK/ULK1 pathway.
    PLoS One. 2018;13:e0200897.
    PubMed     Abstract available

  456. BOTEON YL, Wallace L, Boteon APCS, Mirza DF, et al
    An effective protocol for pharmacological defatting of primary human hepatocytes which is non-toxic to cholangiocytes or intrahepatic endothelial cells.
    PLoS One. 2018;13:e0201419.
    PubMed     Abstract available

  457. SENDI H, Mead I, Wan M, Mehrab-Mohseni M, et al
    miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling.
    PLoS One. 2018;13:e0200847.
    PubMed     Abstract available

  458. COZZI L, Comito T, Fogliata A, Franzese C, et al
    Critical appraisal of the potential role of intensity modulated proton therapy in the hypofractionated treatment of advanced hepatocellular carcinoma.
    PLoS One. 2018;13:e0201992.
    PubMed     Abstract available

  459. CHEN J
    The prognostic analysis of different metastatic patterns in advanced liver cancer patients: A population based analysis.
    PLoS One. 2018;13:e0200909.
    PubMed     Abstract available

  460. KIM SE, Park JW, Kim MJ, Jang B, et al
    Accumulation of citrullinated glial fibrillary acidic protein in a mouse model of bile duct ligation-induced hepatic fibrosis.
    PLoS One. 2018;13:e0201744.
    PubMed     Abstract available

  461. ZHENG J, Sadot E, Vigidal JA, Klimstra DS, et al
    Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing.
    PLoS One. 2018;13:e0200776.
    PubMed     Abstract available

  462. VANGOITSENHOVEN R, van der Ende M, Corbeels K, Monteiro Carvalho Mori Cunha JP, et al
    At similar weight loss, dietary composition determines the degree of glycemic improvement in diet-induced obese C57BL/6 mice.
    PLoS One. 2018;13:e0200779.
    PubMed     Abstract available

  463. FINKELMEIER F, Canli O, Peiffer KH, Walter D, et al
    Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis.
    PLoS One. 2018;13:e0200855.
    PubMed     Abstract available

  464. PIASECKI P, Narloch J, Brzozowski K, Ziecina P, et al
    The Predictive Value of SPECT/CT imaging in colorectal liver metastases response after 90Y-radioembolization.
    PLoS One. 2018;13:e0200488.
    PubMed     Abstract available

  465. XU W, Rao Q, An Y, Li M, et al
    Identification of biomarkers for Barcelona Clinic Liver Cancer staging and overall survival of patients with hepatocellular carcinoma.
    PLoS One. 2018;13:e0202763.
    PubMed     Abstract available

  466. GUMMESSON A, Stromberg U, Schmidt C, Kullberg J, et al
    Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects.
    PLoS One. 2018;13:e0202666.
    PubMed     Abstract available

  467. LAPOINTE-SHAW L, Georgie F, Carlone D, Cerocchi O, et al
    Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study.
    PLoS One. 2018;13:e0201120.
    PubMed     Abstract available

  468. PELEG N, Sneh Arbib O, Issachar A, Cohen-Naftaly M, et al
    Noninvasive scoring systems predict hepatic and extra-hepatic cancers in patients with nonalcoholic fatty liver disease.
    PLoS One. 2018;13:e0202393.
    PubMed     Abstract available

  469. ALISI A, Pampanini V, De Stefanis C, Panera N, et al
    Expression of insulin-like growth factor I and its receptor in the liver of children with biopsy-proven NAFLD.
    PLoS One. 2018;13:e0201566.
    PubMed     Abstract available

  470. WANG Y, Ma L, Yuan Z, Zheng J, et al
    Percutaneous thermal ablation combined with TACE versus TACE monotherapy in the treatment for liver cancer with hepatic vein tumor thrombus: A retrospective study.
    PLoS One. 2018;13:e0201525.
    PubMed     Abstract available

  471. CHOI YJ, Lee DH, Han KD, Yoon H, et al
    Is nonalcoholic fatty liver disease associated with the development of prostate cancer? A nationwide study with 10,516,985 Korean men.
    PLoS One. 2018;13:e0201308.
    PubMed     Abstract available

  472. FABRELLAS N, Hernandez R, Graupera I, Sola E, et al
    Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study.
    PLoS One. 2018;13:e0200656.
    PubMed     Abstract available

  473. MEHTA AS, Lau DT, Wang M, Islam A, et al
    Application of the Doylestown algorithm for the early detection of hepatocellular carcinoma.
    PLoS One. 2018;13:e0203149.
    PubMed     Abstract available

  474. KRUK B, Liebe R, Milkiewicz M, Wunsch E, et al
    PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC.
    PLoS One. 2018;13:e0202942.
    PubMed     Abstract available

  475. MORI S, Arima N, Ito M, Fujiyama S, et al
    Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.
    PLoS One. 2018;13:e0203084.
    PubMed     Abstract available

  476. ABDELHAFEZ OH, Fawzy MA, Fahim JR, Desoukey SY, et al
    Hepatoprotective potential of Malvaviscus arboreus against carbon tetrachloride-induced liver injury in rats.
    PLoS One. 2018;13:e0202362.
    PubMed     Abstract available

  477. PEISELER M, Reiners D, Pinnschmidt HO, Sebode M, et al
    Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis.
    PLoS One. 2018;13:e0202686.
    PubMed     Abstract available

  478. KANG SJ, Kim HJ, Kim D, Ahmed A, et al
    Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States.
    PLoS One. 2018;13:e0202325.
    PubMed     Abstract available

  479. HARRISON SA, Dennis A, Fiore MM, Kelly MD, et al
    Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial.
    PLoS One. 2018;13:e0203054.
    PubMed     Abstract available

  480. KIMER N, Gudmann NS, Pedersen JS, Moller S, et al
    No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial.
    PLoS One. 2018;13:e0203200.
    PubMed     Abstract available

  481. FRANSEN PETTERSSON N, Deronic A, Nilsson J, Hannibal TD, et al
    The immunomodulatory quinoline-3-carboxamide paquinimod reverses established fibrosis in a novel mouse model for liver fibrosis.
    PLoS One. 2018;13:e0203228.
    PubMed     Abstract available

  482. WEGERMANN K, Henao R, Diehl AM, Murphy SK, et al
    Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study.
    PLoS One. 2018;13:e0204308.
    PubMed     Abstract available

  483. ALKHOURI N, Johnson C, Adams L, Kitajima S, et al
    Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis.
    PLoS One. 2018;13:e0202226.
    PubMed     Abstract available

  484. WANG Z, Wang J, Wang P
    The prognostic value of prognostic nutritional index in hepatocellular carcinoma patients: A meta-analysis of observational studies.
    PLoS One. 2018;13:e0202987.
    PubMed     Abstract available

  485. DE BARI B, Breuneval T, Zeverino M, Godin S, et al
    Hepatobiliary scintigraphy allows the evaluation of short-term functional toxicity of liver stereotactic body radiotherapy: Results of a pilot study.
    PLoS One. 2018;13:e0204013.
    PubMed     Abstract available

  486. MIRZADEH A, Yoosefy A, Kazemirad E, Barati Z, et al
    Evaluation of a set of refolded recombinant antigens for serodiagnosis of human fascioliasis.
    PLoS One. 2018;13:e0203490.
    PubMed     Abstract available

  487. WARNER DR, Liu H, Ghosh Dastidar S, Warner JB, et al
    Ethanol and unsaturated dietary fat induce unique patterns of hepatic omega-6 and omega-3 PUFA oxylipins in a mouse model of alcoholic liver disease.
    PLoS One. 2018;13:e0204119.
    PubMed     Abstract available

  488. DILLARD KJ, Hytonen MK, Fischer D, Tanhuanpaa K, et al
    A splice site variant in INPP5E causes diffuse cystic renal dysplasia and hepatic fibrosis in dogs.
    PLoS One. 2018;13:e0204073.
    PubMed     Abstract available

  489. CHOI YR, Chung JW, Yu MH, Lee M, et al
    Diagnostic accuracy of contrast-enhanced dynamic CT for small hypervascular hepatocellular carcinoma and assessment of dynamic enhancement patterns: Results of two-year follow-up using cone-beam CT hepatic arteriography.
    PLoS One. 2018;13:e0203940.
    PubMed     Abstract available

  490. THISTLE JE, Yang B, Petrick JL, Fan JH, et al
    Association of tooth loss with liver cancer incidence and chronic liver disease mortality in a rural Chinese population.
    PLoS One. 2018;13:e0203926.
    PubMed     Abstract available

  491. ROMUALDO GR, Prata GB, da Silva TC, Fernandes AAH, et al
    Fibrosis-associated hepatocarcinogenesis revisited: Establishing standard medium-term chemically-induced male and female models.
    PLoS One. 2018;13:e0203879.
    PubMed     Abstract available

  492. LEE CH, Hung SP, Hong JH, Chang JT, et al
    How small is TOO small? New liver constraint is needed- Proton therapy of hepatocellular carcinoma patients with small normal liver.
    PLoS One. 2018;13:e0203854.
    PubMed     Abstract available

  493. MCCOWAN C, Crameri S, Kocak A, Shan S, et al
    A novel group A rotavirus associated with acute illness and hepatic necrosis in pigeons (Columba livia), in Australia.
    PLoS One. 2018;13:e0203853.
    PubMed     Abstract available

  494. SU L, Chang L, Sun Q, Hu L, et al
    Effects of low-dose energy spectrum scanning combined with adaptive statistical iterative reconstruction on the quality of imaging in Budd-Chiari syndrome.
    PLoS One. 2018;13:e0204797.
    PubMed     Abstract available

  495. TORAIH EA, Alghamdi SA, El-Wazir A, Hosny MM, et al
    Dual biomarkers long non-coding RNA GAS5 and microRNA-34a co-expression signature in common solid tumors.
    PLoS One. 2018;13:e0198231.
    PubMed     Abstract available

  496. GHOBRIAL C, Mogahed EA, El-Karaksy H
    Routine analysis of ascitic fluid for evidence of infection in children with chronic liver disease: Is it mandatory?
    PLoS One. 2018;13:e0203808.
    PubMed     Abstract available

  497. POLINENI D, Piccorelli AV, Hannah WB, Dalrymple SN, et al
    Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population.
    PLoS One. 2018;13:e0205257.
    PubMed     Abstract available

  498. FERRARA-ROMEO I, Martinez P, Blasco MA
    Mice lacking RAP1 show early onset and higher rates of DEN-induced hepatocellular carcinomas in female mice.
    PLoS One. 2018;13:e0204909.
    PubMed     Abstract available

  499. ALMEER RS, El-Khadragy MF, Abdelhabib S, Abdel Moneim AE, et al
    Ziziphus spina-christi leaf extract ameliorates schistosomiasis liver granuloma, fibrosis, and oxidative stress through downregulation of fibrinogenic signaling in mice.
    PLoS One. 2018;13:e0204923.
    PubMed     Abstract available

  500. IOANNOU GN, Green P, Lowy E, Mun EJ, et al
    Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosis.
    PLoS One. 2018;13:e0204412.
    PubMed     Abstract available

  501. TSAI YW, Tzeng IS, Chen YC, Hsieh TH, et al
    Survival prediction among patients with non-cancer-related end-stage liver disease.
    PLoS One. 2018;13:e0202692.
    PubMed     Abstract available

  502. OKABE H, Yoshizumi T, Yamashita YI, Imai K, et al
    Histological architectural classification determines recurrence pattern and prognosis after curative hepatectomy in patients with hepatocellular carcinoma.
    PLoS One. 2018;13:e0203856.
    PubMed     Abstract available

  503. PETTINELLI P, Arendt BM, Teterina A, McGilvray I, et al
    Altered hepatic genes related to retinol metabolism and plasma retinol in patients with non-alcoholic fatty liver disease.
    PLoS One. 2018;13:e0205747.
    PubMed     Abstract available

  504. LEE SH, Park M, Park KM, Gwag HB, et al
    Corrected QT interval on the electrocardiogram after liver transplantation: Surrogate marker of poor clinical outcomes?
    PLoS One. 2018;13:e0206463.
    PubMed     Abstract available

  505. BHAGAT HA, Compton SA, Musso DL, Laudeman CP, et al
    N-substituted phenylbenzamides of the niclosamide chemotype attenuate obesity related changes in high fat diet fed mice.
    PLoS One. 2018;13:e0204605.
    PubMed     Abstract available

  506. FAROUK S, Sabet S, Abu Zahra FA, El-Ghor AA, et al
    Bone marrow derived-mesenchymal stem cells downregulate IL17A dependent IL6/STAT3 signaling pathway in CCl4-induced rat liver fibrosis.
    PLoS One. 2018;13:e0206130.
    PubMed     Abstract available

  507. SILVA VIEIRA M, Arthurs CJ, Hussain T, Razavi R, et al
    Patient-specific modeling of right coronary circulation vulnerability post-liver transplant in Alagille's syndrome.
    PLoS One. 2018;13:e0205829.
    PubMed     Abstract available

  508. HANDGRAAF HJM, Sibinga Mulder BG, Shahbazi Feshtali S, Boogerd LSF, et al
    Staging laparoscopy with ultrasound and near-infrared fluorescence imaging to detect occult metastases of pancreatic and periampullary cancer.
    PLoS One. 2018;13:e0205960.
    PubMed     Abstract available

  509. JUN BG, Kim SG, Kim YD, Cheon GJ, et al
    Combined therapy of transarterial chemoembolization and stereotactic body radiation therapy versus transarterial chemoembolization for </=5cm hepatocellular carcinoma: Propensity score matching analysis.
    PLoS One. 2018;13:e0206381.
    PubMed     Abstract available

  510. SUH JK, Lee J, Lee JH, Shin S, et al
    Risk factors for developing liver cancer in people with and without liver disease.
    PLoS One. 2018;13:e0206374.
    PubMed     Abstract available

  511. MOSTAFAEI F, Tai A, Omari E, Song Y, et al
    Variations of MRI-assessed peristaltic motions during radiation therapy.
    PLoS One. 2018;13:e0205917.
    PubMed     Abstract available

  512. SUWARTO S, Diahtantri RA, Hidayat MJ, Widjaya B, et al
    Nonalcoholic fatty liver disease is associated with increased hemoconcentration, thrombocytopenia, and longer hospital stay in dengue-infected patients with plasma leakage.
    PLoS One. 2018;13:e0205965.
    PubMed     Abstract available

  513. CHIANG HC, Chien YC, Lin PY, Lee HL, et al
    Assessing men with erectile dysfunction before and after living donor liver transplantation in real-world practice: Integrating laboratories into clinical settings.
    PLoS One. 2018;13:e0206438.
    PubMed     Abstract available

  514. KIM EJ, Chung DH, Kim YJ, Kim YS, et al
    Endobiliary radiofrequency ablation for distal extrahepatic cholangiocarcinoma: A clinicopathological study.
    PLoS One. 2018;13:e0206694.
    PubMed     Abstract available

  515. ADAMS LC, Lubbe F, Bressem K, Wagner M, et al
    Non-alcoholic fatty liver disease in underweight patients with inflammatory bowel disease: A case-control study.
    PLoS One. 2018;13:e0206450.
    PubMed     Abstract available

  516. XIONG Y, Zhang Q, Ye J, Pan S, et al
    Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies.
    PLoS One. 2018;13:e0206853.
    PubMed     Abstract available

  517. CHANG E, Kim DH, Yang H, Lee DH, et al
    CB1 receptor blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes.
    PLoS One. 2018;13:e0206152.
    PubMed     Abstract available

  518. BONKOVSKY HL, Barnhart HX, Foureau DM, Steuerwald N, et al
    Cytokine profiles in acute liver injury-Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group.
    PLoS One. 2018;13:e0206389.
    PubMed     Abstract available

  519. LIEN HC, Jeng YM, Jhuang YL, Yuan RH, et al
    Increased Trimethylation of histone H3K36 associates with biliary differentiation and predicts poor prognosis in resectable hepatocellular carcinoma.
    PLoS One. 2018;13:e0206261.
    PubMed     Abstract available

  520. VAN DER WAALS LM, Borel Rinkes IHM, Kranenburg O
    ALDH1A1 expression is associated with poor differentiation, 'right-sidedness' and poor survival in human colorectal cancer.
    PLoS One. 2018;13:e0205536.
    PubMed     Abstract available

  521. DAHER S, Lev Cohen N, Massarwa M, Mahamid M, et al
    Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.
    PLoS One. 2018;13:e0207479.
    PubMed     Abstract available

  522. DEGROAT AR, Fleming CK, Dunlay SM, Hagood KL, et al
    The sex specific effect of alcohol consumption on circulating levels of CTRP3.
    PLoS One. 2018;13:e0207011.
    PubMed     Abstract available

  523. MEHTA R, Shaw G, Masschelin P, Felix S, et al
    Polymorphisms in the receptor for advanced glycation end-products (RAGE) gene and circulating RAGE levels as a susceptibility factor for non-alcoholic steatohepatitis (NASH).
    PLoS One. 2018;13:e0199294.
    PubMed     Abstract available

  524. NAVARRO-ALVAREZ N, Machaidze Z, Schuetz C, Zhu A, et al
    Xenogeneic Heterotopic Auxiliary Liver transplantation (XHALT) promotes native liver regeneration in a Post-Hepatectomy Liver failure model.
    PLoS One. 2018;13:e0207272.
    PubMed     Abstract available

  525. KUBESCH A, Quenstedt L, Saleh M, Ruschenbaum S, et al
    Vitamin D deficiency is associated with hepatic decompensation and inflammation in patients with liver cirrhosis: A prospective cohort study.
    PLoS One. 2018;13:e0207162.
    PubMed     Abstract available

  526. HSIEH YC, Lee KC, Wang YW, Yang YY, et al
    Correlation and prognostic accuracy between noninvasive liver fibrosismarkers and portal pressure in cirrhosis: Role of ALBI score.
    PLoS One. 2018;13:e0208903.
    PubMed     Abstract available

  527. SCHUBERT M, Hackl H, Gassner FJ, Greil R, et al
    Investigating epigenetic effects of activation-induced deaminase in chronic lymphocytic leukemia.
    PLoS One. 2018;13:e0208753.
    PubMed     Abstract available

    January 2017
  528. CARVALHO AC, Leal F, Sasse AD
    Cost-effectiveness of cetuximab and panitumumab for chemotherapy-refractory metastatic colorectal cancer.
    PLoS One. 2017;12:e0175409.
    PubMed     Abstract available

  529. GERTH HU, Pohlen M, Tholking G, Pavenstadt H, et al
    Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control study.
    PLoS One. 2017;12:e0175529.
    PubMed     Abstract available

  530. YAO L, Chen W, Song K, Han C, et al
    15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury.
    PLoS One. 2017;12:e0176106.
    PubMed     Abstract available

  531. LYTLE KA, Wong CP, Jump DB
    Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.
    PLoS One. 2017;12:e0173376.
    PubMed     Abstract available

  532. HE J, Yi B, Chen Y, Huang Q, et al
    The ET-1-mediated carbonylation and degradation of ANXA1 induce inflammatory phenotype and proliferation of pulmonary artery smooth muscle cells in HPS.
    PLoS One. 2017;12:e0175443.
    PubMed     Abstract available

  533. ALVA A, Cangalaya C, Quiliano M, Krebs C, et al
    Mathematical algorithm for the automatic recognition of intestinal parasites.
    PLoS One. 2017;12:e0175646.
    PubMed     Abstract available

  534. PEREZ P, Rodriguez-Peralvarez M, Guerrero L, Gonzalez V, et al
    Incidental hepatocellular carcinoma after liver transplantation: Prevalence, histopathological features and prognostic impact.
    PLoS One. 2017;12:e0175010.
    PubMed     Abstract available

  535. IBUSUKI R, Uto H, Oda K, Ohshige A, et al
    Human neutrophil peptide-1 promotes alcohol-induced hepatic fibrosis and hepatocyte apoptosis.
    PLoS One. 2017;12:e0174913.
    PubMed     Abstract available

  536. PEREYRA D, Offensperger F, Klinglmueller F, Haegele S, et al
    Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activity.
    PLoS One. 2017;12:e0175359.
    PubMed     Abstract available

  537. KANG YM, Jung CH, Cho YK, Lee SE, et al
    Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population.
    PLoS One. 2017;12:e0175762.
    PubMed     Abstract available

  538. YOON K, Jeong WK, Kim Y, Kim MY, et al
    2-dimensional shear wave elastography: Interobserver agreement and factors related to interobserver discrepancy.
    PLoS One. 2017;12:e0175747.
    PubMed     Abstract available

  539. ROTH JA, Widmer AF, Tschudin-Sutter S, Dangel M, et al
    The Model for End-stage Liver Disease (MELD) as a predictor of short-term mortality in Staphylococcus aureus bloodstream infection: A single-centre observational study.
    PLoS One. 2017;12:e0175669.
    PubMed     Abstract available

  540. WANKHADE UD, Zhong Y, Kang P, Alfaro M, et al
    Enhanced offspring predisposition to steatohepatitis with maternal high-fat diet is associated with epigenetic and microbiome alterations.
    PLoS One. 2017;12:e0175675.
    PubMed     Abstract available

  541. MCPHERSON S, Wilkinson N, Tiniakos D, Wilkinson J, et al
    A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis.
    PLoS One. 2017;12:e0175717.
    PubMed     Abstract available

  542. YANG SC, Hsu CN, Liang CM, Tai WC, et al
    Risk of Rebleeding and Mortality in Cirrhotic Patients with Peptic Ulcer Bleeding: A 12-Year Nationwide Cohort Study.
    PLoS One. 2017;12:e0168918.
    PubMed     Abstract available

  543. MULDER P, van den Hoek AM, Kleemann R
    The CCR2 Inhibitor Propagermanium Attenuates Diet-Induced Insulin Resistance, Adipose Tissue Inflammation and Non-Alcoholic Steatohepatitis.
    PLoS One. 2017;12:e0169740.
    PubMed     Abstract available

  544. WANG HL, Zhang H, Wu SL, Liao GC, et al
    Red blood cell count has an independent contribution to the prediction of ultrasonography-diagnosed fatty liver disease.
    PLoS One. 2017;12:e0172027.
    PubMed     Abstract available

  545. GRZELAK CA, Sigglekow ND, Tirnitz-Parker JE, Hamson EJ, et al
    Widespread GLI expression but limited canonical hedgehog signaling restricted to the ductular reaction in human chronic liver disease.
    PLoS One. 2017;12:e0171480.
    PubMed     Abstract available

  546. GIMENEZ-GARZO C, Garces JJ, Urios A, Mangas-Losada A, et al
    The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients.
    PLoS One. 2017;12:e0171211.
    PubMed     Abstract available

  547. TRAYKOVA D, Schneider B, Chojkier M, Buck M, et al
    Blood Microbiome Quantity and the Hyperdynamic Circulation in Decompensated Cirrhotic Patients.
    PLoS One. 2017;12:e0169310.
    PubMed     Abstract available

  548. HU W, Shao X, Guo D, Hao H, et al
    Relationship of Serum Betatrophin with Nonalcoholic Fatty Liver in a Chinese Population.
    PLoS One. 2017;12:e0170758.
    PubMed     Abstract available

  549. CROOME KP, Lee DD, Harnois D, Taner CB, et al
    Effects of the Share 35 Rule on Waitlist and Liver Transplantation Outcomes for Patients with Hepatocellular Carcinoma.
    PLoS One. 2017;12:e0170673.
    PubMed     Abstract available

  550. ZHAO J, Zhai F, Cheng J, He Q, et al
    Evaluating the Significance of Viscoelasticity in Diagnosing Early-Stage Liver Fibrosis with Transient Elastography.
    PLoS One. 2017;12:e0170073.
    PubMed     Abstract available

  551. XU X, Su L, Gao Y, Ding Y, et al
    The Prevalence of Nonalcoholic Fatty Liver Disease and Related Metabolic Comorbidities Was Associated with Age at Onset of Moderate to Severe Plaque Psoriasis: A Cross-Sectional Study.
    PLoS One. 2017;12:e0169952.
    PubMed     Abstract available

  552. WAKAMATSU T, Ogasawara S, Chiba T, Yokoyama M, et al
    Impact of Radiofrequency Ablation-Induced Glisson's Capsule-Associated Complications in Patients with Hepatocellular Carcinoma.
    PLoS One. 2017;12:e0170153.
    PubMed     Abstract available

  553. RISHI P, Arora S, Kaur UJ, Chopra K, et al
    Better Management of Alcohol Liver Disease Using a 'Microstructured Synbox' System Comprising L. plantarum and EGCG.
    PLoS One. 2017;12:e0168459.
    PubMed     Abstract available

  554. YOUNS M, Abdel Halim Hegazy W
    The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways.
    PLoS One. 2017;12:e0169335.
    PubMed     Abstract available

  555. KARAJAMAKI AJ, Kettunen O, Lepojarvi S, Koivurova OP, et al
    Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population.
    PLoS One. 2017;12:e0173855.
    PubMed     Abstract available

  556. CANNITO S, Morello E, Bocca C, Foglia B, et al
    Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis.
    PLoS One. 2017;12:e0172575.
    PubMed     Abstract available

  557. JIN F, Wan C, Li W, Yao L, et al
    Formononetin protects against acetaminophen-induced hepatotoxicity through enhanced NRF2 activity.
    PLoS One. 2017;12:e0170900.
    PubMed     Abstract available

  558. SOTHMANN T, Gauer T, Werner R
    4D dose simulation in volumetric arc therapy: Accuracy and affecting parameters.
    PLoS One. 2017;12:e0172810.
    PubMed     Abstract available

  559. HOLLENBACH M, Thonig A, Pohl S, Ripoll C, et al
    Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosis.
    PLoS One. 2017;12:e0171260.
    PubMed     Abstract available

  560. SHEU MJ, Hsieh MJ, Chou YE, Wang PH, et al
    Effects of ADAMTS14 genetic polymorphism and cigarette smoking on the clinicopathologic development of hepatocellular carcinoma.
    PLoS One. 2017;12:e0172506.
    PubMed     Abstract available

  561. BORGATTI A, Winter AL, Stuebner K, Scott R, et al
    Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study.
    PLoS One. 2017;12:e0172651.
    PubMed     Abstract available

  562. LI Q, Wang Y, Ma T, Lv Y, et al
    Clinical outcomes of patients with and without diabetes mellitus after hepatectomy: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0171129.
    PubMed     Abstract available

  563. ZHANG BB, Yan C, Fang F, Du Y, et al
    Increased hepatic Th2 and Treg subsets are associated with biliary fibrosis in different strains of mice caused by Clonorchis sinensis.
    PLoS One. 2017;12:e0171005.
    PubMed     Abstract available

  564. WERNLY B, Lichtenauer M, Franz M, Kabisch B, et al
    Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance.
    PLoS One. 2017;12:e0170987.
    PubMed     Abstract available

  565. SALDANA RS, Schrem H, Barthold M, Kaltenborn A, et al
    Prognostic Abilities and Quality Assessment of Models for the Prediction of 90-Day Mortality in Liver Transplant Waiting List Patients.
    PLoS One. 2017;12:e0170499.
    PubMed     Abstract available

  566. YOO JE, Kim YJ, Rhee H, Kim H, et al
    Progressive Enrichment of Stemness Features and Tumor Stromal Alterations in Multistep Hepatocarcinogenesis.
    PLoS One. 2017;12:e0170465.
    PubMed     Abstract available

  567. LEE DH, Lee JH, Jung YJ, Gim J, et al
    Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area.
    PLoS One. 2017;12:e0170394.
    PubMed     Abstract available

  568. GAO W, Zhao J, Gao Z, Li H, et al
    Synergistic Interaction of Light Alcohol Administration in the Presence of Mild Iron Overload in a Mouse Model of Liver Injury: Involvement of Triosephosphate Isomerase Nitration and Inactivation.
    PLoS One. 2017;12:e0170350.
    PubMed     Abstract available

  569. LEE LH, Hwang JI, Cheng YC, Wu CY, et al
    Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma.
    PLoS One. 2017;12:e0169655.
    PubMed     Abstract available

  570. LU M, Zessin AS, Glover W, Hsu DS, et al
    Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis.
    PLoS One. 2017;12:e0169439.
    PubMed     Abstract available

  571. LE MH, Devaki P, Ha NB, Jun DW, et al
    Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.
    PLoS One. 2017;12:e0173499.
    PubMed     Abstract available

  572. MO HY, Liao YY, You XM, Cucchetti A, et al
    Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy.
    PLoS One. 2017;12:e0174222.
    PubMed     Abstract available

  573. MA S, Yang J, Song C, Ge Z, et al
    Expression quantitative trait loci for PAX8 contributes to the prognosis of hepatocellular carcinoma.
    PLoS One. 2017;12:e0173700.
    PubMed     Abstract available

  574. TROUVE P, Genin E, Ferec C
    In silico search for modifier genes associated with pancreatic and liver disease in Cystic Fibrosis.
    PLoS One. 2017;12:e0173822.
    PubMed     Abstract available

  575. ABO-HADED HM, Elkablawy MA, Al-Johani Z, Al-Ahmadi O, et al
    Hepatoprotective effect of sitagliptin against methotrexate induced liver toxicity.
    PLoS One. 2017;12:e0174295.
    PubMed     Abstract available

  576. XIE Z, Wang J, Liu M, Chen D, et al
    CC-223 blocks mTORC1/C2 activation and inhibits human hepatocellular carcinoma cells in vitro and in vivo.
    PLoS One. 2017;12:e0173252.
    PubMed     Abstract available

  577. BECKER S, Kinny-Koster B, Bartels M, Scholz M, et al
    Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis.
    PLoS One. 2017;12:e0174424.
    PubMed     Abstract available

  578. SU YW, Liu PH, Hsu CY, Lee YH, et al
    Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective.
    PLoS One. 2017;12:e0174333.
    PubMed     Abstract available

  579. HOLMILA R, Sklias A, Muller DC, Degli Esposti D, et al
    Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma.
    PLoS One. 2017;12:e0174265.
    PubMed     Abstract available

  580. LOWDON RF, Wang T
    Epigenomic annotation of noncoding mutations identifies mutated pathways in primary liver cancer.
    PLoS One. 2017;12:e0174032.
    PubMed     Abstract available

  581. WIEGERING A, Riegel J, Wagner J, Kunzmann V, et al
    The impact of pulmonary metastasectomy in patients with previously resected colorectal cancer liver metastases.
    PLoS One. 2017;12:e0173933.
    PubMed     Abstract available

  582. GUTIERREZ-DE-JUAN V, Lopez de Davalillo S, Fernandez-Ramos D, Barbier-Torres L, et al
    A morphological method for ammonia detection in liver.
    PLoS One. 2017;12:e0173914.
    PubMed     Abstract available

  583. INZAUGARAT ME, De Matteo E, Baz P, Lucero D, et al
    New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans.
    PLoS One. 2017;12:e0172900.
    PubMed     Abstract available

  584. KATHER JN, Zollner FG, Schad LR, Melchers SM, et al
    Identification of a characteristic vascular belt zone in human colorectal cancer.
    PLoS One. 2017;12:e0171378.
    PubMed     Abstract available

  585. LEE J, Yoon K, Ryu S, Chang Y, et al
    High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men.
    PLoS One. 2017;12:e0172666.
    PubMed     Abstract available

  586. WU PY, Cheng CY, Liu CE, Lee YC, et al
    Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naive HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan.
    PLoS One. 2017;12:e0171596.
    PubMed     Abstract available

    Treatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolization.
    PLoS One. 2017;12:e0170750.
    PubMed     Abstract available

  588. TAI CS, Lin YR, Teng TH, Lin PY, et al
    Haptoglobin expression correlates with tumor differentiation and five-year overall survival rate in hepatocellular carcinoma.
    PLoS One. 2017;12:e0171269.
    PubMed     Abstract available

  589. VAN DEN BERG EH, Amini M, Schreuder TC, Dullaart RP, et al
    Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.
    PLoS One. 2017;12:e0171502.
    PubMed     Abstract available

  590. LACOSTE B, Raymond VA, Cassim S, Lapierre P, et al
    Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like properties.
    PLoS One. 2017;12:e0171215.
    PubMed     Abstract available

  591. KAJI K, Mizukoshi E, Yamashita T, Arai K, et al
    Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma.
    PLoS One. 2017;12:e0170291.
    PubMed     Abstract available

  592. CHENG SB, Liu HT, Chen SY, Lin PT, et al
    Changes of Oxidative Stress, Glutathione, and Its Dependent Antioxidant Enzyme Activities in Patients with Hepatocellular Carcinoma before and after Tumor Resection.
    PLoS One. 2017;12:e0170016.
    PubMed     Abstract available

  593. LI C, Ni J, Liu YX, Wang H, et al
    Response of MiRNA-22-3p and MiRNA-149-5p to Folate Deficiency and the Differential Regulation of MTHFR Expression in Normal and Cancerous Human Hepatocytes.
    PLoS One. 2017;12:e0168049.
    PubMed     Abstract available

  594. YOO HJ, Hwang SY, Choi JH, Lee HJ, et al
    Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis.
    PLoS One. 2017;12:e0174717.
    PubMed     Abstract available

  595. TAKAHASHI A, Kono S, Wada A, Oshima S, et al
    Reduced brain activity in female patients with non-alcoholic fatty liver disease as measured by near-infrared spectroscopy.
    PLoS One. 2017;12:e0174169.
    PubMed     Abstract available

  596. KOMIYAMA Y, Kurosaki M, Nakanishi H, Takahashi Y, et al
    Prediction of diuretic response to tolvaptan by a simple, readily available spot urine Na/K ratio.
    PLoS One. 2017;12:e0174649.
    PubMed     Abstract available

  597. LEE M, Jo A, Lee S, Kim JB, et al
    3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells.
    PLoS One. 2017;12:e0174271.
    PubMed     Abstract available

  598. GAO B, Zhang X, Huang Y, Yang Z, et al
    Coding and non-coding gene regulatory networks underlie the immune response in liver cirrhosis.
    PLoS One. 2017;12:e0174142.
    PubMed     Abstract available

  599. JIN X, Liu J, Chen YP, Xiang Z, et al
    Effect of miR-146 targeted HDMCP up-regulation in the pathogenesis of nonalcoholic steatohepatitis.
    PLoS One. 2017;12:e0174218.
    PubMed     Abstract available

  600. LI Y, Dong Y, Huang Z, Kuang Q, et al
    Computational identifying and characterizing circular RNAs and their associated genes in hepatocellular carcinoma.
    PLoS One. 2017;12:e0174436.
    PubMed     Abstract available

  601. STRATIGOPOULOU P, Paul A, Hoyer DP, Kykalos S, et al
    High MELD score and extended operating time predict prolonged initial ICU stay after liver transplantation and influence the outcome.
    PLoS One. 2017;12:e0174173.
    PubMed     Abstract available

  602. LEE JS, Yoo JE, Kim H, Rhee H, et al
    Tumor stroma with senescence-associated secretory phenotype in steatohepatitic hepatocellular carcinoma.
    PLoS One. 2017;12:e0171922.
    PubMed     Abstract available

  603. WANG Y, Stewart E, Desjardins L, Hadway J, et al
    Assessment of intratumor hypoxia by integrated 18F-FDG PET / perfusion CT in a liver tumor model.
    PLoS One. 2017;12:e0173016.
    PubMed     Abstract available

  604. DIJKSTRA H, Wolff D, van Melle JP, Bartelds B, et al
    Diminished liver microperfusion in Fontan patients: A biexponential DWI study.
    PLoS One. 2017;12:e0173149.
    PubMed     Abstract available

  605. LEDE V, Meusel A, Garten A, Popkova Y, et al
    Altered hepatic lipid metabolism in mice lacking both the melanocortin type 4 receptor and low density lipoprotein receptor.
    PLoS One. 2017;12:e0172000.
    PubMed     Abstract available

  606. WU L, Pang Y, Qin G, Xi G, et al
    Farnesylthiosalicylic acid sensitizes hepatocarcinoma cells to artemisinin derivatives.
    PLoS One. 2017;12:e0171840.
    PubMed     Abstract available

  607. ZHU Z, Tran H, Mathahs MM, Moninger TO, et al
    HCV Induces Telomerase Reverse Transcriptase, Increases Its Catalytic Activity, and Promotes Caspase Degradation in Infected Human Hepatocytes.
    PLoS One. 2017;12:e0166853.
    PubMed     Abstract available

  608. LEE SM, Lee JM, Kang HJ, Yang HK, et al
    Liver fibrosis staging with a new 2D-shear wave elastography using comb-push technique: Applicability, reproducibility, and diagnostic performance.
    PLoS One. 2017;12:e0177264.
    PubMed     Abstract available

  609. YANG C, Yang S, Xu W, Zhang J, et al
    Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study.
    PLoS One. 2017;12:e0177249.
    PubMed     Abstract available

  610. HUANG JF, Yeh ML, Huang CF, Huang CI, et al
    Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients.
    PLoS One. 2017;12:e0174394.
    PubMed     Abstract available

  611. ZHANG S, Xiao Q, Shi Z, Yu G, et al
    Caspase polymorphisms and prognosis of hepatocellular carcinoma.
    PLoS One. 2017;12:e0176802.
    PubMed     Abstract available

  612. RUEDA-ZARATE HA, Imaz-Rosshandler I, Cardenas-Ovando RA, Castillo-Fernandez JE, et al
    A computational toxicogenomics approach identifies a list of highly hepatotoxic compounds from a large microarray database.
    PLoS One. 2017;12:e0176284.
    PubMed     Abstract available

  613. NAOUR S, Espinoza BM, Aedo JE, Zuloaga R, et al
    Transcriptomic analysis of the hepatic response to stress in the red cusk-eel (Genypterus chilensis): Insights into lipid metabolism, oxidative stress and liver steatosis.
    PLoS One. 2017;12:e0176447.
    PubMed     Abstract available

  614. CHANG W, Lee JM, Yoon JH, Lee DH, et al
    No-touch radiofrequency ablation using multiple electrodes: An in vivo comparison study of switching monopolar versus switching bipolar modes in porcine livers.
    PLoS One. 2017;12:e0176350.
    PubMed     Abstract available

  615. ROKUSZ A, Veres D, Szucs A, Bugyik E, et al
    Ductular reaction correlates with fibrogenesis but does not contribute to liver regeneration in experimental fibrosis models.
    PLoS One. 2017;12:e0176518.
    PubMed     Abstract available

  616. ADEJUMO AC, Alliu S, Ajayi TO, Adejumo KL, et al
    Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study.
    PLoS One. 2017;12:e0176416.
    PubMed     Abstract available

  617. OLDRINI G, Huertas A, Renard-Oldrini S, Taste-George H, et al
    Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma.
    PLoS One. 2017;12:e0176118.
    PubMed     Abstract available

  618. ESTIU MC, Frailuna MA, Otero C, Dericco M, et al
    Relationship between early onset severe intrahepatic cholestasis of pregnancy and higher risk of meconium-stained fluid.
    PLoS One. 2017;12:e0176504.
    PubMed     Abstract available

  619. YEN YH, Chen JB, Cheng BC, Chen JF, et al
    Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study.
    PLoS One. 2017;12:e0176027.
    PubMed     Abstract available

  620. LEE HL, Cheng HL, Liu YF, Chou MC, et al
    Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk.
    PLoS One. 2017;12:e0176141.
    PubMed     Abstract available

  621. YANG KL, Chang WT, Hong MY, Hung KC, et al
    Prevention of TGF-beta-induced early liver fibrosis by a maleic acid derivative anti-oxidant through suppression of ROS, inflammation and hepatic stellate cells activation.
    PLoS One. 2017;12:e0174008.
    PubMed     Abstract available

  622. LAHTI S, Ludwig JM, Xing M, Sun L, et al
    In vitro biologic efficacy of sunitinib drug-eluting beads on human colorectal and hepatocellular carcinoma-A pilot study.
    PLoS One. 2017;12:e0174539.
    PubMed     Abstract available

  623. CHAN M, Chiang CL, Lee V, Cheung S, et al
    Target localization of 3D versus 4D cone beam computed tomography in lipiodol-guided stereotactic radiotherapy of hepatocellular carcinomas.
    PLoS One. 2017;12:e0174929.
    PubMed     Abstract available

  624. PEYROUX E, Santaella N, Broussolle E, Rigard C, et al
    Social cognition in Wilson's disease: A new phenotype?
    PLoS One. 2017;12:e0173467.
    PubMed     Abstract available

  625. HERRADOR Z, Fernandez-Martinez A, Gomez-Barroso D, Leon I, et al
    Mediterranean spotted fever in Spain, 1997-2014: Epidemiological situation based on hospitalization records.
    PLoS One. 2017;12:e0174745.
    PubMed     Abstract available

  626. HE CB, Lin XJ
    Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
    PLoS One. 2017;12:e0174769.
    PubMed     Abstract available

  627. CHU YW, Lin HM, Wang JJ, Weng SF, et al
    Epidemiology and outcomes of hypoglycemia in patients with advanced diabetic kidney disease on dialysis: A national cohort study.
    PLoS One. 2017;12:e0174601.
    PubMed     Abstract available

  628. WANG YC, Chou CT, Lin CP, Chen YL, et al
    The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images.
    PLoS One. 2017;12:e0174594.
    PubMed     Abstract available

  629. LI Y, Wang J, Tang Y, Han X, et al
    Bidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: Evidence from the Dongfeng-Tongji cohort study.
    PLoS One. 2017;12:e0174291.
    PubMed     Abstract available

  630. KRAWCZYK M, Zimmermann S, Hess G, Holz R, et al
    Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease.
    PLoS One. 2017;12:e0173506.
    PubMed     Abstract available

  631. SONG YN, Dong S, Wei B, Liu P, et al
    Metabolomic mechanisms of gypenoside against liver fibrosis in rats: An integrative analysis of proteomics and metabolomics data.
    PLoS One. 2017;12:e0173598.
    PubMed     Abstract available

  632. VALBUSA F, Bonapace S, Agnoletti D, Scala L, et al
    Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure.
    PLoS One. 2017;12:e0173398.
    PubMed     Abstract available

  633. HAGLUND S, Vikingsson S, Almer S, Soderman J, et al
    Combination treatment with 6-mercaptopurine and allopurinol in HepG2 and HEK293 cells - Effects on gene expression levels and thiopurine metabolism.
    PLoS One. 2017;12:e0173825.
    PubMed     Abstract available

  634. TAKAHARA I, Akazawa Y, Tabuchi M, Matsuda K, et al
    Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.
    PLoS One. 2017;12:e0170591.
    PubMed     Abstract available

  635. WILMAN HR, Kelly M, Garratt S, Matthews PM, et al
    Characterisation of liver fat in the UK Biobank cohort.
    PLoS One. 2017;12:e0172921.
    PubMed     Abstract available

  636. WEN YF, Yang XZ, Zeng LS, Peng HH, et al
    Prognostic impact of pretherapeutic gamma-glutamyltransferase on patients with nasopharyngeal carcinoma.
    PLoS One. 2017;12:e0172345.
    PubMed     Abstract available

  637. XUE M, Liu Y, Lyu R, Ge N, et al
    Protective effect of aplysin on liver tissue and the gut microbiota in alcohol-fed rats.
    PLoS One. 2017;12:e0178684.
    PubMed     Abstract available

  638. JOLY P, Vignaud H, Di Martino J, Ruiz M, et al
    ERAD defects and the HFE-H63D variant are associated with increased risk of liver damages in Alpha 1-Antitrypsin Deficiency.
    PLoS One. 2017;12:e0179369.
    PubMed     Abstract available

  639. RAO ZZ, Zhang XW, Ding YL, Yang MY, et al
    miR-148a-mediated estrogen-induced cholestasis in intrahepatic cholestasis of pregnancy: Role of PXR/MRP3.
    PLoS One. 2017;12:e0178702.
    PubMed     Abstract available

  640. SIGRUENER A, Wolfrum C, Boettcher A, Kopf T, et al
    Lipidomic and metabolic changes in the P4-type ATPase ATP10D deficient C57BL/6J wild type mice upon rescue of ATP10D function.
    PLoS One. 2017;12:e0178368.
    PubMed     Abstract available

  641. BUECHTER M, Kahraman A, Manka P, Gerken G, et al
    Partial spleen embolization reduces the risk of portal hypertension-induced upper gastrointestinal bleeding in patients not eligible for TIPS implantation.
    PLoS One. 2017;12:e0177401.
    PubMed     Abstract available

  642. PRIETO V, Ludwig JM, Farris AB, Nagaraju GP, et al
    Establishment of human metastatic colorectal cancer model in rabbit liver: A pilot study.
    PLoS One. 2017;12:e0177212.
    PubMed     Abstract available

  643. LAI LL, Chan WK, Sthaneshwar P, Nik Mustapha NR, et al
    Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0174982.
    PubMed     Abstract available

  644. ASTROM E, Stal P, Zenlander R, Edenvik P, et al
    Reverse lectin ELISA for detecting fucosylated forms of alpha1-acid glycoprotein associated with hepatocellular carcinoma.
    PLoS One. 2017;12:e0173897.
    PubMed     Abstract available

  645. HUH JH, Kim JY, Choi E, Kim JS, et al
    The fatty liver index as a predictor of incident chronic kidney disease in a 10-year prospective cohort study.
    PLoS One. 2017;12:e0180951.
    PubMed     Abstract available

  646. LIU W, Li X, Zhou B, Fang S, et al
    Differential induction of apoptosis and autophagy by pyrrolizidine alkaloid clivorine in human hepatoma Huh-7.5 cells and its toxic implication.
    PLoS One. 2017;12:e0179379.
    PubMed     Abstract available

  647. PARK SH, Won HJ, Kim SY, Shin YM, et al
    Efficacy and safety of ultrasound-guided implantation of fiducial markers in the liver for stereotactic body radiation therapy.
    PLoS One. 2017;12:e0179676.
    PubMed     Abstract available

  648. GRANATA V, Fusco R, Catalano O, Avallone A, et al
    Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases.
    PLoS One. 2017;12:e0179951.
    PubMed     Abstract available

  649. CHANG CC, Lee WS, Hsieh HG, Chuang CL, et al
    Selective cyclooxygenase inhibition by SC-560 improves hepatopulmonary syndrome in cirrhotic rats.
    PLoS One. 2017;12:e0179809.
    PubMed     Abstract available

  650. PEREIRA ENGDS, Silvares RR, Flores EEI, Rodrigues KL, et al
    Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0179654.
    PubMed     Abstract available

  651. GAO B, Yu T, Xue D, Sun B, et al
    A multidimensional integration analysis reveals potential bridging targets in the process of colorectal cancer liver metastasis.
    PLoS One. 2017;12:e0178760.
    PubMed     Abstract available

  652. DOLD L, Luda C, Schwarze-Zander C, Boesecke C, et al
    Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART).
    PLoS One. 2017;12:e0178685.
    PubMed     Abstract available

  653. NAKADE Y, Sakamoto K, Yamauchi T, Inoue T, et al
    Conophylline inhibits non-alcoholic steatohepatitis in mice.
    PLoS One. 2017;12:e0178436.
    PubMed     Abstract available

  654. CHANG YP, Chen YM, Lai CH, Lin CY, et al
    The impact of de novo liver metastasis on clinical outcome in patients with advanced non-small-cell lung cancer.
    PLoS One. 2017;12:e0178676.
    PubMed     Abstract available

  655. HAN EC, Ryoo SB, Park JW, Yi JW, et al
    Oncologic and surgical outcomes in colorectal cancer patients with liver cirrhosis: A propensity-matched study.
    PLoS One. 2017;12:e0178920.
    PubMed     Abstract available

  656. ANDRIANTSOA M, Hoibian S, Autret A, Gilabert M, et al
    An elevated serum alkaline phosphatase level in hepatic metastases of grade 1 and 2 gastrointestinal neuroendocrine tumors is unusual and of prognostic value.
    PLoS One. 2017;12:e0177971.
    PubMed     Abstract available

  657. LO CH, Yang JF, Liu MY, Jen YM, et al
    Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy.
    PLoS One. 2017;12:e0177793.
    PubMed     Abstract available

  658. LIN WC, Lin HH, Hung CY, Shih SC, et al
    Clinical endoscopic management and outcome of post-endoscopic sphincterotomy bleeding.
    PLoS One. 2017;12:e0177449.
    PubMed     Abstract available

  659. KAFFARNIK MF, Ahmadi N, Lock JF, Wuensch T, et al
    Correlation between plasma endothelin-1 levels and severity of septic liver failure quantified by maximal liver function capacity (LiMAx test). A prospective study.
    PLoS One. 2017;12:e0178237.
    PubMed     Abstract available

  660. SORENSON EC, Khanin R, Bamboat ZM, Cavnar MJ, et al
    Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation.
    PLoS One. 2017;12:e0176562.
    PubMed     Abstract available

  661. KREMERS RMW, Kleinegris MC, Ninivaggi M, de Laat B, et al
    Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis.
    PLoS One. 2017;12:e0177020.
    PubMed     Abstract available

  662. WANG C, Yang Y, Sun D, Jiang Y, et al
    Prognosis of hepatocellular carcinoma patients with bile duct tumor thrombus after hepatic resection or liver transplantation in Asian populations: A meta-analysis.
    PLoS One. 2017;12:e0176827.
    PubMed     Abstract available

  663. WONG MW, Chen MJ, Chen HL, Kuo YC, et al
    Application of chronic liver failure-sequential organ failure assessment score for the predication of mortality after esophageal variceal hemorrhage post endoscopic ligation.
    PLoS One. 2017;12:e0182529.
    PubMed     Abstract available

  664. LI SC, Lee CH, Hung CL, Wu JC, et al
    Surgical resection of metachronous hepatic metastases from gastric cancer improves long-term survival: A population-based study.
    PLoS One. 2017;12:e0182255.
    PubMed     Abstract available

  665. KIM G, Kim KJ, Rhee Y, Lim SK, et al
    Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0182202.
    PubMed     Abstract available

  666. HUA MC, Su HM, Yao TC, Kuo ML, et al
    Alternation of plasma fatty acids composition and desaturase activities in children with liver steatosis.
    PLoS One. 2017;12:e0182277.
    PubMed     Abstract available

  667. HUNG TH, Liang CM, Hsu CN, Tai WC, et al
    Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan.
    PLoS One. 2017;12:e0181858.
    PubMed     Abstract available

  668. LIU P, Xu Y, Tang Y, Du M, et al
    Independent and joint effects of moderate alcohol consumption and smoking on the risks of non-alcoholic fatty liver disease in elderly Chinese men.
    PLoS One. 2017;12:e0181497.
    PubMed     Abstract available

  669. SCHLEGEL V, Treuner-Kaueroff T, Seehofer D, Berg T, et al
    Low PCSK9 levels are correlated with mortality in patients with end-stage liver disease.
    PLoS One. 2017;12:e0181540.
    PubMed     Abstract available

  670. GOEBEL J, Sulke M, Lazik-Palm A, Goebel T, et al
    Factors associated with contralateral liver hypertrophy after unilateral radioembolization for hepatocellular carcinoma.
    PLoS One. 2017;12:e0181488.
    PubMed     Abstract available

  671. KAUFMANN B, Wang B, Zhong S, Laschinger M, et al
    BRG1 promotes hepatocarcinogenesis by regulating proliferation and invasiveness.
    PLoS One. 2017;12:e0180225.
    PubMed     Abstract available

  672. KIRCHNER J, Sawicki LM, Deuschl C, Gruneisen J, et al
    18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
    PLoS One. 2017;12:e0180349.
    PubMed     Abstract available

  673. RISSIN DM, Lopez-Longarela B, Pernagallo S, Ilyine H, et al
    Polymerase-free measurement of microRNA-122 with single base specificity using single molecule arrays: Detection of drug-induced liver injury.
    PLoS One. 2017;12:e0179669.
    PubMed     Abstract available

  674. CAI G, Chen B, Li Z, Wei W, et al
    The different expressed serum proteins in rhCygb treated rat model of liver fibrosis by the optimized two-dimensional gel electrophoresis.
    PLoS One. 2017;12:e0177968.
    PubMed     Abstract available

  675. KAMMOUN HL, Allen TL, Henstridge DC, Kraakman MJ, et al
    Over-expressing the soluble gp130-Fc does not ameliorate methionine and choline deficient diet-induced non alcoholic steatohepatitis in mice.
    PLoS One. 2017;12:e0179099.
    PubMed     Abstract available

  676. MATSUMOTO K, Ichimura M, Tsuneyama K, Moritoki Y, et al
    Fructo-oligosaccharides and intestinal barrier function in a methionine-choline-deficient mouse model of nonalcoholic steatohepatitis.
    PLoS One. 2017;12:e0175406.
    PubMed     Abstract available

  677. KAMIMURA K, Yokoo T, Kamimura H, Sakamaki A, et al
    Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses.
    PLoS One. 2017;12:e0178991.
    PubMed     Abstract available

  678. KIM HM, Kim YM, Huh JH, Lee ES, et al
    alpha-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2.
    PLoS One. 2017;12:e0179204.
    PubMed     Abstract available

  679. KLOTTER V, Gunchick C, Siemers E, Rath T, et al
    Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort study.
    PLoS One. 2017;12:e0178784.
    PubMed     Abstract available

  680. SOGABE M, Okahisa T, Nakasono M, Fukuno H, et al
    The differing influence of several factors on the development of fatty liver with elevation of liver enzymes between genders with metabolic syndrome: A cross-sectional study.
    PLoS One. 2017;12:e0177925.
    PubMed     Abstract available

  681. HONG M, Jung J, Park HS, Lee SM, et al
    Shaofu Zhuyu decoction ameliorates obesity-mediated hepatic steatosis and systemic inflammation by regulating metabolic pathways.
    PLoS One. 2017;12:e0178514.
    PubMed     Abstract available

  682. HO SW, Yeh CB, Yang SF, Yeh HW, et al
    Pneumonia is an independent risk factor for pyogenic liver abscess: A population-based, nested, case-control study.
    PLoS One. 2017;12:e0178571.
    PubMed     Abstract available

  683. LI Z, Lin B, Lin G, Wu Y, et al
    Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis.
    PLoS One. 2017;12:e0178580.
    PubMed     Abstract available

  684. MASARONE M, Rosato V, Aglitti A, Bucci T, et al
    Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage.
    PLoS One. 2017;12:e0178473.
    PubMed     Abstract available

  685. LI M, Chen D, Huang H, Wang J, et al
    Caveolin1 protects against diet induced hepatic lipid accumulation in mice.
    PLoS One. 2017;12:e0178748.
    PubMed     Abstract available

  686. ZHENG H, Zou AE, Saad MA, Wang XQ, et al
    Alcohol-dysregulated microRNAs in hepatitis B virus-related hepatocellular carcinoma.
    PLoS One. 2017;12:e0178547.
    PubMed     Abstract available

  687. OHNO Y, Koizumi M, Nakayama H, Watanabe T, et al
    Downregulation of ANP32B exerts anti-apoptotic effects in hepatocellular carcinoma.
    PLoS One. 2017;12:e0177343.
    PubMed     Abstract available

  688. HAGA Y, Kanda T, Nakamura M, Nakamoto S, et al
    Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines.
    PLoS One. 2017;12:e0174153.
    PubMed     Abstract available

  689. JIA J, Qiao Y, Pilo MG, Cigliano A, et al
    Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade.
    PLoS One. 2017;12:e0184068.
    PubMed     Abstract available

  690. HOU W, Gupta S, Beauchamp MC, Yuan L, et al
    Non-alcoholic fatty liver disease in mice with heterozygous mutation in TMED2.
    PLoS One. 2017;12:e0182995.
    PubMed     Abstract available

  691. MATSUSHITA N, Hassanein MT, Martinez-Clemente M, Lazaro R, et al
    Gender difference in NASH susceptibility: Roles of hepatocyte Ikkbeta and Sult1e1.
    PLoS One. 2017;12:e0181052.
    PubMed     Abstract available

  692. CRUZ-BAQUERO A, Cardenas Jaramillo LM, Gutierrez-Meza M, Jarillo-Luna RA, et al
    Different behavior of myeloperoxidase in two rodent amoebic liver abscess models.
    PLoS One. 2017;12:e0182480.
    PubMed     Abstract available

  693. RODRIGUEZ K, Srivaths PR, Tal L, Watson MN, et al
    Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.
    PLoS One. 2017;12:e0182134.
    PubMed     Abstract available

  694. PINTER M, Haupt L, Hucke F, Bota S, et al
    The impact of thyroid hormones on patients with hepatocellular carcinoma.
    PLoS One. 2017;12:e0181878.
    PubMed     Abstract available

  695. XIMENEZ C, Gonzalez E, Nieves M, Magana U, et al
    Differential expression of pathogenic genes of Entamoeba histolytica vs E. dispar in a model of infection using human liver tissue explants.
    PLoS One. 2017;12:e0181962.
    PubMed     Abstract available

  696. ZHANG Y, Kim DK, Lu Y, Jung YS, et al
    Orphan nuclear receptor ERRgamma is a key regulator of human fibrinogen gene expression.
    PLoS One. 2017;12:e0182141.
    PubMed     Abstract available

  697. DUCHEIX S, Montagner A, Polizzi A, Lasserre F, et al
    Dietary oleic acid regulates hepatic lipogenesis through a liver X receptor-dependent signaling.
    PLoS One. 2017;12:e0181393.
    PubMed     Abstract available

  698. GASLJEVIC G, Edhemovic I, Cemazar M, Brecelj E, et al
    Histopathological findings in colorectal liver metastases after electrochemotherapy.
    PLoS One. 2017;12:e0180709.
    PubMed     Abstract available

  699. KIM J, Lee DY, Park SE, Park CY, et al
    Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation.
    PLoS One. 2017;12:e0180118.
    PubMed     Abstract available

  700. YU J, Yang X, Luo Y, Yang X, et al
    Adverse effects of chronic exposure to nonylphenol on non-alcoholic fatty liver disease in male rats.
    PLoS One. 2017;12:e0180218.
    PubMed     Abstract available

  701. SCHOEMAKER MH, Kleemann R, Morrison MC, Verheij J, et al
    A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice.
    PLoS One. 2017;12:e0180648.
    PubMed     Abstract available

  702. KONG E, Chun KA, Cho IH
    Quantitative assessment of simultaneous F-18 FDG PET/MRI in patients with various types of hepatic tumors: Correlation between glucose metabolism and apparent diffusion coefficient.
    PLoS One. 2017;12:e0180184.
    PubMed     Abstract available

  703. HO SY, Liu PH, Hsu CY, Hsia CY, et al
    Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    PLoS One. 2017;12:e0180408.
    PubMed     Abstract available

  704. YEN CH, Wang KT, Lee PY, Liu CC, et al
    Gender-differences in the associations between circulating creatine kinase, blood pressure, body mass and non-alcoholic fatty liver disease in asymptomatic asians.
    PLoS One. 2017;12:e0179898.
    PubMed     Abstract available

  705. PRESTIGIACOMO V, Weston A, Messner S, Lampart F, et al
    Pro-fibrotic compounds induce stellate cell activation, ECM-remodelling and Nrf2 activation in a human 3D-multicellular model of liver fibrosis.
    PLoS One. 2017;12:e0179995.
    PubMed     Abstract available

  706. KANAMORI H, Nakade Y, Yamauchi T, Sakamoto K, et al
    Influence of nicotine on choline-deficient, L-amino acid-defined diet-induced non-alcoholic steatohepatitis in rats.
    PLoS One. 2017;12:e0180475.
    PubMed     Abstract available

  707. BAE JS, Kim JH, Yu MH, Lee DH, et al
    Diagnostic accuracy of gadoxetic acid-enhanced MR for small hypervascular hepatocellular carcinoma and the concordance rate of Liver Imaging Reporting and Data System (LI-RADS).
    PLoS One. 2017;12:e0178495.
    PubMed     Abstract available

  708. ZENG T, Wang D, Chen J, Tian Y, et al
    LncRNA-AF113014 promotes the expression of Egr2 by interaction with miR-20a to inhibit proliferation of hepatocellular carcinoma cells.
    PLoS One. 2017;12:e0177843.
    PubMed     Abstract available

  709. YANG YJ, Bang CS, Shin SP, Baik GH, et al
    Clinical impact of non-alcoholic fatty liver disease on the occurrence of colorectal neoplasm: Propensity score matching analysis.
    PLoS One. 2017;12:e0182014.
    PubMed     Abstract available

  710. CHAN SL, Chua APG, Aminkeng F, Chee CBE, et al
    Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients.
    PLoS One. 2017;12:e0186200.
    PubMed     Abstract available

  711. DING L, Wo L, Du Z, Tang L, et al
    Danshen protects against early-stage alcoholic liver disease in mice via inducing PPARalpha activation and subsequent 4-HNE degradation.
    PLoS One. 2017;12:e0186357.
    PubMed     Abstract available

  712. CICALESE L, Curcuru G, Montalbano M, Shirafkan A, et al
    Hazardous air pollutants and primary liver cancer in Texas.
    PLoS One. 2017;12:e0185610.
    PubMed     Abstract available

  713. THEIN HH, Qiao Y, Zaheen A, Jembere N, et al
    Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting.
    PLoS One. 2017;12:e0185198.
    PubMed     Abstract available

  714. KHAN MAH, Ullah R, Rehman A, Rehman L, et al
    Immunolocalization and immunodetection of the excretory/secretory (ES) antigens of Fasciola gigantica.
    PLoS One. 2017;12:e0185870.
    PubMed     Abstract available

  715. YEH ML, Huang CI, Huang CF, Hsieh MY, et al
    The impact of an additional extra-hepatic primary malignancy on the outcomes of patients with hepatocellular carcinoma.
    PLoS One. 2017;12:e0184878.
    PubMed     Abstract available

  716. AREVALO-HERRERA M, Rengifo L, Lopez-Perez M, Arce-Plata MI, et al
    Complicated malaria in children and adults from three settings of the Colombian Pacific Coast: A prospective study.
    PLoS One. 2017;12:e0185435.
    PubMed     Abstract available

  717. CHEN CT, Liu CY, Yu YB, Liu CJ, et al
    Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients.
    PLoS One. 2017;12:e0185210.
    PubMed     Abstract available

  718. KATSANOS K, Kitrou P, Spiliopoulos S, Maroulis I, et al
    Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials.
    PLoS One. 2017;12:e0184597.
    PubMed     Abstract available

  719. LAMBERT A, Jarlier M, Gourgou Bourgade S, Conroy T, et al
    Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial.
    PLoS One. 2017;12:e0183288.
    PubMed     Abstract available

  720. PUENGEL T, Krenkel O, Kohlhepp M, Lefebvre E, et al
    Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury.
    PLoS One. 2017;12:e0184694.
    PubMed     Abstract available

  721. GUO H, Wu T, Lu Q, Dong J, et al
    Hepatocellular carcinoma in elderly: Clinical characteristics, treatments and outcomes compared with younger adults.
    PLoS One. 2017;12:e0184160.
    PubMed     Abstract available

  722. WAN X, Liu Y, Zhao Y, Sun X, et al
    Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1alpha-dependent and -independent mechanism.
    PLoS One. 2017;12:e0184213.
    PubMed     Abstract available

  723. LIU H, Zhang C, Fan X, Duan Y, et al
    Robust phase-retrieval-based X-ray tomography for morphological assessment of early hepatic echinococcosis infection in rats.
    PLoS One. 2017;12:e0183396.
    PubMed     Abstract available

  724. NIER A, Engstler AJ, Maier IB, Bergheim I, et al
    Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children.
    PLoS One. 2017;12:e0183282.
    PubMed     Abstract available

  725. TSUDA T, Kaibori M, Hishikawa H, Nakatake R, et al
    Near-infrared fluorescence imaging and photodynamic therapy with indocyanine green lactosome has antineoplastic effects for hepatocellular carcinoma.
    PLoS One. 2017;12:e0183527.
    PubMed     Abstract available

  726. LEE JY, Shin DW, Oh JW, Kim W, et al
    Non-alcoholic fatty liver disease as a risk factor for female sexual dysfunction in premenopausal women.
    PLoS One. 2017;12:e0182708.
    PubMed     Abstract available

  727. ALSHAREEDA AT, Sakaguchi K, Abumaree M, Mohd Zin NK, et al
    The potential of cell sheet technique on the development of hepatocellular carcinoma in rat models.
    PLoS One. 2017;12:e0184004.
    PubMed     Abstract available

  728. KURUVILLA SP, Tiruchinapally G, Crouch AC, ElSayed MEH, et al
    Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model.
    PLoS One. 2017;12:e0181944.
    PubMed     Abstract available

  729. KULKARNI S, Dolezal JM, Wang H, Jackson L, et al
    Ribosomopathy-like properties of murine and human cancers.
    PLoS One. 2017;12:e0182705.
    PubMed     Abstract available

  730. WANG L, Feng Y, Ma X, Wang G, et al
    Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis.
    PLoS One. 2017;12:e0182969.
    PubMed     Abstract available

  731. DING S, Jiang J, Zhang G, Bu Y, et al
    Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats.
    PLoS One. 2017;12:e0183541.
    PubMed     Abstract available

  732. MA Z, Zhang Y, Li Q, Xu M, et al
    Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1alpha expression and mitochondrial ROS production.
    PLoS One. 2017;12:e0183426.
    PubMed     Abstract available

  733. DONAIRES FS, Scatena NF, Alves-Paiva RM, Podlevsky JD, et al
    Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma.
    PLoS One. 2017;12:e0183287.
    PubMed     Abstract available

  734. JUN BG, Park WY, Park EJ, Jang JY, et al
    A prospective comparative assessment of the accuracy of the FibroScan in evaluating liver steatosis.
    PLoS One. 2017;12:e0182784.
    PubMed     Abstract available

  735. LI J, Ghazwani M, Liu K, Huang Y, et al
    Regulation of hepatic stellate cell proliferation and activation by glutamine metabolism.
    PLoS One. 2017;12:e0182679.
    PubMed     Abstract available

  736. JIAO Y, Ding L, Chu M, Wang T, et al
    Effects of cancer-testis antigen, TFDP3, on cell cycle regulation and its mechanism in L-02 and HepG2 cell lines in vitro.
    PLoS One. 2017;12:e0182781.
    PubMed     Abstract available

  737. CHOI YR, Kim JH, Park SJ, Hur BY, et al
    Therapeutic response assessment using 3D ultrasound for hepatic metastasis from colorectal cancer: Application of a personalized, 3D-printed tumor model using CT images.
    PLoS One. 2017;12:e0182596.
    PubMed     Abstract available

  738. GARCIA-GARCIA R, Cruz-Gomez AJ, Mangas-Losada A, Urios A, et al
    Reduced resting state connectivity and gray matter volume correlate with cognitive impairment in minimal hepatic encephalopathy.
    PLoS One. 2017;12:e0186463.
    PubMed     Abstract available

  739. BHAT M, Tazari M, Sebastiani G
    Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: A meta-analysis.
    PLoS One. 2017;12:e0185192.
    PubMed     Abstract available

  740. DONG J, Zhai B, Sun W, Hu F, et al
    Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells.
    PLoS One. 2017;12:e0185088.
    PubMed     Abstract available

  741. TUDORANCEA I, Porumb V, Trandabat A, Neaga D, et al
    New experimental model for single liver lobe hyperthermia in small animals using non-directional microwaves.
    PLoS One. 2017;12:e0184810.
    PubMed     Abstract available

  742. LUNDGREN H, Martinsson K, Cederbrant K, Jirholt J, et al
    HLA-DR7 and HLA-DQ2: Transgenic mouse strains tested as a model system for ximelagatran hepatotoxicity.
    PLoS One. 2017;12:e0184744.
    PubMed     Abstract available

  743. WEISS TS, Lupke M, Ibrahim S, Buechler C, et al
    Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.
    PLoS One. 2017;12:e0184282.
    PubMed     Abstract available

  744. KIM AY, Frantz S, Krishnan P, DeMulder D, et al
    Short-term imaging response after drug-eluting embolic trans-arterial chemoembolization delivered with the Surefire Infusion System(R) for the treatment of hepatocellular carcinoma.
    PLoS One. 2017;12:e0183861.
    PubMed     Abstract available

  745. RATNASARI N, Nurdjanah S, Sadewa AH, Hakimi M, et al
    Difference of polymorphism VEGF-gene rs699947 in Indonesian chronic liver disease population.
    PLoS One. 2017;12:e0183503.
    PubMed     Abstract available

  746. MARTINELLI I, Ponziani FR, Maino A, Bhoori S, et al
    Thrombosis after liver transplantation for hepatocellular carcinoma.
    PLoS One. 2017;12:e0186699.
    PubMed     Abstract available

  747. FRIEDRICH-RUST M, Schoelzel F, Maier S, Seeger F, et al
    Severity of coronary artery disease is associated with non-alcoholic fatty liver dis-ease: A single-blinded prospective mono-center study.
    PLoS One. 2017;12:e0186720.
    PubMed     Abstract available

  748. HUBER W, Gruber A, Eckmann M, Elkmann F, et al
    Comparison of pulmonary vascular permeability index PVPI and global ejection fraction GEF derived from jugular and femoral indicator injection using the PiCCO-2 device: A prospective observational study.
    PLoS One. 2017;12:e0178372.
    PubMed     Abstract available

  749. ALCALA M, Calderon-Dominguez M, Serra D, Herrero L, et al
    Short-term vitamin E treatment impairs reactive oxygen species signaling required for adipose tissue expansion, resulting in fatty liver and insulin resistance in obese mice.
    PLoS One. 2017;12:e0186579.
    PubMed     Abstract available

  750. MANCINI M, Salomone Megna A, Ragucci M, De Luca M, et al
    Reproducibility of shear wave elastography (SWE) in patients with chronic liver disease.
    PLoS One. 2017;12:e0185391.
    PubMed     Abstract available

  751. LAURIDSEN MM, Mikkelsen S, Svensson T, Holm J, et al
    The continuous reaction time test for minimal hepatic encephalopathy validated by a randomized controlled multi-modal intervention-A pilot study.
    PLoS One. 2017;12:e0185412.
    PubMed     Abstract available

  752. CHANG JY, Kim SE, Kim TH, Woo SY, et al
    Emergence of rifampin-resistant staphylococci after rifaximin administration in cirrhotic patients.
    PLoS One. 2017;12:e0186120.
    PubMed     Abstract available

  753. MANTOVANI A, Rigolon R, Pichiri I, Bonapace S, et al
    Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus.
    PLoS One. 2017;12:e0185459.
    PubMed     Abstract available

  754. LIU D, Hu Y, Guo Y, Zhu Z, et al
    Mycoplasma-associated multidrug resistance of hepatocarcinoma cells requires the interaction of P37 and Annexin A2.
    PLoS One. 2017;12:e0184578.
    PubMed     Abstract available

  755. MORUZZI S, Guarini P, Udali S, Ruzzenente A, et al
    One-carbon genetic variants and the role of MTHFD1 1958G>A in liver and colon cancer risk according to global DNA methylation.
    PLoS One. 2017;12:e0185792.
    PubMed     Abstract available

  756. DAI D, Wen F, Zhou S, Su Z, et al
    Association of MTTP gene variants with pediatric NAFLD: A candidate-gene-based analysis of single nucleotide variations in obese children.
    PLoS One. 2017;12:e0185396.
    PubMed     Abstract available

  757. SULTAN M, Ben-Ari Z, Masoud R, Pappo O, et al
    Interleukin-1alpha and Interleukin-1beta play a central role in the pathogenesis of fulminant hepatic failure in mice.
    PLoS One. 2017;12:e0184084.
    PubMed     Abstract available

  758. MAO L, Wang Y, Wang D, Han G, et al
    TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
    PLoS One. 2017;12:e0183880.
    PubMed     Abstract available

  759. YE Y, Li Z, Feng Q, Chen Z, et al
    Downregulation of microRNA-145 may contribute to liver fibrosis in biliary atresia by targeting ADD3.
    PLoS One. 2017;12:e0180896.
    PubMed     Abstract available

  760. YOKOTA T, Omachi K, Suico MA, Kojima H, et al
    Bromide supplementation exacerbated the renal dysfunction, injury and fibrosis in a mouse model of Alport syndrome.
    PLoS One. 2017;12:e0183959.
    PubMed     Abstract available

  761. PIERCE AA, Duwaerts CC, Siao K, Mattis AN, et al
    CD18 deficiency improves liver injury in the MCD model of steatohepatitis.
    PLoS One. 2017;12:e0183912.
    PubMed     Abstract available

  762. LEI Y, Wang S, Ren B, Wang J, et al
    CHOP favors endoplasmic reticulum stress-induced apoptosis in hepatocellular carcinoma cells via inhibition of autophagy.
    PLoS One. 2017;12:e0183680.
    PubMed     Abstract available

  763. MUKHERJEE PS, Vishnubhatla S, Amarapurkar DN, Das K, et al
    Etiology and mode of presentation of chronic liver diseases in India: A multi centric study.
    PLoS One. 2017;12:e0187033.
    PubMed     Abstract available

  764. VAN DEN BOSSCHE L, Schoonenberg VAC, Burgener IA, Penning LC, et al
    Aberrant hepatic lipid storage and metabolism in canine portosystemic shunts.
    PLoS One. 2017;12:e0186491.
    PubMed     Abstract available

  765. KIM D, Kim W, Kwak MS, Chung GE, et al
    Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States.
    PLoS One. 2017;12:e0186702.
    PubMed     Abstract available

  766. KIM JH, Kwon HY, Ryu DH, Nam MH, et al
    Inhibition of CUG-binding protein 1 and activation of caspases are critically involved in piperazine derivative BK10007S induced apoptosis in hepatocellular carcinoma cells.
    PLoS One. 2017;12:e0186490.
    PubMed     Abstract available

  767. COEBERGH VAN DEN BRAAK RRJ, Sieuwerts AM, Kandimalla R, Lalmahomed ZS, et al
    High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.
    PLoS One. 2017;12:e0185607.
    PubMed     Abstract available

  768. KIM S, Chang Y, Sung E, Kim CH, et al
    Non-alcoholic fatty liver disease and the development of nephrolithiasis: A cohort study.
    PLoS One. 2017;12:e0184506.
    PubMed     Abstract available

  769. KIM G, Kang SH, Kim MY, Baik SK, et al
    Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0186990.
    PubMed     Abstract available

  770. AUGUET T, Aragones G, Berlanga A, Martinez S, et al
    Hepcidin in morbidly obese women with non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0187065.
    PubMed     Abstract available

  771. LI S, Takahara T, Fujino M, Fukuhara Y, et al
    Astaxanthin prevents ischemia-reperfusion injury of the steatotic liver in mice.
    PLoS One. 2017;12:e0187810.
    PubMed     Abstract available

  772. RICHTIG G, Aigelsreiter A, Schwarzenbacher D, Ress AL, et al
    SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
    PLoS One. 2017;12:e0187814.
    PubMed     Abstract available

  773. QIU J, Zhou Z, Wang J, Wang Y, et al
    Associations between fatty liver index and asymptomatic intracranial vertebrobasilar stenosis in Chinese population.
    PLoS One. 2017;12:e0187502.
    PubMed     Abstract available

  774. LEE Y, Kwon DJ, Kim YH, Ra M, et al
    HIMH0021 attenuates ethanol-induced liver injury and steatosis in mice.
    PLoS One. 2017;12:e0185134.
    PubMed     Abstract available

  775. LEE HW, Kim KJ, Jung KS, Chon YE, et al
    The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter.
    PLoS One. 2017;12:e0187066.
    PubMed     Abstract available

  776. XU Y, Li N, Lu M, Dixon E, et al
    The effects of patient cost sharing on inpatient utilization, cost, and outcome.
    PLoS One. 2017;12:e0187096.
    PubMed     Abstract available

  777. KARTOUN U, Corey KE, Simon TG, Zheng H, et al
    The MELD-Plus: A generalizable prediction risk score in cirrhosis.
    PLoS One. 2017;12:e0186301.
    PubMed     Abstract available

  778. MARTINEZ-SERNANDEZ V, Perteguer MJ, Mezo M, Gonzalez-Warleta M, et al
    Fasciola spp: Mapping of the MF6 epitope and antigenic analysis of the MF6p/HDM family of heme-binding proteins.
    PLoS One. 2017;12:e0188520.
    PubMed     Abstract available

  779. PETTA S, Ciresi A, Bianco J, Geraci V, et al
    Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS.
    PLoS One. 2017;12:e0186136.
    PubMed     Abstract available

  780. HSU CY, Liu PH, Ho SY, Huang YH, et al
    Impact of tumor burden on prognostic prediction for patients with terminal stage hepatocellular carcinoma: A nomogram study.
    PLoS One. 2017;12:e0188031.
    PubMed     Abstract available

  781. YATES KP, Deppe R, Comerford M, Masuoka H, et al
    Serum high mobility group box 1 protein levels are not associated with either histological severity or treatment response in children and adults with nonalcoholic fatty liver disease.
    PLoS One. 2017;12:e0185813.
    PubMed     Abstract available

  782. LEE MS, Bae JM, Joo SK, Woo H, et al
    Prospective comparison among transient elastography, supersonic shear imaging, and ARFI imaging for predicting fibrosis in nonalcoholic fatty liver disease.
    PLoS One. 2017;12:e0188321.
    PubMed     Abstract available

  783. PAN JH, Lim Y, Kim JH, Heo W, et al
    Root bark of Ulmus davidiana var. japonica restrains acute alcohol-induced hepatic steatosis onset in mice by inhibiting ROS accumulation.
    PLoS One. 2017;12:e0188381.
    PubMed     Abstract available

  784. PINHEIRO D, Leiros L, Dau JBT, Stumbo AC, et al
    Cytokines, hepatic cell profiling and cell interactions during bone marrow cell therapy for liver fibrosis in cholestatic mice.
    PLoS One. 2017;12:e0187970.
    PubMed     Abstract available

  785. MORELL CM, Fiorotto R, Meroni M, Raizner A, et al
    Notch signaling and progenitor/ductular reaction in steatohepatitis.
    PLoS One. 2017;12:e0187384.
    PubMed     Abstract available

  786. WOO HY, Han SY, Heo J, Kim DU, et al
    Role of endoscopic biliary drainage in advanced hepatocellular carcinoma with jaundice.
    PLoS One. 2017;12:e0187469.
    PubMed     Abstract available

  787. TAN Y, Zhang W, Jiang L, Yang J, et al
    Efficacy and safety of anatomic resection versus nonanatomic resection in patients with hepatocellular carcinoma: A systemic review and meta-analysis.
    PLoS One. 2017;12:e0186930.
    PubMed     Abstract available

  788. ALAZAWI W, Bernabe E, Tai D, Janicki T, et al
    Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease.
    PLoS One. 2017;12:e0185902.
    PubMed     Abstract available

  789. BACIU C, Pasini E, Angeli M, Schwenger K, et al
    Systematic integrative analysis of gene expression identifies HNF4A as the central gene in pathogenesis of non-alcoholic steatohepatitis.
    PLoS One. 2017;12:e0189223.
    PubMed     Abstract available

  790. FIGORILLI F, Putignano A, Roux O, Houssel-Debry P, et al
    Development of an organ failure score in acute liver failure for transplant selection and identification of patients at high risk of futility.
    PLoS One. 2017;12:e0188151.
    PubMed     Abstract available

  791. ROGAL SS, Udawatta V, Akpan I, Moghe A, et al
    Risk factors for hospitalizations among patients with cirrhosis: A prospective cohort study.
    PLoS One. 2017;12:e0187176.
    PubMed     Abstract available

  792. YANG A, Guo Z, Ren Q, Wu L, et al
    Active immunization in patients transplanted for hepatitis B virus related liver diseases: A prospective study.
    PLoS One. 2017;12:e0188190.
    PubMed     Abstract available

  793. FEIG JL, Mediero A, Corciulo C, Liu H, et al
    The antiviral drug tenofovir, an inhibitor of Pannexin-1-mediated ATP release, prevents liver and skin fibrosis by downregulating adenosine levels in the liver and skin.
    PLoS One. 2017;12:e0188135.
    PubMed     Abstract available

  794. YOO W, Gjuka D, Stevenson HL, Song X, et al
    Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid.
    PLoS One. 2017;12:e0189965.
    PubMed     Abstract available

  795. CEDO L, Santos D, Roglans N, Julve J, et al
    Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake.
    PLoS One. 2017;12:e0189834.
    PubMed     Abstract available

  796. KO Y, Kim J, Park JK, Kim H, et al
    Limited detection of small (</= 10 mm) colorectal liver metastasis at preoperative CT in patients undergoing liver resection.
    PLoS One. 2017;12:e0189797.
    PubMed     Abstract available

  797. ZHENG XY, Zhao X, Yang YF, Jiang HJ, et al
    Antioxidant, antiapoptotic and amino acid balance regulating activities of 1,7-dihydroxy-3,4,8-trimethoxyxanthone against dimethylnitrosamine-induced liver fibrosis.
    PLoS One. 2017;12:e0189344.
    PubMed     Abstract available

  798. HUANG YK, Yen CL, Shiu SI, Lee SW, et al
    Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma.
    PLoS One. 2017;12:e0188999.
    PubMed     Abstract available

  799. RENAULT V, Tost J, Pichon F, Wang-Renault SF, et al
    aCNViewer: Comprehensive genome-wide visualization of absolute copy number and copy neutral variations.
    PLoS One. 2017;12:e0189334.
    PubMed     Abstract available

  800. JEFFERY HC, McDowell P, Lutz P, Wawman RE, et al
    Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score.
    PLoS One. 2017;12:e0188649.
    PubMed     Abstract available

  801. SANDAHL TD, Stoy SH, Laursen TL, Rodgaard-Hansen S, et al
    The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients.
    PLoS One. 2017;12:e0189345.
    PubMed     Abstract available

  802. PARK J, Masaki T, Mezaki Y, Yokoyama H, et al
    Alpha-1 antichymotrypsin is involved in astrocyte injury in concert with arginine-vasopressin during the development of acute hepatic encephalopathy.
    PLoS One. 2017;12:e0189346.
    PubMed     Abstract available

  803. PETA V, Tse C, Perazzo H, Munteanu M, et al
    Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery.
    PLoS One. 2017;12:e0189436.
    PubMed     Abstract available

    January 2016
  804. SUN MY, Zhang L, Shi SL, Lin JN, et al
    Associations between Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: A Meta-Analysis.
    PLoS One. 2016;11:e0154337.
    PubMed     Abstract available

  805. MOUZAKI M, Wang AY, Bandsma R, Comelli EM, et al
    Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0151829.
    PubMed     Abstract available

  806. PAN C, Wang X, Shi K, Zheng Y, et al
    MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism.
    PLoS One. 2016;11:e0152090.
    PubMed     Abstract available

  807. ARAGONES G, Auguet T, Berlanga A, Guiu-Jurado E, et al
    Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0154601.
    PubMed     Abstract available

  808. CHIBA T, Suzuki S, Sato Y, Itoh T, et al
    Evaluation of Methionine Content in a High-Fat and Choline-Deficient Diet on Body Weight Gain and the Development of Non-Alcoholic Steatohepatitis in Mice.
    PLoS One. 2016;11:e0164191.
    PubMed     Abstract available

  809. EHLKEN H, Wroblewski R, Corpechot C, Arrive L, et al
    Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis.
    PLoS One. 2016;11:e0164224.
    PubMed     Abstract available

  810. LIU TL, Barritt Iv AS, Weinberger M, Paul JE, et al
    Who Treats Patients with Diabetes and Compensated Cirrhosis.
    PLoS One. 2016;11:e0165574.
    PubMed     Abstract available

  811. BOUTTELL J, Lewsey J, Geue C, Antony G, et al
    The SCottish Alcoholic Liver disease Evaluation: A Population-Level Matched Cohort Study of Hospital-Based Costs, 1991-2011.
    PLoS One. 2016;11:e0162980.
    PubMed     Abstract available

  812. AMARAL KB, Silva TP, Malta KK, Carmo LA, et al
    Natural Schistosoma mansoni Infection in the Wild Reservoir Nectomys squamipes Leads to Excessive Lipid Droplet Accumulation in Hepatocytes in the Absence of Liver Functional Impairment.
    PLoS One. 2016;11:e0166979.
    PubMed     Abstract available

  813. ZHENG S, Zhang P, Chen Y, Zheng S, et al
    Inhibition of Notch Signaling Attenuates Schistosomiasis Hepatic Fibrosis via Blocking Macrophage M2 Polarization.
    PLoS One. 2016;11:e0166808.
    PubMed     Abstract available

  814. HE XX, Wu XL, Chen RP, Chen C, et al
    Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2016;11:e0162368.
    PubMed     Abstract available

  815. CHENG CW, Liu FC, Lin JR, Tsai YF, et al
    The Impact of Hospital/Surgeon Volume on Acute Renal Failure and Mortality in Liver Transplantation: A Nationwide Cohort Study.
    PLoS One. 2016;11:e0162992.
    PubMed     Abstract available

  816. NOVO-VELEIRO I, Cieza-Borrella C, Pastor I, Chamorro AJ, et al
    A Single Nucleotide Polymorphism in the RASGRF2 Gene Is Associated with Alcoholic Liver Cirrhosis in Men.
    PLoS One. 2016;11:e0168685.
    PubMed     Abstract available

  817. TUTTOLOMONDO A, Di Raimondo D, Bellia C, Clemente G, et al
    Immune-Inflammatory and Metabolic Effects of High Dose Furosemide plus Hypertonic Saline Solution (HSS) Treatment in Cirrhotic Subjects with Refractory Ascites.
    PLoS One. 2016;11:e0165443.
    PubMed     Abstract available

  818. LECUBE A, Valladares S, Lopez-Cano C, Gutierrez L, et al
    The Role of Morbid Obesity in the Promotion of Metabolic Disruptions and Non-Alcoholic Steatohepatitis by Helicobacter Pylori.
    PLoS One. 2016;11:e0166741.
    PubMed     Abstract available

  819. FAN WC, Liu CW, Ou SM, Huang CC, et al
    TLR4/CD14 Variants-Related Serologic and Immunologic Dys-Regulations Predict Severe Sepsis in Febrile De-Compensated Cirrhotic Patients.
    PLoS One. 2016;11:e0166458.
    PubMed     Abstract available

  820. FJELD K, Beer S, Johnstone M, Zimmer C, et al
    Length of Variable Numbers of Tandem Repeats in the Carboxyl Ester Lipase (CEL) Gene May Confer Susceptibility to Alcoholic Liver Cirrhosis but Not Alcoholic Chronic Pancreatitis.
    PLoS One. 2016;11:e0165567.
    PubMed     Abstract available

  821. LEDE V, Franke C, Meusel A, Teupser D, et al
    Severe Atherosclerosis and Hypercholesterolemia in Mice Lacking Both the Melanocortin Type 4 Receptor and Low Density Lipoprotein Receptor.
    PLoS One. 2016;11:e0167888.
    PubMed     Abstract available

  822. LANKARANI KB, Malek-Hosseini SA, Nikeghbalian S, Dehghani M, et al
    Fourteen Years of Experience of Liver Transplantation for Wilson's Disease; a Report on 107 Cases from Shiraz, Iran.
    PLoS One. 2016;11:e0167890.
    PubMed     Abstract available

  823. IGUCHI T, Nambara S, Masuda T, Komatsu H, et al
    miR-146a Polymorphism (rs2910164) Predicts Colorectal Cancer Patients' Susceptibility to Liver Metastasis.
    PLoS One. 2016;11:e0165912.
    PubMed     Abstract available

  824. GONZALEZ-PAREDES FJ, Hernandez Mesa G, Morales Arraez D, Marcelino Reyes R, et al
    Contribution of Cyclooxygenase End Products and Oxidative Stress to Intrahepatic Endothelial Dysfunction in Early Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0156650.
    PubMed     Abstract available

  825. SCHUSTER C, Akslen LA, Straume O
    Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study.
    PLoS One. 2016;11:e0155242.
    PubMed     Abstract available

  826. KIM JC, Ha YJ, Tak KH, Roh SA, et al
    Complex Behavior of ALDH1A1 and IGFBP1 in Liver Metastasis from a Colorectal Cancer.
    PLoS One. 2016;11:e0155160.
    PubMed     Abstract available

  827. SHANAKI M, Fadaei R, Moradi N, Emamgholipour S, et al
    The Circulating CTRP13 in Type 2 Diabetes and Non-Alcoholic Fatty Liver Patients.
    PLoS One. 2016;11:e0168082.
    PubMed     Abstract available

  828. ZHOU Z, Song K, Qiu J, Wang Y, et al
    Associations between Serum Uric Acid and the Remission of Non-Alcoholic Fatty Liver Disease in Chinese Males.
    PLoS One. 2016;11:e0166072.
    PubMed     Abstract available

  829. WU S, Wang YJ, Tang X, Wang Y, et al
    Genetic Polymorphisms of Glutathione S-Transferase P1 (GSTP1) and the Incidence of Anti-Tuberculosis Drug-Induced Hepatotoxicity.
    PLoS One. 2016;11:e0157478.
    PubMed     Abstract available

  830. VESPASIANI-GENTILUCCI U, Gallo P, Piemonte F, Riva E, et al
    Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology.
    PLoS One. 2016;11:e0156113.
    PubMed     Abstract available

  831. GADALEAN F, Lighezan D, Stoian D, Schiller O, et al
    The Survival of Roma Minority Patients on Chronic Hemodialysis Therapy - A Romanian Multicenter Survey.
    PLoS One. 2016;11:e0155271.
    PubMed     Abstract available

  832. FIX OK, Liou I, Karvellas CJ, Ganger DR, et al
    Development and Pilot of a Checklist for Management of Acute Liver Failure in the Intensive Care Unit.
    PLoS One. 2016;11:e0155500.
    PubMed     Abstract available

  833. TISCHENDORF M, Miesbach W, Chattah U, Chattah Z, et al
    Differential Kinetics of Coagulation Factors and Natural Anticoagulants in Patients with Liver Cirrhosis: Potential Clinical Implications.
    PLoS One. 2016;11:e0155337.
    PubMed     Abstract available

  834. APRELIKOVA O, Tomlinson CC, Hoenerhoff M, Hixon JA, et al
    Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases.
    PLoS One. 2016;11:e0155262.
    PubMed     Abstract available

  835. OKAMOTO K, Koda M, Okamoto T, Onoyama T, et al
    A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.
    PLoS One. 2016;11:e0154676.
    PubMed     Abstract available

  836. JEURISSEN ML, Walenbergh SM, Houben T, Hendrikx T, et al
    Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr-/- Mice.
    PLoS One. 2016;11:e0167199.
    PubMed     Abstract available

  837. DELEURAN T, Vilstrup H, Overgaard S, Jepsen P, et al
    No Increased Risk for Primary Osteoarthritis in Liver Cirrhosis - A Danish Nationwide Cohort Study.
    PLoS One. 2016;11:e0167134.
    PubMed     Abstract available

  838. PARK SD, Moon J, Kwon SW, Suh YJ, et al
    Prognostic Impact of Combined Contrast-Induced Acute Kidney Injury and Hypoxic Liver Injury in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results from INTERSTELLAR Registry.
    PLoS One. 2016;11:e0159416.
    PubMed     Abstract available

  839. MARIN V, Rosso N, Dal Ben M, Raseni A, et al
    An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.
    PLoS One. 2016;11:e0158817.
    PubMed     Abstract available

  840. LAHMER T, Brandl A, Rasch S, Schmid RM, et al
    Fungal Peritonitis: Underestimated Disease in Critically Ill Patients with Liver Cirrhosis and Spontaneous Peritonitis.
    PLoS One. 2016;11:e0158389.
    PubMed     Abstract available

  841. SI WK, Chung JW, Cho J, Baeg JY, et al
    Predictors of Increased Risk of Hepatocellular Carcinoma in Patients with Type 2 Diabetes.
    PLoS One. 2016;11:e0158066.
    PubMed     Abstract available

  842. GAVITO AL, Bautista D, Suarez J, Badran S, et al
    Chronic IL-6 Administration Desensitizes IL-6 Response in Liver, Causes Hyperleptinemia and Aggravates Steatosis in Diet-Induced-Obese Mice.
    PLoS One. 2016;11:e0157956.
    PubMed     Abstract available

  843. ARAUJO-MARIZ C, Lopes EP, Acioli-Santos B, Maruza M, et al
    Hepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS.
    PLoS One. 2016;11:e0157725.
    PubMed     Abstract available

  844. JURADO-GARCIA J, Munoz Garcia-Borruel M, Rodriguez-Peralvarez ML, Ruiz-Cuesta P, et al
    Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality.
    PLoS One. 2016;11:e0155822.
    PubMed     Abstract available

  845. WANG D, Lin H, Xia M, Aleteng Q, et al
    Vitamin D Levels Are Inversely Associated with Liver Fat Content and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Middle-Aged and Elderly Population: The Shanghai Changfeng Study.
    PLoS One. 2016;11:e0157515.
    PubMed     Abstract available

  846. LEE KF, Tsai YT, Lin CY, Hsieh CB, et al
    Cancer Incidence among Heart, Kidney, and Liver Transplant Recipients in Taiwan.
    PLoS One. 2016;11:e0155602.
    PubMed     Abstract available

  847. XIA MF, Yki-Jarvinen H, Bian H, Lin HD, et al
    Influence of Ethnicity on the Accuracy of Non-Invasive Scores Predicting Non-Alcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0160526.
    PubMed     Abstract available

  848. ZHANG C, Yuan W, Fang J, Wang W, et al
    Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials.
    PLoS One. 2016;11:e0161792.
    PubMed     Abstract available

  849. GADDAM RR, Fraser R, Badiei A, Chambers S, et al
    Cystathionine-Gamma-Lyase Gene Deletion Protects Mice against Inflammation and Liver Sieve Injury following Polymicrobial Sepsis.
    PLoS One. 2016;11:e0160521.
    PubMed     Abstract available

  850. GRAUPERA I, Sola E, Fabrellas N, Moreira R, et al
    Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis.
    PLoS One. 2016;11:e0157371.
    PubMed     Abstract available

  851. HU S, Zou Z, Li H, Zou G, et al
    The Preoperative Peripheral Blood Monocyte Count Is Associated with Liver Metastasis and Overall Survival in Colorectal Cancer Patients.
    PLoS One. 2016;11:e0157486.
    PubMed     Abstract available

  852. SUZUKI-KEMURIYAMA N, Matsuzaka T, Kuba M, Ohno H, et al
    Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.
    PLoS One. 2016;11:e0157580.
    PubMed     Abstract available

  853. HUNG TH, Lay CJ, Tseng CW, Tsai CC, et al
    The Effect of Renal Function Impairment on the Mortality of Cirrhotic Patients: A Nationwide Population-Based 3-Year Follow-up Study.
    PLoS One. 2016;11:e0162987.
    PubMed     Abstract available

  854. KLEIN S, Hinuber C, Hittatiya K, Schierwagen R, et al
    Novel Rat Model of Repetitive Portal Venous Embolization Mimicking Human Non-Cirrhotic Idiopathic Portal Hypertension.
    PLoS One. 2016;11:e0162144.
    PubMed     Abstract available

  855. HASEGAWA K, Saiura A, Takayama T, Miyagawa S, et al
    Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial.
    PLoS One. 2016;11:e0162400.
    PubMed     Abstract available

  856. RACHAKONDA V, Borhani AA, Dunn MA, Andrzejewski M, et al
    Serum Leptin Is a Biomarker of Malnutrition in Decompensated Cirrhosis.
    PLoS One. 2016;11:e0159142.
    PubMed     Abstract available

  857. SANSOE G, Aragno M, Mastrocola R, Mengozzi G, et al
    Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data.
    PLoS One. 2016;11:e0162644.
    PubMed     Abstract available

  858. LIU Y, Zhang S, Zhao Y, Du J, et al
    Development and Application of the Chinese (Mainland) Version of Chronic Liver Disease Questionnaire to Assess the Health-Related Quality of Life (HRQoL) in Patients with Chronic Hepatitis B.
    PLoS One. 2016;11:e0162763.
    PubMed     Abstract available

  859. CHANG M, Tang H, Liu D, Li Y, et al
    Comparison of Melatonin, Hypertonic Saline, and Hydroxyethyl Starch for Resuscitation of Secondary Intra-Abdominal Hypertension in an Animal Model.
    PLoS One. 2016;11:e0161688.
    PubMed     Abstract available

  860. PELUSI S, Petta S, Rosso C, Borroni V, et al
    Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0163069.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.